id	sid	tid	token	lemma	pos
chd-73	1	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-73	1	2	e1	e1	NOUN
chd-73	1	3	cancer	cancer	NOUN
chd-73	1	4	health	health	NOUN
chd-73	1	5	disparities	disparity	NOUN
chd-73	1	6	research	research	VERB
chd-73	1	7	notch	notch	NOUN
chd-73	1	8	as	as	ADP
chd-73	1	9	an	an	DET
chd-73	1	10	immunologic	immunologic	ADJ
chd-73	1	11	basis	basis	NOUN
chd-73	1	12	of	of	ADP
chd-73	1	13	cancer	cancer	NOUN
chd-73	1	14	disparities	disparity	NOUN
chd-73	1	15	portia	portia	PROPN
chd-73	1	16	laliah	laliah	PROPN
chd-73	1	17	thomas1,2,3	thomas1,2,3	PROPN
chd-73	1	18	and	and	CCONJ
chd-73	1	19	anil	anil	PROPN
chd-73	1	20	shanker1,3,4,5,*1	shanker1,3,4,5,*1	PROPN
chd-73	1	21	1department	1department	PROPN
chd-73	1	22	of	of	ADP
chd-73	1	23	biochemistry	biochemistry	NOUN
chd-73	1	24	,	,	PUNCT
chd-73	1	25	cancer	cancer	NOUN
chd-73	1	26	biology	biology	NOUN
chd-73	1	27	,	,	PUNCT
chd-73	1	28	neuroscience	neuroscience	NOUN
chd-73	1	29	and	and	CCONJ
chd-73	1	30	pharmacology	pharmacology	NOUN
chd-73	1	31	,	,	PUNCT
chd-73	1	32	school	school	NOUN
chd-73	1	33	of	of	ADP
chd-73	1	34	medicine	medicine	NOUN
chd-73	1	35	,	,	PUNCT
chd-73	1	36	meharry	meharry	PROPN
chd-73	1	37	medical	medical	PROPN
chd-73	1	38	college	college	PROPN
chd-73	1	39	,	,	PUNCT
chd-73	1	40	nashville	nashville	PROPN
chd-73	1	41	,	,	PUNCT
chd-73	1	42	tn	tn	PROPN
chd-73	1	43	,	,	PUNCT
chd-73	1	44	usa	usa	PROPN
chd-73	1	45	2department	2department	NUM
chd-73	1	46	of	of	ADP
chd-73	1	47	microbiology	microbiology	NOUN
chd-73	1	48	,	,	PUNCT
chd-73	1	49	immunology	immunology	NOUN
chd-73	1	50	and	and	CCONJ
chd-73	1	51	physiology	physiology	NOUN
chd-73	1	52	,	,	PUNCT
chd-73	1	53	school	school	NOUN
chd-73	1	54	of	of	ADP
chd-73	1	55	medicine	medicine	NOUN
chd-73	1	56	,	,	PUNCT
chd-73	1	57	meharry	meharry	PROPN
chd-73	1	58	medical	medical	PROPN
chd-73	1	59	college	college	PROPN
chd-73	1	60	,	,	PUNCT
chd-73	1	61	nashville	nashville	PROPN
chd-73	1	62	,	,	PUNCT
chd-73	1	63	tn	tn	PROPN
chd-73	1	64	,	,	PUNCT
chd-73	1	65	usa	usa	PROPN
chd-73	1	66	3school	3school	PROPN
chd-73	1	67	of	of	ADP
chd-73	1	68	graduate	graduate	NOUN
chd-73	1	69	studies	study	NOUN
chd-73	1	70	and	and	CCONJ
chd-73	1	71	research	research	NOUN
chd-73	1	72	,	,	PUNCT
chd-73	1	73	meharry	meharry	PROPN
chd-73	1	74	medical	medical	PROPN
chd-73	1	75	college	college	PROPN
chd-73	1	76	,	,	PUNCT
chd-73	1	77	nashville	nashville	PROPN
chd-73	1	78	,	,	PUNCT
chd-73	1	79	tn	tn	PROPN
chd-73	1	80	,	,	PUNCT
chd-73	1	81	usa	usa	PROPN
chd-73	1	82	4host	4host	PROPN
chd-73	1	83	–	–	PUNCT
chd-73	1	84	tumor	tumor	NOUN
chd-73	1	85	interactions	interaction	NOUN
chd-73	1	86	research	research	NOUN
chd-73	1	87	program	program	NOUN
chd-73	1	88	,	,	PUNCT
chd-73	1	89	vanderbilt	vanderbilt	PROPN
chd-73	1	90	-	-	PUNCT
chd-73	1	91	ingram	ingram	PROPN
chd-73	1	92	comprehensive	comprehensive	ADJ
chd-73	1	93	cancer	cancer	NOUN
chd-73	1	94	center	center	NOUN
chd-73	1	95	,	,	PUNCT
chd-73	1	96	vanderbilt	vanderbilt	PROPN
chd-73	1	97	university	university	PROPN
chd-73	1	98	school	school	NOUN
chd-73	1	99	of	of	ADP
chd-73	1	100	medicine	medicine	NOUN
chd-73	1	101	,	,	PUNCT
chd-73	1	102	nashville	nashville	PROPN
chd-73	1	103	,	,	PUNCT
chd-73	1	104	tn	tn	PROPN
chd-73	1	105	,	,	PUNCT
chd-73	1	106	usa	usa	PROPN
chd-73	1	107	5vanderbilt	5vanderbilt	PROPN
chd-73	1	108	institute	institute	NOUN
chd-73	1	109	for	for	ADP
chd-73	1	110	infection	infection	NOUN
chd-73	1	111	,	,	PUNCT
chd-73	1	112	immunology	immunology	NOUN
chd-73	1	113	and	and	CCONJ
chd-73	1	114	inflammation	inflammation	NOUN
chd-73	1	115	,	,	PUNCT
chd-73	1	116	vanderbilt	vanderbilt	PROPN
chd-73	1	117	university	university	PROPN
chd-73	1	118	school	school	NOUN
chd-73	1	119	of	of	ADP
chd-73	1	120	medicine	medicine	NOUN
chd-73	1	121	,	,	PUNCT
chd-73	1	122	nashville	nashville	PROPN
chd-73	1	123	,	,	PUNCT
chd-73	1	124	tn	tn	PROPN
chd-73	1	125	,	,	PUNCT
chd-73	1	126	usa	usa	PROPN
chd-73	1	127	*	*	PUNCT
chd-73	1	128	corresponding	correspond	VERB
chd-73	1	129	author	author	NOUN
chd-73	1	130	:	:	PUNCT
chd-73	1	131	email	email	NOUN
chd-73	1	132	:	:	PUNCT
chd-73	1	133	ashanker@mmc.edu	ashanker@mmc.edu	X
chd-73	2	1	abstract	abstract	ADJ
chd-73	2	2	inter	inter	ADJ
chd-73	2	3	-	-	ADJ
chd-73	2	4	individual	individual	ADJ
chd-73	2	5	differences	difference	NOUN
chd-73	2	6	due	due	ADP
chd-73	2	7	to	to	ADP
chd-73	2	8	racial	racial	ADJ
chd-73	2	9	/	/	SYM
chd-73	2	10	ethnic	ethnic	ADJ
chd-73	2	11	backgrounds	background	NOUN
chd-73	2	12	may	may	AUX
chd-73	2	13	alter	alter	VERB
chd-73	2	14	host	host	NOUN
chd-73	2	15	immunity	immunity	NOUN
chd-73	2	16	responsible	responsible	ADJ
chd-73	2	17	for	for	ADP
chd-73	2	18	the	the	DET
chd-73	2	19	cancer	cancer	NOUN
chd-73	2	20	immunosurveillance	immunosurveillance	NOUN
chd-73	2	21	and	and	CCONJ
chd-73	2	22	elimination	elimination	NOUN
chd-73	2	23	,	,	PUNCT
chd-73	2	24	leading	lead	VERB
chd-73	2	25	to	to	ADP
chd-73	2	26	disparate	disparate	ADJ
chd-73	2	27	cancer	cancer	NOUN
chd-73	2	28	incidence	incidence	NOUN
chd-73	2	29	and	and	CCONJ
chd-73	2	30	relapse	relapse	NOUN
chd-73	2	31	.	.	PUNCT
chd-73	3	1	one	one	NUM
chd-73	3	2	basis	basis	NOUN
chd-73	3	3	of	of	ADP
chd-73	3	4	disparity	disparity	NOUN
chd-73	3	5	in	in	ADP
chd-73	3	6	tumor	tumor	NOUN
chd-73	3	7	incidence	incidence	NOUN
chd-73	3	8	,	,	PUNCT
chd-73	3	9	progression	progression	NOUN
chd-73	3	10	or	or	CCONJ
chd-73	3	11	therapeutic	therapeutic	ADJ
chd-73	3	12	outcomes	outcome	NOUN
chd-73	3	13	could	could	AUX
chd-73	3	14	lie	lie	VERB
chd-73	3	15	in	in	ADP
chd-73	3	16	the	the	DET
chd-73	3	17	components	component	NOUN
chd-73	3	18	of	of	ADP
chd-73	3	19	notch	notch	ADJ
chd-73	3	20	intercellular	intercellular	ADJ
chd-73	3	21	communication	communication	NOUN
chd-73	3	22	system	system	NOUN
chd-73	3	23	,	,	PUNCT
chd-73	3	24	which	which	PRON
chd-73	3	25	provide	provide	VERB
chd-73	3	26	instructive	instructive	ADJ
chd-73	3	27	signals	signal	NOUN
chd-73	3	28	for	for	ADP
chd-73	3	29	a	a	DET
chd-73	3	30	variety	variety	NOUN
chd-73	3	31	of	of	ADP
chd-73	3	32	pathways	pathway	NOUN
chd-73	3	33	regulating	regulate	VERB
chd-73	3	34	cell	cell	NOUN
chd-73	3	35	commitment	commitment	NOUN
chd-73	3	36	and	and	CCONJ
chd-73	3	37	differentiation	differentiation	NOUN
chd-73	3	38	including	include	VERB
chd-73	3	39	context	context	NOUN
chd-73	3	40	-	-	PUNCT
chd-73	3	41	dependent	dependent	ADJ
chd-73	3	42	lymphocyte	lymphocyte	ADJ
chd-73	3	43	polarization	polarization	NOUN
chd-73	3	44	in	in	ADP
chd-73	3	45	tumor	tumor	NOUN
chd-73	3	46	microenvironment	microenvironment	NOUN
chd-73	3	47	.	.	PUNCT
chd-73	4	1	notch	notch	NOUN
chd-73	4	2	signaling	signal	VERB
chd-73	4	3	in	in	ADP
chd-73	4	4	hematopoietic	hematopoietic	ADJ
chd-73	4	5	cells	cell	NOUN
chd-73	4	6	is	be	AUX
chd-73	4	7	perturbed	perturb	VERB
chd-73	4	8	by	by	ADP
chd-73	4	9	tumor	tumor	NOUN
chd-73	4	10	growth	growth	NOUN
chd-73	4	11	for	for	ADP
chd-73	4	12	its	its	PRON
chd-73	4	13	advantage	advantage	NOUN
chd-73	4	14	,	,	PUNCT
chd-73	4	15	and	and	CCONJ
chd-73	4	16	there	there	PRON
chd-73	4	17	are	be	VERB
chd-73	4	18	indications	indication	NOUN
chd-73	4	19	that	that	SCONJ
chd-73	4	20	differences	difference	NOUN
chd-73	4	21	in	in	ADP
chd-73	4	22	notch	notch	ADJ
chd-73	4	23	components	component	NOUN
chd-73	4	24	could	could	AUX
chd-73	4	25	underlie	underlie	VERB
chd-73	4	26	poor	poor	ADJ
chd-73	4	27	cancer	cancer	NOUN
chd-73	4	28	prognosis	prognosis	NOUN
chd-73	4	29	in	in	ADP
chd-73	4	30	certain	certain	ADJ
chd-73	4	31	populations	population	NOUN
chd-73	4	32	.	.	PUNCT
chd-73	5	1	here	here	ADV
chd-73	5	2	,	,	PUNCT
chd-73	5	3	we	we	PRON
chd-73	5	4	discuss	discuss	VERB
chd-73	5	5	the	the	DET
chd-73	5	6	oncogenic	oncogenic	ADJ
chd-73	5	7	and	and	CCONJ
chd-73	5	8	immunologic	immunologic	ADJ
chd-73	5	9	aspects	aspect	NOUN
chd-73	5	10	of	of	ADP
chd-73	5	11	notch	notch	NOUN
chd-73	5	12	,	,	PUNCT
chd-73	5	13	which	which	PRON
chd-73	5	14	should	should	AUX
chd-73	5	15	inform	inform	VERB
chd-73	5	16	on	on	ADP
chd-73	5	17	cancer	cancer	NOUN
chd-73	5	18	health	health	NOUN
chd-73	5	19	disparities	disparity	NOUN
chd-73	5	20	and	and	CCONJ
chd-73	5	21	therapeutic	therapeutic	ADJ
chd-73	5	22	outcomes	outcome	NOUN
chd-73	5	23	.	.	PUNCT
chd-73	6	1	keywords	keyword	NOUN
chd-73	6	2	:	:	PUNCT
chd-73	6	3	cancer	cancer	NOUN
chd-73	6	4	immunity	immunity	NOUN
chd-73	6	5	,	,	PUNCT
chd-73	6	6	health	health	NOUN
chd-73	6	7	disparity	disparity	NOUN
chd-73	6	8	,	,	PUNCT
chd-73	6	9	notch	notch	ADJ
chd-73	6	10	,	,	PUNCT
chd-73	6	11	lymphocytes	lymphocyte	NOUN
chd-73	6	12	,	,	PUNCT
chd-73	6	13	immunosurveillance	immunosurveillance	NOUN
chd-73	6	14	,	,	PUNCT
chd-73	6	15	immunotherapy	immunotherapy	NOUN
chd-73	6	16	citation	citation	NOUN
chd-73	6	17	:	:	PUNCT
chd-73	6	18	thomas	thomas	PROPN
chd-73	6	19	pl	pl	PROPN
chd-73	6	20	,	,	PUNCT
chd-73	6	21	shanker	shanker	PROPN
chd-73	6	22	a	a	PRON
chd-73	6	23	(	(	PUNCT
chd-73	6	24	2019	2019	NUM
chd-73	6	25	)	)	PUNCT
chd-73	6	26	notch	notch	NOUN
chd-73	6	27	as	as	ADP
chd-73	6	28	an	an	DET
chd-73	6	29	immunologic	immunologic	ADJ
chd-73	6	30	basis	basis	NOUN
chd-73	6	31	of	of	ADP
chd-73	6	32	cancer	cancer	NOUN
chd-73	6	33	disparities	disparity	NOUN
chd-73	6	34	.	.	PUNCT
chd-73	7	1	cancer	cancer	NOUN
chd-73	7	2	health	health	NOUN
chd-73	7	3	disparities	disparity	NOUN
chd-73	7	4	3	3	NUM
chd-73	7	5	:	:	PUNCT
chd-73	7	6	e1	e1	NOUN
chd-73	7	7	-	-	PUNCT
chd-73	7	8	e-10	e-10	PROPN
chd-73	7	9	.	.	PUNCT
chd-73	7	10	doi:10.9777	doi:10.9777	PROPN
chd-73	7	11	/	/	SYM
chd-73	7	12	chd.2019.1006	chd.2019.1006	PROPN
chd-73	7	13	.	.	PUNCT
chd-73	7	14	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-73	7	15	e2	e2	PROPN
chd-73	7	16	cancer	cancer	NOUN
chd-73	7	17	health	health	NOUN
chd-73	7	18	disparities	disparity	NOUN
chd-73	7	19	research	research	NOUN
chd-73	7	20	introduction	introduction	NOUN
chd-73	7	21	immunologic	immunologic	ADJ
chd-73	7	22	basis	basis	NOUN
chd-73	7	23	of	of	ADP
chd-73	7	24	racial	racial	ADJ
chd-73	7	25	disparities	disparity	NOUN
chd-73	7	26	racial	racial	ADJ
chd-73	7	27	disparities	disparity	NOUN
chd-73	7	28	in	in	ADP
chd-73	7	29	cancer	cancer	NOUN
chd-73	7	30	are	be	AUX
chd-73	7	31	well	well	ADV
chd-73	7	32	documented	document	VERB
chd-73	7	33	in	in	ADP
chd-73	7	34	various	various	ADJ
chd-73	7	35	solid	solid	ADJ
chd-73	7	36	cancers	cancer	NOUN
chd-73	7	37	.	.	PUNCT
chd-73	8	1	this	this	DET
chd-73	8	2	disparity	disparity	NOUN
chd-73	8	3	is	be	AUX
chd-73	8	4	particularly	particularly	ADV
chd-73	8	5	evident	evident	ADJ
chd-73	8	6	in	in	ADP
chd-73	8	7	breast	breast	NOUN
chd-73	8	8	cancer	cancer	NOUN
chd-73	8	9	,	,	PUNCT
chd-73	8	10	where	where	SCONJ
chd-73	8	11	paradoxically	paradoxically	ADV
chd-73	8	12	,	,	PUNCT
chd-73	8	13	the	the	DET
chd-73	8	14	mortality	mortality	NOUN
chd-73	8	15	rates	rate	NOUN
chd-73	8	16	in	in	ADP
chd-73	8	17	african	african	ADJ
chd-73	8	18	-	-	PUNCT
chd-73	8	19	american	american	PROPN
chd-73	8	20	compared	compare	VERB
chd-73	8	21	to	to	ADP
chd-73	8	22	white	white	ADJ
chd-73	8	23	american	american	PROPN
chd-73	8	24	/	/	SYM
chd-73	8	25	caucasian	caucasian	ADJ
chd-73	8	26	women	woman	NOUN
chd-73	8	27	are	be	AUX
chd-73	8	28	considerably	considerably	ADV
chd-73	8	29	higher	high	ADJ
chd-73	8	30	despite	despite	SCONJ
chd-73	8	31	lower	low	ADJ
chd-73	8	32	lifetime	lifetime	NOUN
chd-73	8	33	incidence	incidence	NOUN
chd-73	8	34	rates	rate	NOUN
chd-73	8	35	of	of	ADP
chd-73	8	36	breast	breast	NOUN
chd-73	8	37	cancer	cancer	NOUN
chd-73	8	38	(	(	PUNCT
chd-73	8	39	fregene	fregene	NOUN
chd-73	8	40	and	and	CCONJ
chd-73	8	41	newman	newman	PROPN
chd-73	8	42	,	,	PUNCT
chd-73	8	43	2005	2005	NUM
chd-73	8	44	;	;	PUNCT
chd-73	8	45	howlader	howlader	NOUN
chd-73	8	46	et	et	PROPN
chd-73	8	47	al	al	PROPN
chd-73	8	48	.	.	PROPN
chd-73	8	49	,	,	PUNCT
chd-73	8	50	2018	2018	NUM
chd-73	8	51	)	)	PUNCT
chd-73	8	52	.	.	PUNCT
chd-73	9	1	although	although	SCONJ
chd-73	9	2	many	many	ADJ
chd-73	9	3	differences	difference	NOUN
chd-73	9	4	in	in	ADP
chd-73	9	5	breast	breast	NOUN
chd-73	9	6	cancer	cancer	NOUN
chd-73	9	7	incidence	incidence	NOUN
chd-73	9	8	/	/	SYM
chd-73	9	9	outcome	outcome	NOUN
chd-73	9	10	can	can	AUX
chd-73	9	11	be	be	AUX
chd-73	9	12	explained	explain	VERB
chd-73	9	13	by	by	ADP
chd-73	9	14	socioeconomic	socioeconomic	ADJ
chd-73	9	15	disadvantages	disadvantage	NOUN
chd-73	9	16	,	,	PUNCT
chd-73	9	17	recent	recent	ADJ
chd-73	9	18	studies	study	NOUN
chd-73	9	19	have	have	AUX
chd-73	9	20	broadened	broaden	VERB
chd-73	9	21	our	our	PRON
chd-73	9	22	understanding	understanding	NOUN
chd-73	9	23	of	of	ADP
chd-73	9	24	the	the	DET
chd-73	9	25	correlation	correlation	NOUN
chd-73	9	26	of	of	ADP
chd-73	9	27	genetic	genetic	ADJ
chd-73	9	28	mutations	mutation	NOUN
chd-73	9	29	and	and	CCONJ
chd-73	9	30	ancestry	ancestry	NOUN
chd-73	9	31	with	with	ADP
chd-73	9	32	race	race	NOUN
chd-73	9	33	/	/	SYM
chd-73	9	34	ethnic	ethnic	ADJ
chd-73	9	35	-	-	PUNCT
chd-73	9	36	associated	associate	VERB
chd-73	9	37	disparities	disparity	NOUN
chd-73	9	38	.	.	PUNCT
chd-73	10	1	it	it	PRON
chd-73	10	2	is	be	AUX
chd-73	10	3	crucial	crucial	ADJ
chd-73	10	4	to	to	PART
chd-73	10	5	note	note	VERB
chd-73	10	6	that	that	SCONJ
chd-73	10	7	genetics	genetic	NOUN
chd-73	10	8	not	not	PART
chd-73	10	9	only	only	ADV
chd-73	10	10	affects	affect	VERB
chd-73	10	11	cancer	cancer	NOUN
chd-73	10	12	susceptibility	susceptibility	NOUN
chd-73	10	13	but	but	CCONJ
chd-73	10	14	the	the	DET
chd-73	10	15	immune	immune	ADJ
chd-73	10	16	response	response	NOUN
chd-73	10	17	to	to	ADP
chd-73	10	18	cancer	cancer	NOUN
chd-73	10	19	as	as	ADV
chd-73	10	20	well	well	ADV
chd-73	10	21	.	.	PUNCT
chd-73	11	1	it	it	PRON
chd-73	11	2	has	have	AUX
chd-73	11	3	long	long	ADV
chd-73	11	4	been	be	AUX
chd-73	11	5	recognized	recognize	VERB
chd-73	11	6	that	that	SCONJ
chd-73	11	7	lymphocytes	lymphocyte	VERB
chd-73	11	8	,	,	PUNCT
chd-73	11	9	specifically	specifically	ADV
chd-73	11	10	natural	natural	ADJ
chd-73	11	11	killer	killer	NOUN
chd-73	11	12	(	(	PUNCT
chd-73	11	13	nk	nk	PROPN
chd-73	11	14	)	)	PUNCT
chd-73	11	15	cells	cell	NOUN
chd-73	11	16	and	and	CCONJ
chd-73	11	17	t	t	NOUN
chd-73	11	18	cells	cell	NOUN
chd-73	11	19	,	,	PUNCT
chd-73	11	20	differ	differ	VERB
chd-73	11	21	significantly	significantly	ADV
chd-73	11	22	in	in	ADP
chd-73	11	23	their	their	PRON
chd-73	11	24	ability	ability	NOUN
chd-73	11	25	to	to	PART
chd-73	11	26	mediate	mediate	VERB
chd-73	11	27	effector	effector	NOUN
chd-73	11	28	responses	response	NOUN
chd-73	11	29	depending	depend	VERB
chd-73	11	30	on	on	ADP
chd-73	11	31	the	the	DET
chd-73	11	32	genetic	genetic	ADJ
chd-73	11	33	constitution	constitution	NOUN
chd-73	11	34	of	of	ADP
chd-73	11	35	an	an	DET
chd-73	11	36	individual	individual	NOUN
chd-73	11	37	.	.	PUNCT
chd-73	12	1	the	the	DET
chd-73	12	2	major	major	ADJ
chd-73	12	3	histocompatibility	histocompatibility	NOUN
chd-73	12	4	and	and	CCONJ
chd-73	12	5	the	the	DET
chd-73	12	6	leukocyte	leukocyte	NOUN
chd-73	12	7	receptor	receptor	NOUN
chd-73	12	8	complexes	complex	NOUN
chd-73	12	9	are	be	AUX
chd-73	12	10	the	the	DET
chd-73	12	11	two	two	NUM
chd-73	12	12	most	most	ADV
chd-73	12	13	polymorphic	polymorphic	ADJ
chd-73	12	14	regions	region	NOUN
chd-73	12	15	of	of	ADP
chd-73	12	16	the	the	DET
chd-73	12	17	immune	immune	ADJ
chd-73	12	18	genome	genome	NOUN
chd-73	12	19	.	.	PUNCT
chd-73	13	1	individuals	individual	NOUN
chd-73	13	2	with	with	ADP
chd-73	13	3	increasingly	increasingly	ADV
chd-73	13	4	diverse	diverse	ADJ
chd-73	13	5	repertoires	repertoire	NOUN
chd-73	13	6	of	of	ADP
chd-73	13	7	mhc	mhc	PROPN
chd-73	13	8	class	class	PROPN
chd-73	13	9	-	-	PUNCT
chd-73	13	10	i	i	PRON
chd-73	13	11	molecules	molecule	NOUN
chd-73	13	12	have	have	VERB
chd-73	13	13	a	a	DET
chd-73	13	14	greater	great	ADJ
chd-73	13	15	potential	potential	NOUN
chd-73	13	16	for	for	SCONJ
chd-73	13	17	their	their	PRON
chd-73	13	18	nk	nk	PROPN
chd-73	13	19	cells	cell	NOUN
chd-73	13	20	to	to	PART
chd-73	13	21	be	be	AUX
chd-73	13	22	more	more	ADV
chd-73	13	23	responsive	responsive	ADJ
chd-73	13	24	.	.	PUNCT
chd-73	14	1	this	this	PRON
chd-73	14	2	is	be	AUX
chd-73	14	3	evident	evident	ADJ
chd-73	14	4	from	from	ADP
chd-73	14	5	the	the	DET
chd-73	14	6	differential	differential	ADJ
chd-73	14	7	susceptibility	susceptibility	NOUN
chd-73	14	8	of	of	ADP
chd-73	14	9	some	some	DET
chd-73	14	10	individuals	individual	NOUN
chd-73	14	11	to	to	ADP
chd-73	14	12	hiv	hiv	PROPN
chd-73	14	13	infection	infection	NOUN
chd-73	14	14	and	and	CCONJ
chd-73	14	15	their	their	PRON
chd-73	14	16	wide	wide	ADJ
chd-73	14	17	range	range	NOUN
chd-73	14	18	of	of	ADP
chd-73	14	19	asymptomatic	asymptomatic	ADJ
chd-73	14	20	phase	phase	NOUN
chd-73	14	21	(	(	PUNCT
chd-73	14	22	kulkarni	kulkarni	PROPN
chd-73	14	23	et	et	PROPN
chd-73	14	24	al	al	PROPN
chd-73	14	25	.	.	PROPN
chd-73	14	26	,	,	PUNCT
chd-73	14	27	2009	2009	NUM
chd-73	14	28	;	;	PUNCT
chd-73	14	29	martin	martin	PROPN
chd-73	14	30	et	et	PROPN
chd-73	14	31	al	al	PROPN
chd-73	14	32	.	.	PROPN
chd-73	14	33	,	,	PUNCT
chd-73	14	34	2018	2018	NUM
chd-73	14	35	;	;	PUNCT
chd-73	14	36	ramsuran	ramsuran	VERB
chd-73	14	37	et	et	PROPN
chd-73	14	38	al	al	PROPN
chd-73	14	39	.	.	PROPN
chd-73	14	40	,	,	PUNCT
chd-73	14	41	2018	2018	NUM
chd-73	14	42	)	)	PUNCT
chd-73	14	43	.	.	PUNCT
chd-73	15	1	the	the	DET
chd-73	15	2	underlying	underlying	ADJ
chd-73	15	3	mechanism	mechanism	NOUN
chd-73	15	4	of	of	ADP
chd-73	15	5	the	the	DET
chd-73	15	6	differences	difference	NOUN
chd-73	15	7	in	in	ADP
chd-73	15	8	lymphocyte	lymphocyte	ADJ
chd-73	15	9	effector	effector	NOUN
chd-73	15	10	responses	response	NOUN
chd-73	15	11	against	against	ADP
chd-73	15	12	tumor	tumor	NOUN
chd-73	15	13	in	in	ADP
chd-73	15	14	disparate	disparate	ADJ
chd-73	15	15	populations	population	NOUN
chd-73	15	16	could	could	AUX
chd-73	15	17	involve	involve	VERB
chd-73	15	18	differential	differential	ADJ
chd-73	15	19	expression	expression	NOUN
chd-73	15	20	of	of	ADP
chd-73	15	21	inhibitory	inhibitory	NOUN
chd-73	15	22	and	and	CCONJ
chd-73	15	23	activating	activate	VERB
chd-73	15	24	receptors	receptor	NOUN
chd-73	15	25	on	on	ADP
chd-73	15	26	lymphocytes	lymphocyte	NOUN
chd-73	15	27	.	.	PUNCT
chd-73	16	1	one	one	NUM
chd-73	16	2	of	of	ADP
chd-73	16	3	these	these	DET
chd-73	16	4	receptors	receptor	NOUN
chd-73	16	5	belongs	belong	VERB
chd-73	16	6	to	to	ADP
chd-73	16	7	the	the	DET
chd-73	16	8	notch	notch	ADJ
chd-73	16	9	family	family	NOUN
chd-73	16	10	,	,	PUNCT
chd-73	16	11	which	which	PRON
chd-73	16	12	offers	offer	VERB
chd-73	16	13	a	a	DET
chd-73	16	14	major	major	ADJ
chd-73	16	15	juxtacrine	juxtacrine	ADJ
chd-73	16	16	signaling	signal	VERB
chd-73	16	17	system	system	NOUN
chd-73	16	18	that	that	PRON
chd-73	16	19	allows	allow	VERB
chd-73	16	20	cellular	cellular	ADJ
chd-73	16	21	crosstalk	crosstalk	NOUN
chd-73	16	22	to	to	ADP
chd-73	16	23	program	program	NOUN
chd-73	16	24	almost	almost	ADV
chd-73	16	25	every	every	PRON
chd-73	16	26	cell	cell	NOUN
chd-73	16	27	type	type	NOUN
chd-73	16	28	in	in	ADP
chd-73	16	29	the	the	DET
chd-73	16	30	body	body	NOUN
chd-73	16	31	.	.	PUNCT
chd-73	17	1	notch	notch	NOUN
chd-73	17	2	signaling	signal	VERB
chd-73	17	3	is	be	AUX
chd-73	17	4	highly	highly	ADV
chd-73	17	5	conserved	conserve	VERB
chd-73	17	6	evolutionarily	evolutionarily	ADV
chd-73	17	7	as	as	SCONJ
chd-73	17	8	it	it	PRON
chd-73	17	9	is	be	AUX
chd-73	17	10	important	important	ADJ
chd-73	17	11	for	for	ADP
chd-73	17	12	cell	cell	NOUN
chd-73	17	13	-	-	PUNCT
chd-73	17	14	to	to	ADP
chd-73	17	15	-	-	PUNCT
chd-73	17	16	cell	cell	NOUN
chd-73	17	17	communication	communication	NOUN
chd-73	17	18	for	for	ADP
chd-73	17	19	tissue	tissue	NOUN
chd-73	17	20	patterning	patterning	NOUN
chd-73	17	21	during	during	ADP
chd-73	17	22	embryonic	embryonic	ADJ
chd-73	17	23	development	development	NOUN
chd-73	17	24	.	.	PUNCT
chd-73	18	1	mammals	mammal	NOUN
chd-73	18	2	express	express	VERB
chd-73	18	3	four	four	NUM
chd-73	18	4	notch	notch	ADJ
chd-73	18	5	receptors	receptor	NOUN
chd-73	18	6	(	(	PUNCT
chd-73	18	7	notch	notch	VERB
chd-73	18	8	1	1	NUM
chd-73	18	9	-	-	SYM
chd-73	18	10	4	4	NUM
chd-73	18	11	)	)	PUNCT
chd-73	18	12	,	,	PUNCT
chd-73	18	13	which	which	PRON
chd-73	18	14	can	can	AUX
chd-73	18	15	bind	bind	VERB
chd-73	18	16	to	to	ADP
chd-73	18	17	five	five	NUM
chd-73	18	18	canonical	canonical	ADJ
chd-73	18	19	transmembrane	transmembrane	NOUN
chd-73	18	20	ligands	ligand	NOUN
chd-73	18	21	from	from	ADP
chd-73	18	22	two	two	NUM
chd-73	18	23	paralogous	paralogous	ADJ
chd-73	18	24	gene	gene	NOUN
chd-73	18	25	families	family	NOUN
chd-73	18	26	–	–	PUNCT
chd-73	18	27	delta	delta	NOUN
chd-73	18	28	-	-	PUNCT
chd-73	18	29	like	like	ADJ
chd-73	18	30	(	(	PUNCT
chd-73	18	31	dll1	dll1	PROPN
chd-73	18	32	,	,	PUNCT
chd-73	18	33	dll3	dll3	PROPN
chd-73	18	34	,	,	PUNCT
chd-73	18	35	dll4	dll4	PROPN
chd-73	18	36	)	)	PUNCT
chd-73	18	37	and	and	CCONJ
chd-73	18	38	jagged	jagged	ADJ
chd-73	18	39	(	(	PUNCT
chd-73	18	40	jag1	jag1	NOUN
chd-73	18	41	and	and	CCONJ
chd-73	18	42	jag2	jag2	PROPN
chd-73	18	43	)	)	PUNCT
chd-73	18	44	(	(	PUNCT
chd-73	18	45	andersson	andersson	PROPN
chd-73	18	46	et	et	PROPN
chd-73	18	47	al	al	PROPN
chd-73	18	48	.	.	PROPN
chd-73	18	49	,	,	PUNCT
chd-73	18	50	2011	2011	NUM
chd-73	18	51	;	;	PUNCT
chd-73	18	52	radtke	radtke	VERB
chd-73	18	53	et	et	PROPN
chd-73	18	54	al	al	PROPN
chd-73	18	55	.	.	PROPN
chd-73	18	56	,	,	PUNCT
chd-73	18	57	2010	2010	NUM
chd-73	18	58	;	;	PUNCT
chd-73	18	59	yuan	yuan	NOUN
chd-73	18	60	et	et	PROPN
chd-73	18	61	al	al	PROPN
chd-73	18	62	.	.	PROPN
chd-73	18	63	,	,	PUNCT
chd-73	18	64	2010	2010	NUM
chd-73	18	65	)	)	PUNCT
chd-73	18	66	.	.	PUNCT
chd-73	19	1	the	the	DET
chd-73	19	2	delta	delta	NOUN
chd-73	19	3	ligands	ligand	NOUN
chd-73	19	4	transactivate	transactivate	VERB
chd-73	19	5	notch	notch	NOUN
chd-73	19	6	amongst	amongst	ADP
chd-73	19	7	neighboring	neighboring	NOUN
chd-73	19	8	cells	cell	NOUN
chd-73	19	9	and	and	CCONJ
chd-73	19	10	cis	cis	NOUN
chd-73	19	11	-	-	PUNCT
chd-73	19	12	inhibit	inhibit	NOUN
chd-73	19	13	notch	notch	NOUN
chd-73	19	14	in	in	ADP
chd-73	19	15	its	its	PRON
chd-73	19	16	own	own	ADJ
chd-73	19	17	cells	cell	NOUN
chd-73	19	18	following	follow	VERB
chd-73	19	19	receptor	receptor	NOUN
chd-73	19	20	engagement	engagement	NOUN
chd-73	19	21	(	(	PUNCT
chd-73	19	22	crabtree	crabtree	PROPN
chd-73	19	23	et	et	PROPN
chd-73	19	24	al	al	PROPN
chd-73	19	25	.	.	PROPN
chd-73	19	26	,	,	PUNCT
chd-73	19	27	2016	2016	NUM
chd-73	19	28	;	;	PUNCT
chd-73	19	29	sprinzak	sprinzak	NOUN
chd-73	19	30	et	et	PROPN
chd-73	19	31	al	al	PROPN
chd-73	19	32	.	.	PROPN
chd-73	19	33	,	,	PUNCT
chd-73	19	34	2010	2010	NUM
chd-73	19	35	;	;	PUNCT
chd-73	19	36	yaron	yaron	PROPN
chd-73	19	37	and	and	CCONJ
chd-73	19	38	sprinzak	sprinzak	NOUN
chd-73	19	39	,	,	PUNCT
chd-73	19	40	2012	2012	NUM
chd-73	19	41	)	)	PUNCT
chd-73	19	42	.	.	PUNCT
chd-73	20	1	the	the	DET
chd-73	20	2	receptor	receptor	NOUN
chd-73	20	3	-	-	PUNCT
chd-73	20	4	ligand	ligand	NOUN
chd-73	20	5	interaction	interaction	NOUN
chd-73	20	6	between	between	ADP
chd-73	20	7	juxtaposing	juxtapose	VERB
chd-73	20	8	cells	cell	NOUN
chd-73	20	9	initiates	initiate	VERB
chd-73	20	10	a	a	DET
chd-73	20	11	cascade	cascade	NOUN
chd-73	20	12	of	of	ADP
chd-73	20	13	events	event	NOUN
chd-73	20	14	involving	involve	VERB
chd-73	20	15	transendocytosis	transendocytosis	ADJ
chd-73	20	16	,	,	PUNCT
chd-73	20	17	proteolytic	proteolytic	ADJ
chd-73	20	18	cleavages	cleavage	NOUN
chd-73	20	19	,	,	PUNCT
chd-73	20	20	ubiquitination	ubiquitination	NOUN
chd-73	20	21	and	and	CCONJ
chd-73	20	22	deubiquitination	deubiquitination	NOUN
chd-73	20	23	transforming	transform	VERB
chd-73	20	24	the	the	DET
chd-73	20	25	cell	cell	NOUN
chd-73	20	26	surface	surface	NOUN
chd-73	20	27	receptor	receptor	NOUN
chd-73	20	28	into	into	ADP
chd-73	20	29	a	a	DET
chd-73	20	30	nuclear	nuclear	ADJ
chd-73	20	31	factor	factor	NOUN
chd-73	20	32	acting	act	VERB
chd-73	20	33	on	on	ADP
chd-73	20	34	the	the	DET
chd-73	20	35	transcription	transcription	NOUN
chd-73	20	36	of	of	ADP
chd-73	20	37	several	several	ADJ
chd-73	20	38	target	target	NOUN
chd-73	20	39	genes	gene	NOUN
chd-73	20	40	.	.	PUNCT
chd-73	21	1	briefly	briefly	NOUN
chd-73	21	2	,	,	PUNCT
chd-73	21	3	a	a	DET
chd-73	21	4	conformational	conformational	ADJ
chd-73	21	5	change	change	NOUN
chd-73	21	6	in	in	ADP
chd-73	21	7	the	the	DET
chd-73	21	8	ligated	ligated	ADJ
chd-73	21	9	receptor	receptor	NOUN
chd-73	21	10	exposes	expose	VERB
chd-73	21	11	the	the	DET
chd-73	21	12	s2	s2	NOUN
chd-73	21	13	cleavage	cleavage	NOUN
chd-73	21	14	site	site	NOUN
chd-73	21	15	(	(	PUNCT
chd-73	21	16	12–13	12–13	NUM
chd-73	21	17	amino	amino	NOUN
chd-73	21	18	acids	acid	NOUN
chd-73	21	19	external	external	NOUN
chd-73	21	20	to	to	ADP
chd-73	21	21	the	the	DET
chd-73	21	22	transmembrane	transmembrane	NOUN
chd-73	21	23	domain	domain	NOUN
chd-73	21	24	)	)	PUNCT
chd-73	21	25	for	for	ADP
chd-73	21	26	proteolysis	proteolysis	NOUN
chd-73	21	27	by	by	ADP
chd-73	21	28	metalloproteases	metalloprotease	NOUN
chd-73	21	29	of	of	ADP
chd-73	21	30	the	the	DET
chd-73	21	31	disintegrin	disintegrin	NOUN
chd-73	21	32	-	-	PUNCT
chd-73	21	33	and	and	CCONJ
chd-73	21	34	-	-	PUNCT
chd-73	21	35	metalloproteinase	metalloproteinase	NOUN
chd-73	21	36	(	(	PUNCT
chd-73	21	37	adam	adam	PROPN
chd-73	21	38	)	)	PUNCT
chd-73	21	39	family	family	NOUN
chd-73	21	40	.	.	PUNCT
chd-73	22	1	the	the	DET
chd-73	22	2	notch	notch	ADJ
chd-73	22	3	extracellular	extracellular	ADJ
chd-73	22	4	domain	domain	NOUN
chd-73	22	5	is	be	AUX
chd-73	22	6	shed	shed	VERB
chd-73	22	7	and	and	CCONJ
chd-73	22	8	endocytosed	endocytose	VERB
chd-73	22	9	by	by	ADP
chd-73	22	10	the	the	DET
chd-73	22	11	ligand	ligand	NOUN
chd-73	22	12	-	-	PUNCT
chd-73	22	13	expressing	express	VERB
chd-73	22	14	cell	cell	NOUN
chd-73	22	15	(	(	PUNCT
chd-73	22	16	radtke	radtke	VERB
chd-73	22	17	et	et	PROPN
chd-73	22	18	al	al	PROPN
chd-73	22	19	.	.	PROPN
chd-73	22	20	,	,	PUNCT
chd-73	22	21	2010	2010	NUM
chd-73	22	22	)	)	PUNCT
chd-73	22	23	.	.	PUNCT
chd-73	23	1	after	after	ADP
chd-73	23	2	shedding	shed	VERB
chd-73	23	3	,	,	PUNCT
chd-73	23	4	the	the	DET
chd-73	23	5	transmembrane	transmembrane	ADJ
chd-73	23	6	domain	domain	NOUN
chd-73	23	7	is	be	AUX
chd-73	23	8	cleaved	cleave	VERB
chd-73	23	9	at	at	ADP
chd-73	23	10	the	the	DET
chd-73	23	11	s3	s3	PROPN
chd-73	23	12	site	site	NOUN
chd-73	23	13	by	by	ADP
chd-73	23	14	secretase	secretase	PROPN
chd-73	23	15	freeing	free	VERB
chd-73	23	16	the	the	DET
chd-73	23	17	notch	notch	ADJ
chd-73	23	18	intracellular	intracellular	ADJ
chd-73	23	19	domain	domain	NOUN
chd-73	23	20	(	(	PUNCT
chd-73	23	21	nicd	nicd	NOUN
chd-73	23	22	)	)	PUNCT
chd-73	23	23	.	.	PUNCT
chd-73	24	1	the	the	DET
chd-73	24	2	nicd	nicd	PROPN
chd-73	24	3	subsequently	subsequently	ADV
chd-73	24	4	traffics	traffic	NOUN
chd-73	24	5	to	to	ADP
chd-73	24	6	the	the	DET
chd-73	24	7	nucleus	nucleus	NOUN
chd-73	24	8	,	,	PUNCT
chd-73	24	9	heterodimerizing	heterodimerize	VERB
chd-73	24	10	with	with	ADP
chd-73	24	11	dna	dna	NOUN
chd-73	24	12	binding	bind	VERB
chd-73	24	13	transcription	transcription	NOUN
chd-73	24	14	factor	factor	NOUN
chd-73	24	15	cbf1	cbf1	PROPN
chd-73	24	16	/	/	SYM
chd-73	24	17	suppressor	suppressor	NOUN
chd-73	24	18	of	of	ADP
chd-73	24	19	hairless	hairless	NOUN
chd-73	24	20	/	/	SYM
chd-73	24	21	lag-1	lag-1	PUNCT
chd-73	24	22	(	(	PUNCT
chd-73	24	23	csl	csl	PROPN
chd-73	24	24	)	)	PUNCT
chd-73	24	25	.	.	PUNCT
chd-73	25	1	the	the	DET
chd-73	25	2	c	c	PROPN
chd-73	25	3	promoter	promoter	NOUN
chd-73	25	4	-	-	PUNCT
chd-73	25	5	binding	bind	VERB
chd-73	25	6	factor	factor	NOUN
chd-73	25	7	(	(	PUNCT
chd-73	25	8	cbf1	cbf1	PROPN
chd-73	25	9	)	)	PUNCT
chd-73	25	10	in	in	ADP
chd-73	25	11	humans	human	NOUN
chd-73	25	12	is	be	AUX
chd-73	25	13	also	also	ADV
chd-73	25	14	known	know	VERB
chd-73	25	15	as	as	ADP
chd-73	25	16	recombination	recombination	NOUN
chd-73	25	17	signal	signal	NOUN
chd-73	25	18	binding	bind	VERB
chd-73	25	19	protein	protein	NOUN
chd-73	25	20	for	for	ADP
chd-73	25	21	immunoglobulin	immunoglobulin	NOUN
chd-73	25	22			VERB
chd-73	25	23	j	j	PROPN
chd-73	25	24	region	region	NOUN
chd-73	25	25	(	(	PUNCT
chd-73	25	26	rbpj-	rbpj-	PROPN
chd-73	25	27	)	)	PUNCT
chd-73	25	28	or	or	CCONJ
chd-73	25	29	-binding	-binde	VERB
chd-73	25	30	factor	factor	NOUN
chd-73	25	31	2	2	NUM
chd-73	25	32	(	(	PUNCT
chd-73	25	33	kbf2	kbf2	PROPN
chd-73	25	34	)	)	PUNCT
chd-73	25	35	in	in	ADP
chd-73	25	36	mice	mouse	NOUN
chd-73	25	37	,	,	PUNCT
chd-73	25	38	as	as	ADP
chd-73	25	39	suppressor	suppressor	NOUN
chd-73	25	40	of	of	ADP
chd-73	25	41	hairless	hairless	NOUN
chd-73	25	42	[	[	X
chd-73	25	43	su(h	su(h	X
chd-73	25	44	)	)	PUNCT
chd-73	25	45	]	]	PUNCT
chd-73	25	46	in	in	ADP
chd-73	25	47	drosophila	drosophila	NOUN
chd-73	25	48	and	and	CCONJ
chd-73	25	49	longevity	longevity	NOUN
chd-73	25	50	-	-	PUNCT
chd-73	25	51	assurance	assurance	NOUN
chd-73	25	52	gene-1	gene-1	PROPN
chd-73	25	53	(	(	PUNCT
chd-73	25	54	lag-1	lag-1	X
chd-73	25	55	)	)	PUNCT
chd-73	25	56	in	in	ADP
chd-73	25	57	caenorhabditis	caenorhabditis	PROPN
chd-73	25	58	elegans	elegan	NOUN
chd-73	25	59	.	.	PUNCT
chd-73	26	1	the	the	DET
chd-73	26	2	csl	csl	PROPN
chd-73	26	3	-	-	PUNCT
chd-73	26	4	bound	bind	VERB
chd-73	26	5	nicd	nicd	NOUN
chd-73	26	6	recruits	recruit	VERB
chd-73	26	7	various	various	ADJ
chd-73	26	8	coactivators	coactivator	NOUN
chd-73	26	9	,	,	PUNCT
chd-73	26	10	including	include	VERB
chd-73	26	11	mastermind	mastermind	NOUN
chd-73	26	12	proteins	protein	NOUN
chd-73	26	13	(	(	PUNCT
chd-73	26	14	maml13	maml13	NOUN
chd-73	26	15	)	)	PUNCT
chd-73	26	16	,	,	PUNCT
chd-73	26	17	inducing	induce	VERB
chd-73	26	18	transcriptional	transcriptional	ADJ
chd-73	26	19	expression	expression	NOUN
chd-73	26	20	of	of	ADP
chd-73	26	21	notch	notch	ADJ
chd-73	26	22	downstream	downstream	ADJ
chd-73	26	23	target	target	NOUN
chd-73	26	24	genes	gene	NOUN
chd-73	26	25	hairy	hairy	ADJ
chd-73	26	26	enhancer	enhancer	NOUN
chd-73	26	27	of	of	ADP
chd-73	26	28	split	split	NOUN
chd-73	26	29	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	VERB
chd-73	26	30	e3	e3	NOUN
chd-73	26	31	cancer	cancer	NOUN
chd-73	26	32	health	health	NOUN
chd-73	26	33	disparities	disparity	NOUN
chd-73	26	34	research	research	NOUN
chd-73	26	35	(	(	PUNCT
chd-73	26	36	hes1	hes1	PROPN
chd-73	26	37	)	)	PUNCT
chd-73	26	38	and	and	CCONJ
chd-73	26	39	hairy	hairy	ADJ
chd-73	26	40	related	relate	VERB
chd-73	26	41	(	(	PUNCT
chd-73	26	42	hey1	hey1	PROPN
chd-73	26	43	or	or	CCONJ
chd-73	26	44	hrt	hrt	PROPN
chd-73	26	45	)	)	PUNCT
chd-73	26	46	.	.	PUNCT
chd-73	27	1	notch	notch	NOUN
chd-73	27	2	signaling	signal	VERB
chd-73	27	3	can	can	AUX
chd-73	27	4	also	also	ADV
chd-73	27	5	crosstalk	crosstalk	VERB
chd-73	27	6	with	with	ADP
chd-73	27	7	other	other	ADJ
chd-73	27	8	signaling	signal	VERB
chd-73	27	9	pathways	pathway	NOUN
chd-73	27	10	such	such	ADJ
chd-73	27	11	as	as	ADP
chd-73	27	12	nf-b	nf-b	PROPN
chd-73	27	13	and	and	CCONJ
chd-73	27	14	tgf-	tgf-	PROPN
chd-73	27	15	widening	widen	VERB
chd-73	27	16	the	the	DET
chd-73	27	17	notch	notch	ADJ
chd-73	27	18	downstream	downstream	ADJ
chd-73	27	19	target	target	NOUN
chd-73	27	20	genes	gene	NOUN
chd-73	27	21	involved	involve	VERB
chd-73	27	22	in	in	ADP
chd-73	27	23	effector	effector	NOUN
chd-73	27	24	t	t	PROPN
chd-73	27	25	cells	cell	NOUN
chd-73	27	26	(	(	PUNCT
chd-73	27	27	kuijk	kuijk	NOUN
chd-73	27	28	et	et	PROPN
chd-73	27	29	al	al	PROPN
chd-73	27	30	.	.	PROPN
chd-73	27	31	,	,	PUNCT
chd-73	27	32	2013	2013	NUM
chd-73	27	33	;	;	PUNCT
chd-73	27	34	radtke	radtke	NOUN
chd-73	27	35	et	et	PROPN
chd-73	27	36	al	al	PROPN
chd-73	27	37	.	.	PROPN
chd-73	27	38	,	,	PUNCT
chd-73	27	39	2010	2010	NUM
chd-73	27	40	;	;	PUNCT
chd-73	27	41	yuan	yuan	NOUN
chd-73	27	42	et	et	PROPN
chd-73	27	43	al	al	PROPN
chd-73	27	44	.	.	PROPN
chd-73	27	45	,	,	PUNCT
chd-73	27	46	2010	2010	NUM
chd-73	27	47	)	)	PUNCT
chd-73	27	48	.	.	PUNCT
chd-73	28	1	promiscuous	promiscuous	ADJ
chd-73	28	2	receptor	receptor	NOUN
chd-73	28	3	-	-	PUNCT
chd-73	28	4	ligand	ligand	NOUN
chd-73	28	5	binding	binding	NOUN
chd-73	28	6	makes	make	VERB
chd-73	28	7	notch	notch	ADJ
chd-73	28	8	signaling	signal	VERB
chd-73	28	9	highly	highly	ADV
chd-73	28	10	doseand	doseand	ADJ
chd-73	28	11	context	context	NOUN
chd-73	28	12	-	-	PUNCT
chd-73	28	13	dependent	dependent	ADJ
chd-73	29	1	(	(	PUNCT
chd-73	29	2	previs	previs	PROPN
chd-73	29	3	et	et	PROPN
chd-73	29	4	al	al	PROPN
chd-73	29	5	.	.	PROPN
chd-73	29	6	,	,	PUNCT
chd-73	29	7	2015	2015	NUM
chd-73	29	8	)	)	PUNCT
chd-73	29	9	.	.	PUNCT
chd-73	30	1	notch	notch	NOUN
chd-73	30	2	can	can	AUX
chd-73	30	3	contribute	contribute	VERB
chd-73	30	4	to	to	ADP
chd-73	30	5	tumorigenesis	tumorigenesis	NOUN
chd-73	30	6	if	if	SCONJ
chd-73	30	7	partnered	partner	VERB
chd-73	30	8	with	with	ADP
chd-73	30	9	another	another	DET
chd-73	30	10	onco	onco	NOUN
chd-73	30	11	-	-	PUNCT
chd-73	30	12	signaling	signal	VERB
chd-73	30	13	,	,	PUNCT
chd-73	30	14	or	or	CCONJ
chd-73	30	15	can	can	AUX
chd-73	30	16	improve	improve	VERB
chd-73	30	17	antitumor	antitumor	PROPN
chd-73	30	18	lymphocyte	lymphocyte	ADJ
chd-73	30	19	function	function	NOUN
chd-73	30	20	if	if	SCONJ
chd-73	30	21	presented	present	VERB
chd-73	30	22	with	with	ADP
chd-73	30	23	the	the	DET
chd-73	30	24	right	right	ADJ
chd-73	30	25	repertoire	repertoire	NOUN
chd-73	30	26	of	of	ADP
chd-73	30	27	notch	notch	ADJ
chd-73	30	28	receptor	receptor	NOUN
chd-73	30	29	-	-	PUNCT
chd-73	30	30	ligands	ligand	NOUN
chd-73	30	31	in	in	ADP
chd-73	30	32	the	the	DET
chd-73	30	33	tumor	tumor	NOUN
chd-73	30	34	microenvironment	microenvironment	NOUN
chd-73	30	35	(	(	PUNCT
chd-73	30	36	biktasova	biktasova	PROPN
chd-73	30	37	et	et	PROPN
chd-73	30	38	al	al	PROPN
chd-73	30	39	.	.	PROPN
chd-73	30	40	,	,	PUNCT
chd-73	30	41	2015	2015	NUM
chd-73	30	42	;	;	PUNCT
chd-73	31	1	huang	huang	PROPN
chd-73	31	2	et	et	PROPN
chd-73	31	3	al	al	PROPN
chd-73	31	4	.	.	PROPN
chd-73	31	5	,	,	PUNCT
chd-73	31	6	2011	2011	NUM
chd-73	31	7	;	;	PUNCT
chd-73	31	8	lobry	lobry	PROPN
chd-73	31	9	et	et	PROPN
chd-73	31	10	al	al	PROPN
chd-73	31	11	.	.	PROPN
chd-73	31	12	,	,	PUNCT
chd-73	31	13	2011	2011	NUM
chd-73	31	14	)	)	PUNCT
chd-73	31	15	.	.	PUNCT
chd-73	32	1	there	there	PRON
chd-73	32	2	are	be	VERB
chd-73	32	3	indications	indication	NOUN
chd-73	32	4	that	that	SCONJ
chd-73	32	5	differences	difference	NOUN
chd-73	32	6	in	in	ADP
chd-73	32	7	notch	notch	ADJ
chd-73	32	8	components	component	NOUN
chd-73	32	9	could	could	AUX
chd-73	32	10	underlie	underlie	VERB
chd-73	32	11	poor	poor	ADJ
chd-73	32	12	disease	disease	NOUN
chd-73	32	13	prognosis	prognosis	NOUN
chd-73	32	14	in	in	ADP
chd-73	32	15	certain	certain	ADJ
chd-73	32	16	populations	population	NOUN
chd-73	32	17	.	.	PUNCT
chd-73	33	1	based	base	VERB
chd-73	33	2	on	on	ADP
chd-73	33	3	data	datum	NOUN
chd-73	33	4	from	from	ADP
chd-73	33	5	the	the	DET
chd-73	33	6	chronic	chronic	ADJ
chd-73	33	7	obstructive	obstructive	ADJ
chd-73	33	8	pulmonary	pulmonary	ADJ
chd-73	33	9	disease	disease	NOUN
chd-73	33	10	(	(	PUNCT
chd-73	33	11	copd	copd	NOUN
chd-73	33	12	)	)	PUNCT
chd-73	33	13	clinical	clinical	ADJ
chd-73	33	14	trial	trial	NOUN
chd-73	33	15	nct00774176	nct00774176	NOUN
chd-73	33	16	,	,	PUNCT
chd-73	33	17	the	the	DET
chd-73	33	18	expression	expression	NOUN
chd-73	33	19	of	of	ADP
chd-73	33	20	mastermind	mastermind	NOUN
chd-73	33	21	-	-	PUNCT
chd-73	33	22	like	like	ADJ
chd-73	33	23	protein	protein	NOUN
chd-73	33	24	1	1	NUM
chd-73	33	25	(	(	PUNCT
chd-73	33	26	maml1	maml1	NOUN
chd-73	33	27	)	)	PUNCT
chd-73	33	28	,	,	PUNCT
chd-73	33	29	which	which	PRON
chd-73	33	30	affects	affect	VERB
chd-73	33	31	notch	notch	ADJ
chd-73	33	32	-	-	PUNCT
chd-73	33	33	dependent	dependent	ADJ
chd-73	33	34	angiogenesis	angiogenesis	NOUN
chd-73	33	35	in	in	ADP
chd-73	33	36	lung	lung	NOUN
chd-73	33	37	,	,	PUNCT
chd-73	33	38	was	be	AUX
chd-73	33	39	found	find	VERB
chd-73	33	40	to	to	PART
chd-73	33	41	be	be	AUX
chd-73	33	42	associated	associate	VERB
chd-73	33	43	with	with	ADP
chd-73	33	44	copd	copd	NOUN
chd-73	33	45	exacerbation	exacerbation	NOUN
chd-73	33	46	in	in	ADP
chd-73	33	47	african	african	ADJ
chd-73	33	48	americans	americans	PROPN
chd-73	33	49	(	(	PUNCT
chd-73	33	50	busch	busch	PROPN
chd-73	33	51	et	et	PROPN
chd-73	33	52	al	al	PROPN
chd-73	33	53	.	.	PROPN
chd-73	33	54	,	,	PUNCT
chd-73	33	55	2016	2016	NUM
chd-73	33	56	)	)	PUNCT
chd-73	33	57	.	.	PUNCT
chd-73	34	1	as	as	ADP
chd-73	34	2	per	per	ADP
chd-73	34	3	the	the	DET
chd-73	34	4	cancer	cancer	NOUN
chd-73	34	5	genome	genome	NOUN
chd-73	34	6	atlas	atlas	PROPN
chd-73	34	7	(	(	PUNCT
chd-73	34	8	tcga	tcga	PROPN
chd-73	34	9	)	)	PUNCT
chd-73	34	10	data	datum	NOUN
chd-73	34	11	,	,	PUNCT
chd-73	34	12	a	a	DET
chd-73	34	13	novel	novel	ADJ
chd-73	34	14	notch	notch	NOUN
chd-73	34	15	protein	protein	NOUN
chd-73	34	16	,	,	PUNCT
chd-73	34	17	notch	notch	VERB
chd-73	34	18	2	2	NUM
chd-73	34	19	nterminal	nterminal	ADJ
chd-73	34	20	like	like	ADP
chd-73	34	21	protein	protein	NOUN
chd-73	34	22	(	(	PUNCT
chd-73	34	23	notch2nl	notch2nl	NOUN
chd-73	34	24	/	/	SYM
chd-73	34	25	n2n	n2n	NOUN
chd-73	34	26	)	)	PUNCT
chd-73	34	27	,	,	PUNCT
chd-73	34	28	was	be	AUX
chd-73	34	29	found	find	VERB
chd-73	34	30	to	to	PART
chd-73	34	31	be	be	AUX
chd-73	34	32	increased	increase	VERB
chd-73	34	33	in	in	ADP
chd-73	34	34	breast	breast	NOUN
chd-73	34	35	cancer	cancer	NOUN
chd-73	34	36	tissue	tissue	NOUN
chd-73	34	37	of	of	ADP
chd-73	34	38	africanamericans	africanamerican	NOUN
chd-73	34	39	relative	relative	ADJ
chd-73	34	40	to	to	ADP
chd-73	34	41	caucasians	caucasian	NOUN
chd-73	34	42	.	.	PUNCT
chd-73	35	1	correspondingly	correspondingly	ADV
chd-73	35	2	,	,	PUNCT
chd-73	35	3	disparities	disparity	NOUN
chd-73	35	4	in	in	ADP
chd-73	35	5	notch	notch	NOUN
chd-73	35	6	signaling	signal	VERB
chd-73	35	7	can	can	AUX
chd-73	35	8	impact	impact	VERB
chd-73	35	9	cancer	cancer	NOUN
chd-73	35	10	development	development	NOUN
chd-73	35	11	and	and	CCONJ
chd-73	35	12	therapy	therapy	NOUN
chd-73	35	13	as	as	SCONJ
chd-73	35	14	discussed	discuss	VERB
chd-73	35	15	below	below	ADV
chd-73	35	16	.	.	PUNCT
chd-73	36	1	notch	notch	VERB
chd-73	36	2	in	in	ADP
chd-73	36	3	cancer	cancer	NOUN
chd-73	36	4	development	development	NOUN
chd-73	36	5	although	although	SCONJ
chd-73	36	6	notch	notch	ADJ
chd-73	36	7	signaling	signal	VERB
chd-73	36	8	plays	play	VERB
chd-73	36	9	a	a	DET
chd-73	36	10	crucial	crucial	ADJ
chd-73	36	11	role	role	NOUN
chd-73	36	12	in	in	ADP
chd-73	36	13	embryonic	embryonic	ADJ
chd-73	36	14	development	development	NOUN
chd-73	36	15	,	,	PUNCT
chd-73	36	16	tissue	tissue	NOUN
chd-73	36	17	homeostasis	homeostasis	NOUN
chd-73	36	18	,	,	PUNCT
chd-73	36	19	cell	cell	NOUN
chd-73	36	20	proliferation	proliferation	NOUN
chd-73	36	21	,	,	PUNCT
chd-73	36	22	apoptosis	apoptosis	NOUN
chd-73	36	23	,	,	PUNCT
chd-73	36	24	hematopoiesis	hematopoiesis	NOUN
chd-73	36	25	,	,	PUNCT
chd-73	36	26	as	as	ADV
chd-73	36	27	well	well	ADV
chd-73	36	28	as	as	ADP
chd-73	36	29	differentiation	differentiation	NOUN
chd-73	36	30	and	and	CCONJ
chd-73	36	31	function	function	NOUN
chd-73	36	32	of	of	ADP
chd-73	36	33	various	various	ADJ
chd-73	36	34	immune	immune	ADJ
chd-73	36	35	cells	cell	NOUN
chd-73	36	36	including	include	VERB
chd-73	36	37	lymphocytes	lymphocyte	NOUN
chd-73	36	38	,	,	PUNCT
chd-73	36	39	dysregulation	dysregulation	NOUN
chd-73	36	40	of	of	ADP
chd-73	36	41	notch	notch	NOUN
chd-73	36	42	signaling	signal	VERB
chd-73	36	43	leads	lead	NOUN
chd-73	36	44	to	to	ADP
chd-73	36	45	several	several	ADJ
chd-73	36	46	diseases	disease	NOUN
chd-73	36	47	,	,	PUNCT
chd-73	36	48	including	include	VERB
chd-73	36	49	cancer	cancer	NOUN
chd-73	36	50	(	(	PUNCT
chd-73	36	51	radtke	radtke	PROPN
chd-73	36	52	et	et	PROPN
chd-73	36	53	al	al	PROPN
chd-73	36	54	.	.	PROPN
chd-73	36	55	,	,	PUNCT
chd-73	36	56	2010	2010	NUM
chd-73	36	57	;	;	PUNCT
chd-73	36	58	yuan	yuan	NOUN
chd-73	36	59	et	et	PROPN
chd-73	36	60	al	al	PROPN
chd-73	36	61	.	.	PROPN
chd-73	36	62	,	,	PUNCT
chd-73	36	63	2010	2010	NUM
chd-73	36	64	)	)	PUNCT
chd-73	36	65	.	.	PUNCT
chd-73	37	1	for	for	ADP
chd-73	37	2	instance	instance	NOUN
chd-73	37	3	,	,	PUNCT
chd-73	37	4	crosstalk	crosstalk	VERB
chd-73	37	5	between	between	ADP
chd-73	37	6	tgf	tgf	PROPN
chd-73	37	7	-	-	PUNCT
chd-73	37	8	β	β	PROPN
chd-73	37	9	and	and	CCONJ
chd-73	37	10	notch	notch	NOUN
chd-73	37	11	is	be	AUX
chd-73	37	12	essential	essential	ADJ
chd-73	37	13	for	for	ADP
chd-73	37	14	epithelial	epithelial	ADJ
chd-73	37	15	-	-	PUNCT
chd-73	37	16	mesenchymal	mesenchymal	NOUN
chd-73	37	17	transition	transition	NOUN
chd-73	37	18	(	(	PUNCT
chd-73	37	19	emt	emt	PROPN
chd-73	37	20	)	)	PUNCT
chd-73	37	21	as	as	SCONJ
chd-73	37	22	notch	notch	ADJ
chd-73	37	23	signaling	signal	VERB
chd-73	37	24	is	be	AUX
chd-73	37	25	needed	need	VERB
chd-73	37	26	to	to	PART
chd-73	37	27	sustain	sustain	VERB
chd-73	37	28	the	the	DET
chd-73	37	29	expression	expression	NOUN
chd-73	37	30	of	of	ADP
chd-73	37	31	tgfβ	tgfβ	ADV
chd-73	37	32	-	-	PUNCT
chd-73	37	33	induced	induce	VERB
chd-73	37	34	notch	notch	NOUN
chd-73	37	35	target	target	NOUN
chd-73	37	36	gene	gene	NOUN
chd-73	37	37	hey1	hey1	PROPN
chd-73	37	38	,	,	PUNCT
chd-73	37	39	which	which	PRON
chd-73	37	40	acts	act	VERB
chd-73	37	41	as	as	ADP
chd-73	37	42	a	a	DET
chd-73	37	43	transcriptional	transcriptional	ADJ
chd-73	37	44	repressor	repressor	NOUN
chd-73	37	45	(	(	PUNCT
chd-73	37	46	klinakis	klinakis	PROPN
chd-73	37	47	et	et	PROPN
chd-73	37	48	al	al	PROPN
chd-73	37	49	.	.	PROPN
chd-73	37	50	,	,	PUNCT
chd-73	37	51	2011	2011	NUM
chd-73	37	52	)	)	PUNCT
chd-73	37	53	.	.	PUNCT
chd-73	38	1	deregulation	deregulation	NOUN
chd-73	38	2	of	of	ADP
chd-73	38	3	the	the	DET
chd-73	38	4	notch	notch	ADJ
chd-73	38	5	pathway	pathway	NOUN
chd-73	38	6	can	can	AUX
chd-73	38	7	occur	occur	VERB
chd-73	38	8	by	by	ADP
chd-73	38	9	various	various	ADJ
chd-73	38	10	mechanisms	mechanism	NOUN
chd-73	38	11	including	include	VERB
chd-73	38	12	overexpression	overexpression	NOUN
chd-73	38	13	,	,	PUNCT
chd-73	38	14	mutational	mutational	ADJ
chd-73	38	15	activation	activation	NOUN
chd-73	38	16	or	or	CCONJ
chd-73	38	17	inactivation	inactivation	NOUN
chd-73	38	18	,	,	PUNCT
chd-73	38	19	posttranslational	posttranslational	ADJ
chd-73	38	20	modifications	modification	NOUN
chd-73	38	21	and	and	CCONJ
chd-73	38	22	epigenetic	epigenetic	ADJ
chd-73	38	23	regulation	regulation	NOUN
chd-73	38	24	(	(	PUNCT
chd-73	38	25	ntziachristos	ntziachristos	NOUN
chd-73	38	26	et	et	PROPN
chd-73	38	27	al	al	PROPN
chd-73	38	28	.	.	PROPN
chd-73	38	29	,	,	PUNCT
chd-73	38	30	2014	2014	NUM
chd-73	38	31	)	)	PUNCT
chd-73	38	32	.	.	PUNCT
chd-73	39	1	notch	notch	NOUN
chd-73	39	2	signaling	signal	VERB
chd-73	39	3	in	in	ADP
chd-73	39	4	breast	breast	NOUN
chd-73	39	5	cancer	cancer	NOUN
chd-73	39	6	progression	progression	NOUN
chd-73	39	7	notch	notch	VERB
chd-73	39	8	signaling	signal	VERB
chd-73	39	9	drives	drive	VERB
chd-73	39	10	many	many	ADJ
chd-73	39	11	human	human	ADJ
chd-73	39	12	hematologic	hematologic	NOUN
chd-73	39	13	and	and	CCONJ
chd-73	39	14	solid	solid	ADJ
chd-73	39	15	malignancies	malignancy	NOUN
chd-73	39	16	including	include	VERB
chd-73	39	17	breast	breast	NOUN
chd-73	39	18	cancer	cancer	NOUN
chd-73	39	19	,	,	PUNCT
chd-73	39	20	medulloblastoma	medulloblastoma	NOUN
chd-73	39	21	,	,	PUNCT
chd-73	39	22	colorectal	colorectal	ADJ
chd-73	39	23	cancer	cancer	NOUN
chd-73	39	24	,	,	PUNCT
chd-73	39	25	lung	lung	NOUN
chd-73	39	26	cancer	cancer	NOUN
chd-73	39	27	and	and	CCONJ
chd-73	39	28	melanoma	melanoma	NOUN
chd-73	39	29	(	(	PUNCT
chd-73	39	30	ntziachristos	ntziachristos	NOUN
chd-73	39	31	et	et	PROPN
chd-73	39	32	al	al	PROPN
chd-73	39	33	.	.	PROPN
chd-73	39	34	,	,	PUNCT
chd-73	39	35	2014	2014	NUM
chd-73	39	36	)	)	PUNCT
chd-73	39	37	.	.	PUNCT
chd-73	40	1	notch	notch	NOUN
chd-73	40	2	signaling	signal	VERB
chd-73	40	3	plays	play	VERB
chd-73	40	4	a	a	DET
chd-73	40	5	central	central	ADJ
chd-73	40	6	role	role	NOUN
chd-73	40	7	in	in	ADP
chd-73	40	8	breast	breast	NOUN
chd-73	40	9	cancer	cancer	NOUN
chd-73	40	10	development	development	NOUN
chd-73	40	11	and	and	CCONJ
chd-73	40	12	progression	progression	NOUN
chd-73	40	13	by	by	ADP
chd-73	40	14	promoting	promote	VERB
chd-73	40	15	tumor	tumor	NOUN
chd-73	40	16	growth	growth	NOUN
chd-73	40	17	,	,	PUNCT
chd-73	40	18	invasiveness	invasiveness	ADJ
chd-73	40	19	and	and	CCONJ
chd-73	40	20	metastasis	metastasis	NOUN
chd-73	40	21	(	(	PUNCT
chd-73	40	22	previs	previs	X
chd-73	40	23	et	et	PROPN
chd-73	40	24	al	al	PROPN
chd-73	40	25	.	.	PROPN
chd-73	40	26	,	,	PUNCT
chd-73	40	27	2015	2015	NUM
chd-73	40	28	)	)	PUNCT
chd-73	40	29	.	.	PUNCT
chd-73	41	1	increased	increase	VERB
chd-73	41	2	expression	expression	NOUN
chd-73	41	3	of	of	ADP
chd-73	41	4	notch1	notch1	NOUN
chd-73	41	5	and	and	CCONJ
chd-73	41	6	notch3	notch3	ADJ
chd-73	41	7	receptors	receptor	NOUN
chd-73	41	8	have	have	AUX
chd-73	41	9	been	be	AUX
chd-73	41	10	associated	associate	VERB
chd-73	41	11	with	with	ADP
chd-73	41	12	triplenegative	triplenegative	ADJ
chd-73	41	13	breast	breast	NOUN
chd-73	41	14	cancer	cancer	NOUN
chd-73	41	15	(	(	PUNCT
chd-73	41	16	tnbc	tnbc	ADJ
chd-73	41	17	)	)	PUNCT
chd-73	41	18	.	.	PUNCT
chd-73	42	1	notch4	notch4	NOUN
chd-73	42	2	overexpression	overexpression	NOUN
chd-73	42	3	has	have	AUX
chd-73	42	4	been	be	AUX
chd-73	42	5	correlated	correlate	VERB
chd-73	42	6	with	with	ADP
chd-73	42	7	hormonereceptor	hormonereceptor	NOUN
chd-73	42	8	positive	positive	ADJ
chd-73	42	9	breast	breast	NOUN
chd-73	42	10	cancer	cancer	NOUN
chd-73	42	11	.	.	PUNCT
chd-73	43	1	on	on	ADP
chd-73	43	2	the	the	DET
chd-73	43	3	contrary	contrary	NOUN
chd-73	43	4	,	,	PUNCT
chd-73	43	5	notch2	notch2	PROPN
chd-73	43	6	has	have	AUX
chd-73	43	7	been	be	AUX
chd-73	43	8	associated	associate	VERB
chd-73	43	9	with	with	ADP
chd-73	43	10	better	well	ADJ
chd-73	43	11	survival	survival	NOUN
chd-73	43	12	(	(	PUNCT
chd-73	43	13	parr	parr	X
chd-73	43	14	et	et	PROPN
chd-73	43	15	al	al	PROPN
chd-73	43	16	.	.	PROPN
chd-73	43	17	,	,	PUNCT
chd-73	43	18	2004	2004	NUM
chd-73	43	19	)	)	PUNCT
chd-73	43	20	.	.	PUNCT
chd-73	44	1	in	in	ADP
chd-73	44	2	addition	addition	NOUN
chd-73	44	3	,	,	PUNCT
chd-73	44	4	notch1	notch1	NOUN
chd-73	44	5	has	have	AUX
chd-73	44	6	lowered	lower	VERB
chd-73	44	7	expression	expression	NOUN
chd-73	44	8	in	in	ADP
chd-73	44	9	her-2	her-2	NUM
chd-73	44	10	positive	positive	ADJ
chd-73	44	11	breast	breast	NOUN
chd-73	44	12	cancers	cancer	NOUN
chd-73	44	13	(	(	PUNCT
chd-73	44	14	touplikioti	touplikioti	NOUN
chd-73	44	15	,	,	PUNCT
chd-73	44	16	2012	2012	NUM
chd-73	44	17	)	)	PUNCT
chd-73	44	18	.	.	PUNCT
chd-73	45	1	studies	study	NOUN
chd-73	45	2	also	also	ADV
chd-73	45	3	indicated	indicate	VERB
chd-73	45	4	that	that	SCONJ
chd-73	45	5	high	high	ADJ
chd-73	45	6	notch1	notch1	NOUN
chd-73	45	7	and	and	CCONJ
chd-73	45	8	jag1	jag1	NOUN
chd-73	45	9	in	in	ADP
chd-73	45	10	breast	breast	NOUN
chd-73	45	11	cancer	cancer	NOUN
chd-73	45	12	patients	patient	NOUN
chd-73	45	13	correlated	correlate	VERB
chd-73	45	14	with	with	ADP
chd-73	45	15	poorer	poor	ADJ
chd-73	45	16	overall	overall	ADJ
chd-73	45	17	survival	survival	NOUN
chd-73	45	18	(	(	PUNCT
chd-73	45	19	reedijk	reedijk	X
chd-73	45	20	et	et	PROPN
chd-73	45	21	al	al	PROPN
chd-73	45	22	.	.	PROPN
chd-73	45	23	,	,	PUNCT
chd-73	45	24	2005	2005	NUM
chd-73	45	25	)	)	PUNCT
chd-73	45	26	.	.	PUNCT
chd-73	46	1	recently	recently	ADV
chd-73	46	2	,	,	PUNCT
chd-73	46	3	notch1	notch1	NOUN
chd-73	46	4	,	,	PUNCT
chd-73	46	5	notch3	notch3	PROPN
chd-73	46	6	and	and	CCONJ
chd-73	46	7	jag1	jag1	NOUN
chd-73	46	8	were	be	AUX
chd-73	46	9	shown	show	VERB
chd-73	46	10	to	to	PART
chd-73	46	11	be	be	AUX
chd-73	46	12	at	at	ADP
chd-73	46	13	the	the	DET
chd-73	46	14	nexus	nexus	NOUN
chd-73	46	15	of	of	ADP
chd-73	46	16	a	a	DET
chd-73	46	17	vicious	vicious	ADJ
chd-73	46	18	cycle	cycle	NOUN
chd-73	46	19	of	of	ADP
chd-73	46	20	macrophage	macrophage	ADJ
chd-73	46	21	infiltration	infiltration	NOUN
chd-73	46	22	into	into	ADP
chd-73	46	23	basal	basal	NOUN
chd-73	46	24	-	-	PUNCT
chd-73	46	25	like	like	ADJ
chd-73	46	26	breast	breast	NOUN
chd-73	46	27	cancers	cancer	NOUN
chd-73	46	28	by	by	ADP
chd-73	46	29	regulating	regulate	VERB
chd-73	46	30	the	the	DET
chd-73	46	31	expression	expression	NOUN
chd-73	46	32	of	of	ADP
chd-73	46	33	proinflammatory	proinflammatory	ADJ
chd-73	46	34	cytokines	cytokine	NOUN
chd-73	46	35	,	,	PUNCT
chd-73	46	36	il-1β	il-1β	PROPN
chd-73	46	37	and	and	CCONJ
chd-73	46	38	ccl2	ccl2	PROPN
chd-73	46	39	,	,	PUNCT
chd-73	46	40	thus	thus	ADV
chd-73	46	41	increasing	increase	VERB
chd-73	46	42	cancer	cancer	NOUN
chd-73	46	43	invasiveness	invasiveness	NOUN
chd-73	46	44	(	(	PUNCT
chd-73	46	45	shen	shen	PROPN
chd-73	46	46	et	et	PROPN
chd-73	46	47	al	al	PROPN
chd-73	46	48	.	.	PROPN
chd-73	46	49	,	,	PUNCT
chd-73	46	50	2017	2017	NUM
chd-73	46	51	)	)	PUNCT
chd-73	46	52	.	.	PUNCT
chd-73	47	1	notch	notch	NOUN
chd-73	47	2	signaling	signal	VERB
chd-73	47	3	in	in	ADP
chd-73	47	4	lung	lung	NOUN
chd-73	47	5	cancer	cancer	NOUN
chd-73	47	6	progression	progression	NOUN
chd-73	47	7	notch	notch	NOUN
chd-73	47	8	signaling	signal	VERB
chd-73	47	9	plays	play	VERB
chd-73	47	10	an	an	DET
chd-73	47	11	integral	integral	ADJ
chd-73	47	12	role	role	NOUN
chd-73	47	13	in	in	ADP
chd-73	47	14	lung	lung	NOUN
chd-73	47	15	cancer	cancer	NOUN
chd-73	47	16	initiation	initiation	NOUN
chd-73	47	17	and	and	CCONJ
chd-73	47	18	progression	progression	NOUN
chd-73	47	19	.	.	PUNCT
chd-73	48	1	in	in	ADP
chd-73	48	2	non	non	ADJ
chd-73	48	3	-	-	ADJ
chd-73	48	4	small	small	ADJ
chd-73	48	5	cell	cell	NOUN
chd-73	48	6	lung	lung	NOUN
chd-73	48	7	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-73	48	8	e4	e4	PROPN
chd-73	48	9	cancer	cancer	NOUN
chd-73	48	10	health	health	NOUN
chd-73	48	11	disparities	disparity	NOUN
chd-73	48	12	research	research	NOUN
chd-73	48	13	cancer	cancer	NOUN
chd-73	48	14	(	(	PUNCT
chd-73	48	15	nsclc	nsclc	NOUN
chd-73	48	16	)	)	PUNCT
chd-73	48	17	,	,	PUNCT
chd-73	48	18	notch	notch	ADJ
chd-73	48	19	signaling	signal	VERB
chd-73	48	20	crosstalks	crosstalk	NOUN
chd-73	48	21	with	with	ADP
chd-73	48	22	various	various	ADJ
chd-73	48	23	transcription	transcription	NOUN
chd-73	48	24	factors	factor	NOUN
chd-73	48	25	to	to	PART
chd-73	48	26	enhance	enhance	VERB
chd-73	48	27	emt	emt	NOUN
chd-73	48	28	during	during	ADP
chd-73	48	29	cancer	cancer	NOUN
chd-73	48	30	development	development	NOUN
chd-73	48	31	.	.	PUNCT
chd-73	49	1	blockade	blockade	NOUN
chd-73	49	2	of	of	ADP
chd-73	49	3	notch	notch	NOUN
chd-73	49	4	signaling	signal	VERB
chd-73	49	5	inhibits	inhibit	VERB
chd-73	49	6	progression	progression	NOUN
chd-73	49	7	and	and	CCONJ
chd-73	49	8	migration	migration	NOUN
chd-73	49	9	of	of	ADP
chd-73	49	10	nsclc	nsclc	NOUN
chd-73	49	11	by	by	ADP
chd-73	49	12	reversing	reverse	VERB
chd-73	49	13	emt	emt	PROPN
chd-73	49	14	(	(	PUNCT
chd-73	49	15	xu	xu	INTJ
chd-73	49	16	et	et	PROPN
chd-73	49	17	al	al	PROPN
chd-73	49	18	.	.	PROPN
chd-73	49	19	,	,	PUNCT
chd-73	49	20	2018	2018	NUM
chd-73	49	21	;	;	PUNCT
chd-73	49	22	yuan	yuan	NOUN
chd-73	49	23	et	et	PROPN
chd-73	49	24	al	al	PROPN
chd-73	49	25	.	.	PROPN
chd-73	49	26	,	,	PUNCT
chd-73	49	27	2014	2014	NUM
chd-73	49	28	)	)	PUNCT
chd-73	49	29	.	.	PUNCT
chd-73	50	1	in	in	ADP
chd-73	50	2	a	a	DET
chd-73	50	3	wide	wide	ADJ
chd-73	50	4	variety	variety	NOUN
chd-73	50	5	of	of	ADP
chd-73	50	6	lung	lung	NOUN
chd-73	50	7	cancer	cancer	NOUN
chd-73	50	8	patients	patient	NOUN
chd-73	50	9	(	(	PUNCT
chd-73	50	10	squamous	squamous	ADJ
chd-73	50	11	cell	cell	NOUN
chd-73	50	12	carcinoma	carcinoma	NOUN
chd-73	50	13	,	,	PUNCT
chd-73	50	14	adenocarcinoma	adenocarcinoma	NOUN
chd-73	50	15	,	,	PUNCT
chd-73	50	16	transitional	transitional	ADJ
chd-73	50	17	cell	cell	NOUN
chd-73	50	18	carcinoma	carcinoma	NOUN
chd-73	50	19	and	and	CCONJ
chd-73	50	20	large	large	ADJ
chd-73	50	21	cell	cell	NOUN
chd-73	50	22	carcinoma	carcinoma	NOUN
chd-73	50	23	)	)	PUNCT
chd-73	50	24	expression	expression	NOUN
chd-73	50	25	levels	level	NOUN
chd-73	50	26	of	of	ADP
chd-73	50	27	delta	delta	NOUN
chd-73	50	28	-	-	PUNCT
chd-73	50	29	like	like	ADJ
chd-73	50	30	notch	notch	NOUN
chd-73	50	31	ligands	ligand	NOUN
chd-73	50	32	dll1	dll1	ADJ
chd-73	50	33	and	and	CCONJ
chd-73	50	34	their	their	PRON
chd-73	50	35	target	target	NOUN
chd-73	50	36	gene	gene	NOUN
chd-73	50	37	hes1	hes1	NOUN
chd-73	50	38	were	be	AUX
chd-73	50	39	significantly	significantly	ADV
chd-73	50	40	altered	alter	VERB
chd-73	50	41	in	in	ADP
chd-73	50	42	hematopoietic	hematopoietic	ADJ
chd-73	50	43	compartment	compartment	NOUN
chd-73	50	44	by	by	ADP
chd-73	50	45	tumor	tumor	NOUN
chd-73	50	46	-	-	PUNCT
chd-73	50	47	derived	derive	VERB
chd-73	50	48	factors	factor	NOUN
chd-73	50	49	.	.	PUNCT
chd-73	51	1	these	these	DET
chd-73	51	2	changes	change	NOUN
chd-73	51	3	in	in	ADP
chd-73	51	4	notch	notch	ADJ
chd-73	51	5	components	component	NOUN
chd-73	51	6	were	be	AUX
chd-73	51	7	reproduced	reproduce	VERB
chd-73	51	8	in	in	ADP
chd-73	51	9	various	various	ADJ
chd-73	51	10	murine	murine	ADJ
chd-73	51	11	cancer	cancer	NOUN
chd-73	51	12	models	model	NOUN
chd-73	51	13	including	include	VERB
chd-73	51	14	lung	lung	NOUN
chd-73	51	15	cancer	cancer	NOUN
chd-73	51	16	.	.	PUNCT
chd-73	52	1	the	the	DET
chd-73	52	2	decreased	decrease	VERB
chd-73	52	3	expression	expression	NOUN
chd-73	52	4	of	of	ADP
chd-73	52	5	notch	notch	ADJ
chd-73	52	6	components	component	NOUN
chd-73	52	7	resulted	result	VERB
chd-73	52	8	in	in	ADP
chd-73	52	9	tumor	tumor	NOUN
chd-73	52	10	-	-	PUNCT
chd-73	52	11	induced	induce	VERB
chd-73	52	12	immunosuppression	immunosuppression	NOUN
chd-73	52	13	in	in	ADP
chd-73	52	14	t	t	PROPN
chd-73	52	15	cell	cell	NOUN
chd-73	52	16	function	function	NOUN
chd-73	52	17	that	that	PRON
chd-73	52	18	correlated	correlate	VERB
chd-73	52	19	with	with	ADP
chd-73	52	20	poor	poor	ADJ
chd-73	52	21	prognosis	prognosis	NOUN
chd-73	52	22	(	(	PUNCT
chd-73	52	23	biktasova	biktasova	PROPN
chd-73	52	24	et	et	PROPN
chd-73	52	25	al	al	PROPN
chd-73	52	26	.	.	PROPN
chd-73	52	27	,	,	PUNCT
chd-73	52	28	2015	2015	NUM
chd-73	52	29	;	;	PUNCT
chd-73	52	30	huang	huang	PROPN
chd-73	52	31	et	et	PROPN
chd-73	52	32	al	al	PROPN
chd-73	52	33	.	.	PROPN
chd-73	52	34	,	,	PUNCT
chd-73	52	35	2011	2011	NUM
chd-73	52	36	;	;	PUNCT
chd-73	52	37	thounaojam	thounaojam	NOUN
chd-73	52	38	et	et	NOUN
chd-73	52	39	al	al	PROPN
chd-73	52	40	.	.	PROPN
chd-73	52	41	,	,	PUNCT
chd-73	52	42	2015	2015	NUM
chd-73	52	43	)	)	PUNCT
chd-73	52	44	.	.	PUNCT
chd-73	53	1	notch	notch	ADJ
chd-73	53	2	basis	basis	NOUN
chd-73	53	3	of	of	ADP
chd-73	53	4	cancer	cancer	NOUN
chd-73	53	5	disparities	disparity	NOUN
chd-73	53	6	expression	expression	NOUN
chd-73	53	7	of	of	ADP
chd-73	53	8	notch	notch	NOUN
chd-73	53	9	in	in	ADP
chd-73	53	10	breast	breast	NOUN
chd-73	53	11	cancer	cancer	NOUN
chd-73	53	12	is	be	AUX
chd-73	53	13	subtypedependent	subtypedependent	NOUN
chd-73	53	14	although	although	SCONJ
chd-73	53	15	the	the	DET
chd-73	53	16	role	role	NOUN
chd-73	53	17	of	of	ADP
chd-73	53	18	notch	notch	NOUN
chd-73	53	19	in	in	ADP
chd-73	53	20	cancer	cancer	NOUN
chd-73	53	21	initiation	initiation	NOUN
chd-73	53	22	and	and	CCONJ
chd-73	53	23	progression	progression	NOUN
chd-73	53	24	is	be	AUX
chd-73	53	25	known	know	VERB
chd-73	53	26	,	,	PUNCT
chd-73	53	27	its	its	PRON
chd-73	53	28	contribution	contribution	NOUN
chd-73	53	29	to	to	ADP
chd-73	53	30	cancer	cancer	NOUN
chd-73	53	31	disparities	disparity	NOUN
chd-73	53	32	has	have	AUX
chd-73	53	33	not	not	PART
chd-73	53	34	been	be	AUX
chd-73	53	35	explored	explore	VERB
chd-73	53	36	.	.	PUNCT
chd-73	54	1	the	the	DET
chd-73	54	2	plausible	plausible	ADJ
chd-73	54	3	effect	effect	NOUN
chd-73	54	4	of	of	ADP
chd-73	54	5	notch	notch	NOUN
chd-73	54	6	on	on	ADP
chd-73	54	7	cancer	cancer	NOUN
chd-73	54	8	disparities	disparity	NOUN
chd-73	54	9	,	,	PUNCT
chd-73	54	10	however	however	ADV
chd-73	54	11	,	,	PUNCT
chd-73	54	12	can	can	AUX
chd-73	54	13	be	be	AUX
chd-73	54	14	seen	see	VERB
chd-73	54	15	in	in	ADP
chd-73	54	16	breast	breast	NOUN
chd-73	54	17	cancer	cancer	NOUN
chd-73	54	18	where	where	SCONJ
chd-73	54	19	more	more	ADV
chd-73	54	20	aggressive	aggressive	ADJ
chd-73	54	21	subtypes	subtype	NOUN
chd-73	54	22	known	know	VERB
chd-73	54	23	to	to	PART
chd-73	54	24	disproportionately	disproportionately	ADV
chd-73	54	25	affect	affect	VERB
chd-73	54	26	minority	minority	NOUN
chd-73	54	27	populations	population	NOUN
chd-73	54	28	have	have	VERB
chd-73	54	29	differential	differential	ADJ
chd-73	54	30	notch	notch	NOUN
chd-73	54	31	signaling	signal	VERB
chd-73	54	32	than	than	ADP
chd-73	54	33	less	less	ADV
chd-73	54	34	aggressive	aggressive	ADJ
chd-73	54	35	types	type	NOUN
chd-73	54	36	(	(	PUNCT
chd-73	54	37	hormone	hormone	NOUN
chd-73	54	38	-	-	PUNCT
chd-73	54	39	receptor	receptor	NOUN
chd-73	54	40	positive	positive	NOUN
chd-73	54	41	)	)	PUNCT
chd-73	54	42	.	.	PUNCT
chd-73	55	1	overexpression	overexpression	NOUN
chd-73	55	2	of	of	ADP
chd-73	55	3	notch	notch	ADJ
chd-73	55	4	target	target	NOUN
chd-73	55	5	gene	gene	NOUN
chd-73	55	6	hes1	hes1	NOUN
chd-73	55	7	,	,	PUNCT
chd-73	55	8	secretase	secretase	VERB
chd-73	55	9	protein	protein	NOUN
chd-73	55	10	presenilin-1	presenilin-1	NUM
chd-73	55	11	(	(	PUNCT
chd-73	55	12	psen1	psen1	ADJ
chd-73	55	13	)	)	PUNCT
chd-73	55	14	,	,	PUNCT
chd-73	55	15	and	and	CCONJ
chd-73	55	16	lunaticfringe	lunaticfringe	NOUN
chd-73	55	17	(	(	PUNCT
chd-73	55	18	lfng	lfng	ADV
chd-73	55	19	)	)	PUNCT
chd-73	55	20	–	–	PUNCT
chd-73	55	21	a	a	DET
chd-73	55	22	β3n	β3n	ADJ
chd-73	55	23	-	-	PUNCT
chd-73	55	24	acetylglucosaminyl	acetylglucosaminyl	NOUN
chd-73	55	25	-	-	PUNCT
chd-73	55	26	tranferase	tranferase	NOUN
chd-73	55	27	,	,	PUNCT
chd-73	55	28	which	which	PRON
chd-73	55	29	regulates	regulate	VERB
chd-73	55	30	ligand	ligand	NOUN
chd-73	55	31	-	-	PUNCT
chd-73	55	32	mediated	mediate	VERB
chd-73	55	33	activation	activation	NOUN
chd-73	55	34	of	of	ADP
chd-73	55	35	the	the	DET
chd-73	55	36	notch	notch	ADJ
chd-73	55	37	pathway	pathway	NOUN
chd-73	55	38	–	–	PUNCT
chd-73	55	39	were	be	AUX
chd-73	55	40	found	find	VERB
chd-73	55	41	to	to	PART
chd-73	55	42	be	be	AUX
chd-73	55	43	favorable	favorable	ADJ
chd-73	55	44	for	for	ADP
chd-73	55	45	disease	disease	NOUN
chd-73	55	46	-	-	PUNCT
chd-73	55	47	free	free	ADJ
chd-73	55	48	survival	survival	NOUN
chd-73	55	49	in	in	ADP
chd-73	55	50	luminal	luminal	ADJ
chd-73	55	51	type	type	NOUN
chd-73	55	52	a	a	DET
chd-73	55	53	breast	breast	NOUN
chd-73	55	54	cancer	cancer	NOUN
chd-73	55	55	.	.	PUNCT
chd-73	56	1	overexpression	overexpression	NOUN
chd-73	56	2	of	of	ADP
chd-73	56	3	these	these	DET
chd-73	56	4	same	same	ADJ
chd-73	56	5	notch	notch	ADJ
chd-73	56	6	genes	gene	NOUN
chd-73	56	7	,	,	PUNCT
chd-73	56	8	however	however	ADV
chd-73	56	9	,	,	PUNCT
chd-73	56	10	was	be	AUX
chd-73	56	11	unfavorable	unfavorable	ADJ
chd-73	56	12	for	for	ADP
chd-73	56	13	disease	disease	NOUN
chd-73	56	14	-	-	PUNCT
chd-73	56	15	free	free	ADJ
chd-73	56	16	survival	survival	NOUN
chd-73	56	17	in	in	ADP
chd-73	56	18	tnbc	tnbc	NOUN
chd-73	56	19	as	as	SCONJ
chd-73	56	20	analyzed	analyze	VERB
chd-73	56	21	in	in	ADP
chd-73	56	22	the	the	DET
chd-73	56	23	tcga	tcga	PROPN
chd-73	56	24	breast	breast	NOUN
chd-73	56	25	cancer	cancer	NOUN
chd-73	56	26	cohort	cohort	NOUN
chd-73	56	27	(	(	PUNCT
chd-73	56	28	orzechowska	orzechowska	PROPN
chd-73	56	29	et	et	PROPN
chd-73	56	30	al	al	PROPN
chd-73	56	31	.	.	PROPN
chd-73	56	32	,	,	PUNCT
chd-73	56	33	2017	2017	NUM
chd-73	56	34	)	)	PUNCT
chd-73	56	35	.	.	PUNCT
chd-73	57	1	in	in	ADP
chd-73	57	2	a	a	DET
chd-73	57	3	study	study	NOUN
chd-73	57	4	using	use	VERB
chd-73	57	5	next	next	ADJ
chd-73	57	6	generation	generation	NOUN
chd-73	57	7	sequencing	sequence	VERB
chd-73	57	8	to	to	PART
chd-73	57	9	identify	identify	VERB
chd-73	57	10	notch	notch	ADJ
chd-73	57	11	mutations	mutation	NOUN
chd-73	57	12	in	in	ADP
chd-73	57	13	solid	solid	ADJ
chd-73	57	14	tumors	tumor	NOUN
chd-73	57	15	,	,	PUNCT
chd-73	57	16	only	only	ADV
chd-73	57	17	tnbcs	tnbc	NOUN
chd-73	57	18	showed	show	VERB
chd-73	57	19	notch1	notch1	NOUN
chd-73	57	20	and	and	CCONJ
chd-73	57	21	notch2	notch2	NOUN
chd-73	57	22	rearrangements	rearrangement	NOUN
chd-73	57	23	which	which	PRON
chd-73	57	24	led	lead	VERB
chd-73	57	25	to	to	ADP
chd-73	57	26	constitutive	constitutive	ADJ
chd-73	57	27	receptor	receptor	NOUN
chd-73	57	28	activation	activation	NOUN
chd-73	57	29	(	(	PUNCT
chd-73	57	30	stoeck	stoeck	NOUN
chd-73	57	31	et	et	PROPN
chd-73	57	32	al	al	PROPN
chd-73	57	33	.	.	PROPN
chd-73	57	34	,	,	PUNCT
chd-73	57	35	2014	2014	NUM
chd-73	57	36	)	)	PUNCT
chd-73	57	37	.	.	PUNCT
chd-73	58	1	these	these	DET
chd-73	58	2	studies	study	NOUN
chd-73	58	3	provide	provide	VERB
chd-73	58	4	evidence	evidence	NOUN
chd-73	58	5	of	of	ADP
chd-73	58	6	distinct	distinct	ADJ
chd-73	58	7	notch	notch	NOUN
chd-73	58	8	signaling	signal	VERB
chd-73	58	9	profiles	profile	NOUN
chd-73	58	10	in	in	ADP
chd-73	58	11	various	various	ADJ
chd-73	58	12	breast	breast	NOUN
chd-73	58	13	cancer	cancer	NOUN
chd-73	58	14	subtypes	subtype	NOUN
chd-73	58	15	,	,	PUNCT
chd-73	58	16	which	which	PRON
chd-73	58	17	also	also	ADV
chd-73	58	18	have	have	AUX
chd-73	58	19	known	know	VERB
chd-73	58	20	racial	racial	ADJ
chd-73	58	21	disparities	disparity	NOUN
chd-73	58	22	of	of	ADP
chd-73	58	23	incidence	incidence	NOUN
chd-73	58	24	and	and	CCONJ
chd-73	58	25	outcome	outcome	NOUN
chd-73	58	26	.	.	PUNCT
chd-73	59	1	findings	finding	NOUN
chd-73	59	2	suggest	suggest	VERB
chd-73	59	3	that	that	SCONJ
chd-73	59	4	the	the	DET
chd-73	59	5	differential	differential	ADJ
chd-73	59	6	expression	expression	NOUN
chd-73	59	7	of	of	ADP
chd-73	59	8	notch	notch	ADJ
chd-73	59	9	components	component	NOUN
chd-73	59	10	can	can	AUX
chd-73	59	11	affect	affect	VERB
chd-73	59	12	breast	breast	NOUN
chd-73	59	13	cancer	cancer	NOUN
chd-73	59	14	progression	progression	NOUN
chd-73	59	15	and	and	CCONJ
chd-73	59	16	elucidate	elucidate	VERB
chd-73	59	17	response	response	NOUN
chd-73	59	18	to	to	ADP
chd-73	59	19	treatment	treatment	NOUN
chd-73	59	20	.	.	PUNCT
chd-73	60	1	expression	expression	NOUN
chd-73	60	2	of	of	ADP
chd-73	60	3	notch2n	notch2n	PROPN
chd-73	60	4	in	in	ADP
chd-73	60	5	breast	breast	NOUN
chd-73	60	6	cancer	cancer	NOUN
chd-73	60	7	is	be	AUX
chd-73	60	8	racedependent	racedependent	ADJ
chd-73	60	9	a	a	DET
chd-73	60	10	novel	novel	ADJ
chd-73	60	11	notch	notch	NOUN
chd-73	60	12	protein	protein	NOUN
chd-73	60	13	,	,	PUNCT
chd-73	60	14	notch	notch	VERB
chd-73	60	15	2	2	NUM
chd-73	60	16	n	n	CCONJ
chd-73	60	17	-	-	PUNCT
chd-73	60	18	terminal	terminal	ADJ
chd-73	60	19	-	-	PUNCT
chd-73	60	20	like	like	ADJ
chd-73	60	21	protein	protein	NOUN
chd-73	60	22	(	(	PUNCT
chd-73	60	23	notch2nl	notch2nl	NOUN
chd-73	60	24	/	/	SYM
chd-73	60	25	n2n	n2n	NOUN
chd-73	60	26	)	)	PUNCT
chd-73	60	27	,	,	PUNCT
chd-73	60	28	has	have	AUX
chd-73	60	29	been	be	AUX
chd-73	60	30	found	find	VERB
chd-73	60	31	to	to	PART
chd-73	60	32	be	be	AUX
chd-73	60	33	highly	highly	ADV
chd-73	60	34	upregulated	upregulate	VERB
chd-73	60	35	in	in	ADP
chd-73	60	36	breast	breast	NOUN
chd-73	60	37	,	,	PUNCT
chd-73	60	38	colorectal	colorectal	NOUN
chd-73	60	39	,	,	PUNCT
chd-73	60	40	and	and	CCONJ
chd-73	60	41	prostate	prostate	NOUN
chd-73	60	42	cancer	cancer	NOUN
chd-73	60	43	as	as	SCONJ
chd-73	60	44	reported	report	VERB
chd-73	60	45	in	in	ADP
chd-73	60	46	the	the	DET
chd-73	60	47	cancer	cancer	NOUN
chd-73	60	48	genome	genome	NOUN
chd-73	60	49	atlas	atlas	PROPN
chd-73	60	50	(	(	PUNCT
chd-73	60	51	tcga	tcga	PROPN
chd-73	60	52	)	)	PUNCT
chd-73	60	53	.	.	PUNCT
chd-73	61	1	notably	notably	ADV
chd-73	61	2	,	,	PUNCT
chd-73	61	3	african	african	ADJ
chd-73	61	4	-	-	PUNCT
chd-73	61	5	americans	americans	PROPN
chd-73	61	6	show	show	VERB
chd-73	61	7	an	an	DET
chd-73	61	8	increase	increase	NOUN
chd-73	61	9	in	in	ADP
chd-73	61	10	n2n	n2n	DET
chd-73	61	11	expression	expression	NOUN
chd-73	61	12	in	in	ADP
chd-73	61	13	breast	breast	NOUN
chd-73	61	14	cancer	cancer	NOUN
chd-73	61	15	relative	relative	ADJ
chd-73	61	16	to	to	ADP
chd-73	61	17	caucasians	caucasian	NOUN
chd-73	61	18	(	(	PUNCT
chd-73	61	19	p	p	NOUN
chd-73	61	20	=	=	NOUN
chd-73	61	21	0.0037	0.0037	NUM
chd-73	61	22	)	)	PUNCT
chd-73	61	23	,	,	PUNCT
chd-73	61	24	per	per	ADP
chd-73	61	25	tcga	tcga	NOUN
chd-73	61	26	database	database	NOUN
chd-73	61	27	(	(	PUNCT
chd-73	61	28	fig	fig	NOUN
chd-73	61	29	.	.	PUNCT
chd-73	61	30	1	1	NUM
chd-73	61	31	)	)	PUNCT
chd-73	61	32	.	.	PUNCT
chd-73	62	1	figure	figure	NOUN
chd-73	62	2	1	1	NUM
chd-73	62	3	.	.	PUNCT
chd-73	63	1	expression	expression	NOUN
chd-73	63	2	of	of	ADP
chd-73	63	3	notch	notch	ADJ
chd-73	63	4	2	2	NUM
chd-73	63	5	n	n	CCONJ
chd-73	63	6	-	-	PUNCT
chd-73	63	7	terminal	terminal	ADJ
chd-73	63	8	like	like	ADP
chd-73	63	9	(	(	PUNCT
chd-73	63	10	n2n	n2n	NOUN
chd-73	63	11	)	)	PUNCT
chd-73	63	12	rna	rna	NOUN
chd-73	63	13	as	as	ADP
chd-73	63	14	a	a	DET
chd-73	63	15	predictor	predictor	NOUN
chd-73	63	16	of	of	ADP
chd-73	63	17	breast	breast	NOUN
chd-73	63	18	cancer	cancer	NOUN
chd-73	63	19	disparities	disparity	NOUN
chd-73	63	20	.	.	PUNCT
chd-73	64	1	genomic	genomic	ADJ
chd-73	64	2	data	datum	NOUN
chd-73	64	3	available	available	ADJ
chd-73	64	4	in	in	ADP
chd-73	64	5	the	the	DET
chd-73	64	6	cancer	cancer	NOUN
chd-73	64	7	genome	genome	NOUN
chd-73	64	8	atlas	atlas	PROPN
chd-73	64	9	(	(	PUNCT
chd-73	64	10	tcga	tcga	PROPN
chd-73	64	11	)	)	PUNCT
chd-73	64	12	were	be	AUX
chd-73	64	13	used	use	VERB
chd-73	64	14	to	to	PART
chd-73	64	15	analyze	analyze	VERB
chd-73	64	16	n2n	n2n	ADP
chd-73	64	17	gene	gene	NOUN
chd-73	64	18	expression	expression	NOUN
chd-73	64	19	of	of	ADP
chd-73	64	20	breast	breast	NOUN
chd-73	64	21	cancer	cancer	NOUN
chd-73	64	22	tissues	tissue	NOUN
chd-73	64	23	from	from	ADP
chd-73	64	24	african	african	ADJ
chd-73	64	25	americans	americans	PROPN
chd-73	64	26	(	(	PUNCT
chd-73	64	27	n	n	NOUN
chd-73	64	28	=	=	SYM
chd-73	64	29	41	41	NUM
chd-73	64	30	)	)	PUNCT
chd-73	64	31	in	in	ADP
chd-73	64	32	comparison	comparison	NOUN
chd-73	64	33	with	with	ADP
chd-73	64	34	caucasians	caucasian	NOUN
chd-73	64	35	(	(	PUNCT
chd-73	64	36	n	n	NOUN
chd-73	64	37	=	=	SYM
chd-73	64	38	423	423	NUM
chd-73	64	39	)	)	PUNCT
chd-73	64	40	.	.	PUNCT
chd-73	65	1	*	*	PUNCT
chd-73	65	2	unpaired	unpaired	ADJ
chd-73	65	3	two	two	NUM
chd-73	65	4	-	-	PUNCT
chd-73	65	5	tailed	tail	VERB
chd-73	65	6	t	t	NOUN
chd-73	65	7	-	-	PUNCT
chd-73	65	8	test	test	NOUN
chd-73	65	9	with	with	ADP
chd-73	65	10	welch	welch	PROPN
chd-73	65	11	’s	’s	PART
chd-73	65	12	correction	correction	NOUN
chd-73	65	13	.	.	PUNCT
chd-73	66	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-73	66	2	e5	e5	PROPN
chd-73	66	3	cancer	cancer	NOUN
chd-73	66	4	health	health	NOUN
chd-73	66	5	disparities	disparity	NOUN
chd-73	66	6	research	research	VERB
chd-73	66	7	in	in	ADP
chd-73	66	8	vitro	vitro	X
chd-73	66	9	,	,	PUNCT
chd-73	66	10	n2n	n2n	PRON
chd-73	66	11	has	have	AUX
chd-73	66	12	been	be	AUX
chd-73	66	13	shown	show	VERB
chd-73	66	14	to	to	PART
chd-73	66	15	repress	repress	VERB
chd-73	66	16	the	the	DET
chd-73	66	17	transcriptional	transcriptional	ADJ
chd-73	66	18	activities	activity	NOUN
chd-73	66	19	of	of	ADP
chd-73	66	20	notch	notch	ADJ
chd-73	66	21	2	2	NUM
chd-73	66	22	and	and	CCONJ
chd-73	66	23	notch	notch	VERB
chd-73	66	24	1	1	NUM
chd-73	66	25	intracellular	intracellular	ADJ
chd-73	66	26	domains	domain	NOUN
chd-73	66	27	,	,	PUNCT
chd-73	66	28	which	which	PRON
chd-73	66	29	are	be	AUX
chd-73	66	30	important	important	ADJ
chd-73	66	31	for	for	ADP
chd-73	66	32	antitumor	antitumor	PROPN
chd-73	66	33	lymphocyte	lymphocyte	ADJ
chd-73	66	34	effector	effector	NOUN
chd-73	66	35	function	function	NOUN
chd-73	66	36	and	and	CCONJ
chd-73	66	37	memory	memory	NOUN
chd-73	66	38	(	(	PUNCT
chd-73	66	39	biktasova	biktasova	PROPN
chd-73	66	40	et	et	PROPN
chd-73	66	41	al	al	PROPN
chd-73	66	42	.	.	PROPN
chd-73	66	43	,	,	PUNCT
chd-73	66	44	2015	2015	NUM
chd-73	66	45	;	;	PUNCT
chd-73	66	46	huang	huang	PROPN
chd-73	66	47	et	et	PROPN
chd-73	66	48	al	al	PROPN
chd-73	66	49	.	.	PROPN
chd-73	66	50	,	,	PUNCT
chd-73	66	51	2011	2011	NUM
chd-73	66	52	;	;	PUNCT
chd-73	66	53	thounaojam	thounaojam	NOUN
chd-73	66	54	et	et	NOUN
chd-73	66	55	al	al	PROPN
chd-73	66	56	.	.	PROPN
chd-73	66	57	,	,	PUNCT
chd-73	66	58	2015	2015	NUM
chd-73	66	59	)	)	PUNCT
chd-73	66	60	.	.	PUNCT
chd-73	67	1	thus	thus	ADV
chd-73	67	2	,	,	PUNCT
chd-73	67	3	n2n	n2n	PRON
chd-73	67	4	could	could	AUX
chd-73	67	5	be	be	AUX
chd-73	67	6	a	a	DET
chd-73	67	7	possible	possible	ADJ
chd-73	67	8	predictive	predictive	ADJ
chd-73	67	9	candidate	candidate	NOUN
chd-73	67	10	for	for	ADP
chd-73	67	11	cancer	cancer	NOUN
chd-73	67	12	disparities	disparity	NOUN
chd-73	67	13	and	and	CCONJ
chd-73	67	14	poor	poor	ADJ
chd-73	67	15	prognosis	prognosis	NOUN
chd-73	67	16	amongst	amongst	ADP
chd-73	67	17	the	the	DET
chd-73	67	18	african	african	ADJ
chd-73	67	19	-	-	PUNCT
chd-73	67	20	american	american	ADJ
chd-73	67	21	population	population	NOUN
chd-73	67	22	.	.	PUNCT
chd-73	68	1	n2n	n2n	PROPN
chd-73	68	2	has	have	AUX
chd-73	68	3	also	also	ADV
chd-73	68	4	been	be	AUX
chd-73	68	5	shown	show	VERB
chd-73	68	6	to	to	PART
chd-73	68	7	be	be	AUX
chd-73	68	8	targeted	target	VERB
chd-73	68	9	by	by	ADP
chd-73	68	10	neutrophil	neutrophil	ADJ
chd-73	68	11	elastase	elastase	NOUN
chd-73	68	12	and	and	CCONJ
chd-73	68	13	implicated	implicate	VERB
chd-73	68	14	in	in	ADP
chd-73	68	15	hereditary	hereditary	ADJ
chd-73	68	16	neutropenia	neutropenia	NOUN
chd-73	68	17	(	(	PUNCT
chd-73	68	18	duan	duan	PROPN
chd-73	68	19	et	et	PROPN
chd-73	68	20	al	al	PROPN
chd-73	68	21	.	.	PROPN
chd-73	68	22	,	,	PUNCT
chd-73	68	23	2004	2004	NUM
chd-73	68	24	)	)	PUNCT
chd-73	68	25	.	.	PUNCT
chd-73	69	1	role	role	NOUN
chd-73	69	2	of	of	ADP
chd-73	69	3	notch	notch	NOUN
chd-73	69	4	in	in	ADP
chd-73	69	5	cancer	cancer	NOUN
chd-73	69	6	immunity	immunity	NOUN
chd-73	69	7	notch	notch	ADJ
chd-73	69	8	signaling	signal	VERB
chd-73	69	9	in	in	ADP
chd-73	69	10	t	t	NOUN
chd-73	69	11	lymphocytes	lymphocyte	NOUN
chd-73	69	12	it	it	PRON
chd-73	69	13	is	be	AUX
chd-73	69	14	well	well	ADV
chd-73	69	15	established	establish	VERB
chd-73	69	16	that	that	SCONJ
chd-73	69	17	tumor	tumor	NOUN
chd-73	69	18	-	-	PUNCT
chd-73	69	19	induced	induce	VERB
chd-73	69	20	immune	immune	ADJ
chd-73	69	21	suppression	suppression	NOUN
chd-73	69	22	by	by	ADP
chd-73	69	23	multiple	multiple	ADJ
chd-73	69	24	mechanisms	mechanism	NOUN
chd-73	69	25	is	be	AUX
chd-73	69	26	a	a	DET
chd-73	69	27	major	major	ADJ
chd-73	69	28	impediment	impediment	NOUN
chd-73	69	29	to	to	ADP
chd-73	69	30	the	the	DET
chd-73	69	31	success	success	NOUN
chd-73	69	32	of	of	ADP
chd-73	69	33	cancer	cancer	NOUN
chd-73	69	34	therapy	therapy	NOUN
chd-73	69	35	.	.	PUNCT
chd-73	70	1	an	an	DET
chd-73	70	2	intact	intact	ADJ
chd-73	70	3	functional	functional	ADJ
chd-73	70	4	immune	immune	ADJ
chd-73	70	5	system	system	NOUN
chd-73	70	6	is	be	AUX
chd-73	70	7	required	require	VERB
chd-73	70	8	for	for	ADP
chd-73	70	9	the	the	DET
chd-73	70	10	induction	induction	NOUN
chd-73	70	11	of	of	ADP
chd-73	70	12	sustained	sustained	ADJ
chd-73	70	13	tumor	tumor	NOUN
chd-73	70	14	regression	regression	NOUN
chd-73	70	15	upon	upon	SCONJ
chd-73	70	16	inactivation	inactivation	NOUN
chd-73	70	17	of	of	ADP
chd-73	70	18	the	the	DET
chd-73	70	19	tumor	tumor	NOUN
chd-73	70	20	-	-	PUNCT
chd-73	70	21	driving	drive	VERB
chd-73	70	22	oncogenes	oncogene	NOUN
chd-73	70	23	(	(	PUNCT
chd-73	70	24	rakhra	rakhra	NOUN
chd-73	70	25	et	et	PROPN
chd-73	70	26	al	al	PROPN
chd-73	70	27	.	.	PROPN
chd-73	70	28	,	,	PUNCT
chd-73	70	29	2010	2010	NUM
chd-73	70	30	)	)	PUNCT
chd-73	70	31	.	.	PUNCT
chd-73	71	1	the	the	DET
chd-73	71	2	generation	generation	NOUN
chd-73	71	3	of	of	ADP
chd-73	71	4	effector	effector	NOUN
chd-73	71	5	cd8	cd8	PROPN
chd-73	71	6	+	+	PROPN
chd-73	71	7	t	t	PROPN
chd-73	71	8	cells	cell	NOUN
chd-73	71	9	is	be	AUX
chd-73	71	10	imperative	imperative	ADJ
chd-73	71	11	for	for	ADP
chd-73	71	12	antitumor	antitumor	PROPN
chd-73	71	13	immunity	immunity	NOUN
chd-73	71	14	(	(	PUNCT
chd-73	71	15	kuijk	kuijk	NOUN
chd-73	71	16	et	et	PROPN
chd-73	71	17	al	al	PROPN
chd-73	71	18	.	.	PROPN
chd-73	71	19	,	,	PUNCT
chd-73	71	20	2013	2013	NUM
chd-73	71	21	;	;	PUNCT
chd-73	71	22	thounaojam	thounaojam	NOUN
chd-73	71	23	et	et	NOUN
chd-73	71	24	al	al	PROPN
chd-73	71	25	.	.	PROPN
chd-73	71	26	,	,	PUNCT
chd-73	71	27	2015	2015	NUM
chd-73	71	28	;	;	PUNCT
chd-73	71	29	uzhachenko	uzhachenko	PROPN
chd-73	71	30	and	and	CCONJ
chd-73	71	31	shanker	shanker	NOUN
chd-73	71	32	,	,	PUNCT
chd-73	71	33	2016	2016	NUM
chd-73	71	34	)	)	PUNCT
chd-73	71	35	.	.	PUNCT
chd-73	72	1	the	the	DET
chd-73	72	2	notch	notch	NOUN
chd-73	72	3	signaling	signal	VERB
chd-73	72	4	pathway	pathway	NOUN
chd-73	72	5	plays	play	VERB
chd-73	72	6	an	an	DET
chd-73	72	7	important	important	ADJ
chd-73	72	8	role	role	NOUN
chd-73	72	9	in	in	ADP
chd-73	72	10	the	the	DET
chd-73	72	11	regulation	regulation	NOUN
chd-73	72	12	of	of	ADP
chd-73	72	13	differentiation	differentiation	NOUN
chd-73	72	14	and	and	CCONJ
chd-73	72	15	function	function	NOUN
chd-73	72	16	of	of	ADP
chd-73	72	17	lymphocytes	lymphocyte	NOUN
chd-73	72	18	,	,	PUNCT
chd-73	72	19	while	while	SCONJ
chd-73	72	20	being	be	AUX
chd-73	72	21	extremely	extremely	ADV
chd-73	72	22	pleiotropic	pleiotropic	ADJ
chd-73	72	23	with	with	ADP
chd-73	72	24	an	an	DET
chd-73	72	25	interrelated	interrelated	ADJ
chd-73	72	26	network	network	NOUN
chd-73	72	27	of	of	ADP
chd-73	72	28	receptorligand	receptorligand	NOUN
chd-73	72	29	interactions	interaction	NOUN
chd-73	72	30	.	.	PUNCT
chd-73	73	1	most	most	ADJ
chd-73	73	2	gain	gain	VERB
chd-73	73	3	-	-	PUNCT
chd-73	73	4	of	of	ADP
chd-73	73	5	-	-	PUNCT
chd-73	73	6	function	function	NOUN
chd-73	73	7	studies	study	NOUN
chd-73	73	8	indicate	indicate	VERB
chd-73	73	9	that	that	SCONJ
chd-73	73	10	delta	delta	NOUN
chd-73	73	11	-	-	PUNCT
chd-73	73	12	like	like	ADJ
chd-73	73	13	ligands	ligand	NOUN
chd-73	73	14	promote	promote	VERB
chd-73	73	15	cd4	cd4	PROPN
chd-73	73	16	+	+	PROPN
chd-73	73	17	t	t	NOUN
chd-73	73	18	cell	cell	NOUN
chd-73	73	19	commitment	commitment	NOUN
chd-73	73	20	to	to	ADP
chd-73	73	21	th1	th1	PROPN
chd-73	73	22	(	(	PUNCT
chd-73	73	23	amsen	amsen	PROPN
chd-73	73	24	et	et	PROPN
chd-73	73	25	al	al	PROPN
chd-73	73	26	.	.	PROPN
chd-73	73	27	,	,	PUNCT
chd-73	73	28	2009	2009	NUM
chd-73	73	29	;	;	PUNCT
chd-73	73	30	amsen	amsen	VERB
chd-73	73	31	et	et	PROPN
chd-73	73	32	al	al	PROPN
chd-73	73	33	.	.	PROPN
chd-73	73	34	,	,	PUNCT
chd-73	73	35	2004	2004	NUM
chd-73	73	36	)	)	PUNCT
chd-73	73	37	.	.	PUNCT
chd-73	74	1	although	although	SCONJ
chd-73	74	2	controversy	controversy	NOUN
chd-73	74	3	exists	exist	VERB
chd-73	74	4	,	,	PUNCT
chd-73	74	5	the	the	DET
chd-73	74	6	bias	bias	NOUN
chd-73	74	7	is	be	AUX
chd-73	74	8	that	that	SCONJ
chd-73	74	9	jag	jag	VERB
chd-73	74	10	ligands	ligand	NOUN
chd-73	74	11	associate	associate	VERB
chd-73	74	12	with	with	ADP
chd-73	74	13	th2	th2	PROPN
chd-73	74	14	-	-	PUNCT
chd-73	74	15	promoting	promote	VERB
chd-73	74	16	notch	notch	NOUN
chd-73	74	17	function	function	NOUN
chd-73	74	18	(	(	PUNCT
chd-73	74	19	amsen	amsen	VERB
chd-73	74	20	et	et	PROPN
chd-73	74	21	al	al	PROPN
chd-73	74	22	.	.	PROPN
chd-73	74	23	,	,	PUNCT
chd-73	74	24	2009	2009	NUM
chd-73	74	25	;	;	PUNCT
chd-73	74	26	krawczyk	krawczyk	PROPN
chd-73	74	27	et	et	PROPN
chd-73	74	28	al	al	PROPN
chd-73	74	29	.	.	PROPN
chd-73	74	30	,	,	PUNCT
chd-73	74	31	2008	2008	NUM
chd-73	74	32	)	)	PUNCT
chd-73	74	33	.	.	PUNCT
chd-73	75	1	notch	notch	NOUN
chd-73	75	2	has	have	AUX
chd-73	75	3	also	also	ADV
chd-73	75	4	been	be	AUX
chd-73	75	5	reported	report	VERB
chd-73	75	6	to	to	PART
chd-73	75	7	associate	associate	VERB
chd-73	75	8	with	with	ADP
chd-73	75	9	the	the	DET
chd-73	75	10	regulation	regulation	NOUN
chd-73	75	11	of	of	ADP
chd-73	75	12	il17	il17	PROPN
chd-73	75	13	and	and	CCONJ
chd-73	75	14	rort	rort	NOUN
chd-73	75	15	gene	gene	NOUN
chd-73	75	16	promoters	promoter	NOUN
chd-73	75	17	to	to	PART
chd-73	75	18	influence	influence	VERB
chd-73	75	19	th17	th17	PROPN
chd-73	75	20	differentiation	differentiation	NOUN
chd-73	75	21	(	(	PUNCT
chd-73	75	22	keerthivasan	keerthivasan	NOUN
chd-73	75	23	et	et	PROPN
chd-73	75	24	al	al	PROPN
chd-73	75	25	.	.	PROPN
chd-73	75	26	,	,	PUNCT
chd-73	75	27	2011	2011	NUM
chd-73	75	28	)	)	PUNCT
chd-73	75	29	.	.	PUNCT
chd-73	76	1	in	in	ADP
chd-73	76	2	addition	addition	NOUN
chd-73	76	3	to	to	ADP
chd-73	76	4	promoting	promote	VERB
chd-73	76	5	th1	th1	PROPN
chd-73	76	6	,	,	PUNCT
chd-73	76	7	th2	th2	PROPN
chd-73	76	8	and	and	CCONJ
chd-73	76	9	th17	th17	PROPN
chd-73	76	10	differentiation	differentiation	NOUN
chd-73	76	11	,	,	PUNCT
chd-73	76	12	some	some	DET
chd-73	76	13	notch	notch	ADJ
chd-73	76	14	ligands	ligand	NOUN
chd-73	76	15	,	,	PUNCT
chd-73	76	16	on	on	ADP
chd-73	76	17	the	the	DET
chd-73	76	18	contrary	contrary	NOUN
chd-73	76	19	,	,	PUNCT
chd-73	76	20	play	play	VERB
chd-73	76	21	an	an	DET
chd-73	76	22	immunosuppressive	immunosuppressive	ADJ
chd-73	76	23	function	function	NOUN
chd-73	76	24	.	.	PUNCT
chd-73	77	1	expression	expression	NOUN
chd-73	77	2	of	of	ADP
chd-73	77	3	jag	jag	NOUN
chd-73	77	4	ligands	ligand	NOUN
chd-73	77	5	by	by	ADP
chd-73	77	6	antigen	antigen	NOUN
chd-73	77	7	-	-	PUNCT
chd-73	77	8	presenting	present	VERB
chd-73	77	9	cells	cell	NOUN
chd-73	77	10	or	or	CCONJ
chd-73	77	11	hematopoietic	hematopoietic	ADJ
chd-73	77	12	progenitors	progenitor	NOUN
chd-73	77	13	favored	favor	VERB
chd-73	77	14	generation	generation	NOUN
chd-73	77	15	of	of	ADP
chd-73	77	16	suppressive	suppressive	ADJ
chd-73	77	17	t	t	PROPN
chd-73	77	18	cells	cell	NOUN
chd-73	77	19	in	in	ADP
chd-73	77	20	vitro	vitro	X
chd-73	77	21	and	and	CCONJ
chd-73	77	22	regulatory	regulatory	ADJ
chd-73	77	23	t	t	NOUN
chd-73	77	24	cells	cell	NOUN
chd-73	77	25	(	(	PUNCT
chd-73	77	26	treg	treg	PROPN
chd-73	77	27	)	)	PUNCT
chd-73	77	28	in	in	ADP
chd-73	77	29	vivo	vivo	NOUN
chd-73	77	30	(	(	PUNCT
chd-73	77	31	kared	kare	VERB
chd-73	77	32	et	et	PROPN
chd-73	77	33	al	al	PROPN
chd-73	77	34	.	.	PROPN
chd-73	77	35	,	,	PUNCT
chd-73	77	36	2006	2006	NUM
chd-73	77	37	;	;	PUNCT
chd-73	77	38	vigouroux	vigouroux	PROPN
chd-73	77	39	et	et	PROPN
chd-73	77	40	al	al	PROPN
chd-73	77	41	.	.	PROPN
chd-73	77	42	,	,	PUNCT
chd-73	77	43	2003	2003	NUM
chd-73	77	44	;	;	PUNCT
chd-73	77	45	yvon	yvon	PROPN
chd-73	77	46	et	et	PROPN
chd-73	77	47	al	al	PROPN
chd-73	77	48	.	.	PROPN
chd-73	77	49	,	,	PUNCT
chd-73	77	50	2003	2003	NUM
chd-73	77	51	)	)	PUNCT
chd-73	77	52	.	.	PUNCT
chd-73	78	1	in	in	ADP
chd-73	78	2	addition	addition	NOUN
chd-73	78	3	,	,	PUNCT
chd-73	78	4	expression	expression	NOUN
chd-73	78	5	of	of	ADP
chd-73	78	6	delta	delta	NOUN
chd-73	78	7	-	-	PUNCT
chd-73	78	8	like	like	ADJ
chd-73	78	9	notch	notch	NOUN
chd-73	78	10	ligands	ligand	NOUN
chd-73	78	11	in	in	ADP
chd-73	78	12	hematopoietic	hematopoietic	ADJ
chd-73	78	13	compartment	compartment	NOUN
chd-73	78	14	is	be	AUX
chd-73	78	15	significantly	significantly	ADV
chd-73	78	16	altered	alter	VERB
chd-73	78	17	by	by	ADP
chd-73	78	18	tumorderived	tumorderived	ADJ
chd-73	78	19	factors	factor	NOUN
chd-73	78	20	resulting	result	VERB
chd-73	78	21	in	in	ADP
chd-73	78	22	tumor	tumor	NOUN
chd-73	78	23	-	-	PUNCT
chd-73	78	24	induced	induce	VERB
chd-73	78	25	immunosuppression	immunosuppression	NOUN
chd-73	78	26	(	(	PUNCT
chd-73	78	27	biktasova	biktasova	PROPN
chd-73	78	28	et	et	PROPN
chd-73	78	29	al	al	PROPN
chd-73	78	30	.	.	PROPN
chd-73	78	31	,	,	PUNCT
chd-73	78	32	2015	2015	NUM
chd-73	78	33	;	;	PUNCT
chd-73	78	34	huang	huang	PROPN
chd-73	78	35	et	et	PROPN
chd-73	78	36	al	al	PROPN
chd-73	78	37	.	.	PROPN
chd-73	78	38	,	,	PUNCT
chd-73	78	39	2011	2011	NUM
chd-73	78	40	;	;	PUNCT
chd-73	78	41	thounaojam	thounaojam	NOUN
chd-73	78	42	et	et	NOUN
chd-73	78	43	al	al	PROPN
chd-73	78	44	.	.	PROPN
chd-73	78	45	,	,	PUNCT
chd-73	78	46	2015	2015	NUM
chd-73	78	47	)	)	PUNCT
chd-73	78	48	.	.	PUNCT
chd-73	79	1	systemic	systemic	ADJ
chd-73	79	2	blockade	blockade	NOUN
chd-73	79	3	of	of	ADP
chd-73	79	4	jag1/2	jag1/2	NUM
chd-73	79	5	or	or	CCONJ
chd-73	79	6	dll1	dll1	NOUN
chd-73	79	7	overexpression	overexpression	NOUN
chd-73	79	8	overcame	overcome	VERB
chd-73	79	9	tumorinduced	tumorinduce	VERB
chd-73	79	10	t	t	NOUN
chd-73	79	11	cell	cell	NOUN
chd-73	79	12	tolerance	tolerance	NOUN
chd-73	79	13	suggesting	suggest	VERB
chd-73	79	14	the	the	DET
chd-73	79	15	involvement	involvement	NOUN
chd-73	79	16	of	of	ADP
chd-73	79	17	these	these	DET
chd-73	79	18	ligands	ligand	NOUN
chd-73	79	19	in	in	ADP
chd-73	79	20	anti	anti	ADJ
chd-73	79	21	-	-	ADJ
chd-73	79	22	tumor	tumor	ADJ
chd-73	79	23	t	t	NOUN
chd-73	79	24	cell	cell	NOUN
chd-73	79	25	function	function	NOUN
chd-73	79	26	(	(	PUNCT
chd-73	79	27	huang	huang	PROPN
chd-73	79	28	et	et	PROPN
chd-73	79	29	al	al	PROPN
chd-73	79	30	.	.	PROPN
chd-73	79	31	,	,	PUNCT
chd-73	79	32	2011	2011	NUM
chd-73	79	33	;	;	PUNCT
chd-73	79	34	palaga	palaga	NOUN
chd-73	79	35	et	et	PROPN
chd-73	79	36	al	al	PROPN
chd-73	79	37	.	.	PROPN
chd-73	79	38	,	,	PUNCT
chd-73	79	39	2003	2003	NUM
chd-73	79	40	;	;	PUNCT
chd-73	79	41	sierra	sierra	PROPN
chd-73	79	42	et	et	PROPN
chd-73	79	43	al	al	PROPN
chd-73	79	44	.	.	PROPN
chd-73	79	45	,	,	PUNCT
chd-73	79	46	2017	2017	NUM
chd-73	79	47	)	)	PUNCT
chd-73	79	48	.	.	PUNCT
chd-73	80	1	evidence	evidence	NOUN
chd-73	80	2	supports	support	VERB
chd-73	80	3	that	that	SCONJ
chd-73	80	4	notch	notch	NOUN
chd-73	80	5	signaling	signal	VERB
chd-73	80	6	promotes	promote	VERB
chd-73	80	7	differentiation	differentiation	NOUN
chd-73	80	8	of	of	ADP
chd-73	80	9	naïve	naïve	ADJ
chd-73	80	10	cd8	cd8	PROPN
chd-73	80	11	+	+	PROPN
chd-73	80	12	t	t	PROPN
chd-73	80	13	cells	cell	NOUN
chd-73	80	14	into	into	ADP
chd-73	80	15	cytotoxic	cytotoxic	ADJ
chd-73	80	16	and	and	CCONJ
chd-73	80	17	memory	memory	NOUN
chd-73	80	18	t	t	NOUN
chd-73	80	19	lymphocytes	lymphocyte	VERB
chd-73	80	20	by	by	ADP
chd-73	80	21	upregulating	upregulate	VERB
chd-73	80	22	the	the	DET
chd-73	80	23	transcription	transcription	NOUN
chd-73	80	24	factor	factor	NOUN
chd-73	80	25	eomesodermin	eomesodermin	VERB
chd-73	80	26	responsible	responsible	ADJ
chd-73	80	27	for	for	ADP
chd-73	80	28	regulating	regulate	VERB
chd-73	80	29	expression	expression	NOUN
chd-73	80	30	of	of	ADP
chd-73	80	31	effector	effector	NOUN
chd-73	80	32	molecules	molecule	NOUN
chd-73	80	33	ifn	ifn	NOUN
chd-73	80	34	,	,	PUNCT
chd-73	80	35	granzymes	granzyme	NOUN
chd-73	80	36	,	,	PUNCT
chd-73	80	37	and	and	CCONJ
chd-73	80	38	perforins	perforin	NOUN
chd-73	80	39	(	(	PUNCT
chd-73	80	40	biktasova	biktasova	PROPN
chd-73	80	41	et	et	PROPN
chd-73	80	42	al	al	PROPN
chd-73	80	43	.	.	PROPN
chd-73	80	44	,	,	PUNCT
chd-73	80	45	2015	2015	NUM
chd-73	80	46	;	;	PUNCT
chd-73	80	47	palaga	palaga	NOUN
chd-73	80	48	et	et	PROPN
chd-73	80	49	al	al	PROPN
chd-73	80	50	.	.	PROPN
chd-73	80	51	,	,	PUNCT
chd-73	80	52	2003	2003	NUM
chd-73	80	53	;	;	PUNCT
chd-73	80	54	radtke	radtke	VERB
chd-73	80	55	et	et	PROPN
chd-73	80	56	al	al	PROPN
chd-73	80	57	.	.	PROPN
chd-73	80	58	,	,	PUNCT
chd-73	80	59	2010	2010	NUM
chd-73	80	60	;	;	PUNCT
chd-73	80	61	sauma	sauma	PROPN
chd-73	80	62	et	et	PROPN
chd-73	80	63	al	al	PROPN
chd-73	80	64	.	.	PROPN
chd-73	80	65	,	,	PUNCT
chd-73	80	66	2012	2012	NUM
chd-73	80	67	;	;	PUNCT
chd-73	80	68	thounaojam	thounaojam	NOUN
chd-73	80	69	et	et	NOUN
chd-73	80	70	al	al	PROPN
chd-73	80	71	.	.	PROPN
chd-73	80	72	,	,	PUNCT
chd-73	80	73	2015	2015	NUM
chd-73	80	74	;	;	PUNCT
chd-73	80	75	tsukumo	tsukumo	ADJ
chd-73	80	76	and	and	CCONJ
chd-73	80	77	yasutomo	yasutomo	NOUN
chd-73	80	78	,	,	PUNCT
chd-73	80	79	2004	2004	NUM
chd-73	80	80	)	)	PUNCT
chd-73	80	81	.	.	PUNCT
chd-73	81	1	conditional	conditional	ADJ
chd-73	81	2	transgenic	transgenic	NOUN
chd-73	81	3	expression	expression	NOUN
chd-73	81	4	of	of	ADP
chd-73	81	5	notch	notch	ADJ
chd-73	81	6	1	1	NUM
chd-73	81	7	intracellular	intracellular	ADJ
chd-73	81	8	domain	domain	NOUN
chd-73	81	9	in	in	ADP
chd-73	81	10	cd8	cd8	PROPN
chd-73	81	11	+	+	PROPN
chd-73	81	12	t	t	NOUN
chd-73	81	13	cells	cell	NOUN
chd-73	81	14	induces	induce	VERB
chd-73	81	15	maturation	maturation	NOUN
chd-73	81	16	towards	towards	ADP
chd-73	81	17	a	a	DET
chd-73	81	18	central	central	ADJ
chd-73	81	19	memory	memory	NOUN
chd-73	81	20	phenotype	phenotype	NOUN
chd-73	81	21	(	(	PUNCT
chd-73	81	22	sierra	sierra	PROPN
chd-73	81	23	et	et	PROPN
chd-73	81	24	al	al	PROPN
chd-73	81	25	.	.	PROPN
chd-73	81	26	,	,	PUNCT
chd-73	81	27	2014	2014	NUM
chd-73	81	28	)	)	PUNCT
chd-73	81	29	.	.	PUNCT
chd-73	82	1	in	in	ADP
chd-73	82	2	murine	murine	PROPN
chd-73	82	3	cd8	cd8	PROPN
chd-73	82	4	+	+	PROPN
chd-73	82	5	t	t	NOUN
chd-73	82	6	cells	cell	NOUN
chd-73	82	7	,	,	PUNCT
chd-73	82	8	notch	notch	ADJ
chd-73	82	9	signaling	signal	VERB
chd-73	82	10	controls	control	NOUN
chd-73	82	11	activated	activate	VERB
chd-73	82	12	cd8	cd8	PROPN
chd-73	82	13	+	+	PROPN
chd-73	82	14	t	t	PROPN
chd-73	82	15	cell	cell	NOUN
chd-73	82	16	fate	fate	NOUN
chd-73	82	17	towards	towards	ADP
chd-73	82	18	terminal	terminal	ADJ
chd-73	82	19	effector	effector	NOUN
chd-73	82	20	cell	cell	NOUN
chd-73	82	21	versus	versus	ADP
chd-73	82	22	memory	memory	NOUN
chd-73	82	23	precursor	precursor	NOUN
chd-73	82	24	cell	cell	NOUN
chd-73	82	25	fates	fate	NOUN
chd-73	82	26	(	(	PUNCT
chd-73	82	27	backer	backer	NOUN
chd-73	82	28	et	et	PROPN
chd-73	82	29	al	al	PROPN
chd-73	82	30	.	.	PROPN
chd-73	82	31	,	,	PUNCT
chd-73	82	32	2014	2014	NUM
chd-73	82	33	)	)	PUNCT
chd-73	82	34	.	.	PUNCT
chd-73	83	1	studies	study	NOUN
chd-73	83	2	also	also	ADV
chd-73	83	3	noted	note	VERB
chd-73	83	4	that	that	SCONJ
chd-73	83	5	notch1/2	notch1/2	PROPN
chd-73	83	6	signaling	signal	VERB
chd-73	83	7	was	be	AUX
chd-73	83	8	associated	associate	VERB
chd-73	83	9	with	with	ADP
chd-73	83	10	increased	increase	VERB
chd-73	83	11	il-2	il-2	NUM
chd-73	83	12	synthesis	synthesis	NOUN
chd-73	83	13	and	and	CCONJ
chd-73	83	14	upregulated	upregulated	ADJ
chd-73	83	15	expression	expression	NOUN
chd-73	83	16	of	of	ADP
chd-73	83	17	il-2	il-2	ADJ
chd-73	83	18	receptor	receptor	NOUN
chd-73	83	19			NOUN
chd-73	83	20	chain	chain	NOUN
chd-73	83	21	,	,	PUNCT
chd-73	83	22	cd25	cd25	PROPN
chd-73	83	23	on	on	ADP
chd-73	83	24	t	t	NOUN
chd-73	83	25	cells	cell	NOUN
chd-73	83	26	and	and	CCONJ
chd-73	83	27	inhibition	inhibition	NOUN
chd-73	83	28	of	of	ADP
chd-73	83	29	notch	notch	NOUN
chd-73	83	30	signaling	signal	VERB
chd-73	83	31	resulted	result	VERB
chd-73	83	32	in	in	ADP
chd-73	83	33	decreased	decreased	ADJ
chd-73	83	34	proliferation	proliferation	NOUN
chd-73	83	35	of	of	ADP
chd-73	83	36	cd4	cd4	PROPN
chd-73	83	37	+	+	PROPN
chd-73	83	38	and	and	CCONJ
chd-73	83	39	cd8	cd8	PROPN
chd-73	83	40	+	+	PROPN
chd-73	83	41	t	t	PROPN
chd-73	83	42	lymphocytes	lymphocyte	VERB
chd-73	83	43	(	(	PUNCT
chd-73	83	44	adler	adler	PROPN
chd-73	83	45	et	et	PROPN
chd-73	83	46	al	al	PROPN
chd-73	83	47	.	.	PROPN
chd-73	83	48	,	,	PUNCT
chd-73	83	49	2003	2003	NUM
chd-73	83	50	;	;	PUNCT
chd-73	83	51	thounaojam	thounaojam	NOUN
chd-73	83	52	et	et	NOUN
chd-73	83	53	al	al	PROPN
chd-73	83	54	.	.	PROPN
chd-73	83	55	,	,	PUNCT
chd-73	83	56	2015	2015	NUM
chd-73	83	57	)	)	PUNCT
chd-73	83	58	.	.	PUNCT
chd-73	84	1	in	in	ADP
chd-73	84	2	addition	addition	NOUN
chd-73	84	3	,	,	PUNCT
chd-73	84	4	treatment	treatment	NOUN
chd-73	84	5	of	of	ADP
chd-73	84	6	tumor	tumor	NOUN
chd-73	84	7	-	-	PUNCT
chd-73	84	8	bearing	bear	VERB
chd-73	84	9	mice	mouse	NOUN
chd-73	84	10	with	with	ADP
chd-73	84	11	cancer	cancer	NOUN
chd-73	84	12	therapeutic	therapeutic	ADJ
chd-73	84	13	drug	drug	NOUN
chd-73	84	14	bortezomib	bortezomib	NOUN
chd-73	84	15	,	,	PUNCT
chd-73	84	16	a	a	DET
chd-73	84	17	proteasome	proteasome	NOUN
chd-73	84	18	inhibitor	inhibitor	NOUN
chd-73	84	19	,	,	PUNCT
chd-73	84	20	enhanced	enhance	VERB
chd-73	84	21	expression	expression	NOUN
chd-73	84	22	of	of	ADP
chd-73	84	23	notch	notch	ADJ
chd-73	84	24	signaling	signal	VERB
chd-73	84	25	components	component	NOUN
chd-73	84	26	in	in	ADP
chd-73	84	27	lymphoid	lymphoid	ADJ
chd-73	84	28	tissues	tissue	NOUN
chd-73	84	29	resulting	result	VERB
chd-73	84	30	in	in	ADP
chd-73	84	31	cd8	cd8	PROPN
chd-73	84	32	+	+	PROPN
chd-73	84	33	t	t	PROPN
chd-73	84	34	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	AUX
chd-73	84	35	e6	e6	VERB
chd-73	84	36	cancer	cancer	NOUN
chd-73	84	37	health	health	NOUN
chd-73	84	38	disparities	disparity	NOUN
chd-73	84	39	research	research	NOUN
chd-73	84	40	cell	cell	NOUN
chd-73	84	41	expression	expression	NOUN
chd-73	84	42	of	of	ADP
chd-73	84	43	effector	effector	NOUN
chd-73	84	44	molecules	molecule	NOUN
chd-73	84	45	,	,	PUNCT
chd-73	84	46	perforin	perforin	NOUN
chd-73	84	47	and	and	CCONJ
chd-73	84	48	granzyme	granzyme	NOUN
chd-73	84	49	b	b	PROPN
chd-73	84	50	as	as	ADV
chd-73	84	51	well	well	ADV
chd-73	84	52	as	as	ADP
chd-73	84	53	ifn-secretion	ifn-secretion	NOUN
chd-73	84	54	(	(	PUNCT
chd-73	84	55	thounaojam	thounaojam	NOUN
chd-73	84	56	et	et	NOUN
chd-73	84	57	al	al	PROPN
chd-73	84	58	.	.	PROPN
chd-73	84	59	,	,	PUNCT
chd-73	84	60	2015	2015	NUM
chd-73	84	61	)	)	PUNCT
chd-73	84	62	.	.	PUNCT
chd-73	85	1	furthermore	furthermore	ADV
chd-73	85	2	,	,	PUNCT
chd-73	85	3	there	there	PRON
chd-73	85	4	appears	appear	VERB
chd-73	85	5	to	to	PART
chd-73	85	6	be	be	AUX
chd-73	85	7	a	a	DET
chd-73	85	8	consensus	consensus	NOUN
chd-73	85	9	in	in	ADP
chd-73	85	10	the	the	DET
chd-73	85	11	published	publish	VERB
chd-73	85	12	data	datum	NOUN
chd-73	85	13	to	to	PART
chd-73	85	14	suggest	suggest	VERB
chd-73	85	15	that	that	SCONJ
chd-73	85	16	notch	notch	VERB
chd-73	85	17	1	1	NUM
chd-73	85	18	and	and	CCONJ
chd-73	85	19	notch	notch	ADJ
chd-73	85	20	2	2	NUM
chd-73	85	21	are	be	AUX
chd-73	85	22	key	key	ADJ
chd-73	85	23	players	player	NOUN
chd-73	85	24	in	in	ADP
chd-73	85	25	the	the	DET
chd-73	85	26	induction	induction	NOUN
chd-73	85	27	of	of	ADP
chd-73	85	28	cytolytic	cytolytic	ADJ
chd-73	85	29	and	and	CCONJ
chd-73	85	30	memory	memory	NOUN
chd-73	85	31	t	t	PROPN
chd-73	85	32	cell	cell	NOUN
chd-73	85	33	function	function	NOUN
chd-73	85	34	(	(	PUNCT
chd-73	85	35	auderset	auderset	VERB
chd-73	85	36	et	et	PROPN
chd-73	85	37	al	al	PROPN
chd-73	85	38	.	.	PROPN
chd-73	85	39	,	,	PUNCT
chd-73	85	40	2012	2012	NUM
chd-73	85	41	;	;	PUNCT
chd-73	85	42	biktasova	biktasova	PROPN
chd-73	85	43	et	et	PROPN
chd-73	85	44	al	al	PROPN
chd-73	85	45	.	.	PROPN
chd-73	85	46	,	,	PUNCT
chd-73	85	47	2015	2015	NUM
chd-73	85	48	;	;	PUNCT
chd-73	85	49	huang	huang	PROPN
chd-73	85	50	et	et	PROPN
chd-73	85	51	al	al	PROPN
chd-73	85	52	.	.	PROPN
chd-73	85	53	,	,	PUNCT
chd-73	85	54	2011	2011	NUM
chd-73	85	55	;	;	PUNCT
chd-73	85	56	laky	laky	PROPN
chd-73	85	57	et	et	PROPN
chd-73	85	58	al	al	PROPN
chd-73	85	59	.	.	PROPN
chd-73	85	60	,	,	PUNCT
chd-73	85	61	2015	2015	NUM
chd-73	85	62	;	;	PUNCT
chd-73	85	63	sierra	sierra	PROPN
chd-73	85	64	et	et	PROPN
chd-73	85	65	al	al	PROPN
chd-73	85	66	.	.	PROPN
chd-73	85	67	,	,	PUNCT
chd-73	85	68	2014	2014	NUM
chd-73	85	69	;	;	PUNCT
chd-73	85	70	sugimoto	sugimoto	PROPN
chd-73	85	71	et	et	PROPN
chd-73	85	72	al	al	PROPN
chd-73	85	73	.	.	PROPN
chd-73	85	74	,	,	PUNCT
chd-73	85	75	2010	2010	NUM
chd-73	85	76	;	;	PUNCT
chd-73	85	77	thounaojam	thounaojam	NOUN
chd-73	85	78	et	et	NOUN
chd-73	85	79	al	al	PROPN
chd-73	85	80	.	.	PROPN
chd-73	85	81	,	,	PUNCT
chd-73	85	82	2015	2015	NUM
chd-73	85	83	)	)	PUNCT
chd-73	85	84	.	.	PUNCT
chd-73	86	1	recently	recently	ADV
chd-73	86	2	,	,	PUNCT
chd-73	86	3	it	it	PRON
chd-73	86	4	was	be	AUX
chd-73	86	5	shown	show	VERB
chd-73	86	6	that	that	SCONJ
chd-73	86	7	notch	notch	NOUN
chd-73	86	8	1	1	NUM
chd-73	86	9	activation	activation	NOUN
chd-73	86	10	could	could	AUX
chd-73	86	11	occur	occur	VERB
chd-73	86	12	in	in	ADP
chd-73	86	13	peripheral	peripheral	ADJ
chd-73	86	14	t	t	NOUN
chd-73	86	15	cells	cell	NOUN
chd-73	86	16	in	in	ADP
chd-73	86	17	a	a	DET
chd-73	86	18	ligand	ligand	NOUN
chd-73	86	19	-	-	PUNCT
chd-73	86	20	independent	independent	ADJ
chd-73	86	21	manner	manner	NOUN
chd-73	86	22	through	through	ADP
chd-73	86	23	chemical	chemical	ADJ
chd-73	86	24	adjustments	adjustment	NOUN
chd-73	86	25	in	in	ADP
chd-73	86	26	the	the	DET
chd-73	86	27	endosome	endosome	NOUN
chd-73	86	28	within	within	ADP
chd-73	86	29	a	a	DET
chd-73	86	30	few	few	ADJ
chd-73	86	31	hours	hour	NOUN
chd-73	86	32	post	post	ADJ
chd-73	86	33	-	-	ADJ
chd-73	86	34	tcr	tcr	ADJ
chd-73	86	35	stimulation	stimulation	NOUN
chd-73	86	36	(	(	PUNCT
chd-73	86	37	steinbuck	steinbuck	NOUN
chd-73	86	38	et	et	PROPN
chd-73	86	39	al	al	PROPN
chd-73	86	40	.	.	PROPN
chd-73	86	41	,	,	PUNCT
chd-73	86	42	2018	2018	NUM
chd-73	86	43	)	)	PUNCT
chd-73	86	44	.	.	PUNCT
chd-73	87	1	alternatively	alternatively	ADV
chd-73	87	2	,	,	PUNCT
chd-73	87	3	notch	notch	NOUN
chd-73	87	4	1/2	1/2	NUM
chd-73	87	5	may	may	AUX
chd-73	87	6	fine	fine	ADJ
chd-73	87	7	-	-	PUNCT
chd-73	87	8	tune	tune	NOUN
chd-73	87	9	the	the	DET
chd-73	87	10	sensitivity	sensitivity	NOUN
chd-73	87	11	,	,	PUNCT
chd-73	87	12	magnitude	magnitude	NOUN
chd-73	87	13	and	and	CCONJ
chd-73	87	14	quality	quality	NOUN
chd-73	87	15	of	of	ADP
chd-73	87	16	the	the	DET
chd-73	87	17	t	t	NOUN
chd-73	87	18	cell	cell	NOUN
chd-73	87	19	response	response	NOUN
chd-73	87	20	by	by	ADP
chd-73	87	21	promoting	promote	VERB
chd-73	87	22	metabolic	metabolic	NOUN
chd-73	87	23	reprogramming	reprogramme	VERB
chd-73	87	24	besides	besides	SCONJ
chd-73	87	25	specifying	specify	VERB
chd-73	87	26	lineage	lineage	NOUN
chd-73	87	27	choice	choice	NOUN
chd-73	87	28	or	or	CCONJ
chd-73	87	29	controlling	control	VERB
chd-73	87	30	expression	expression	NOUN
chd-73	87	31	of	of	ADP
chd-73	87	32	regulators	regulator	NOUN
chd-73	87	33	following	follow	VERB
chd-73	87	34	the	the	DET
chd-73	87	35	initial	initial	ADJ
chd-73	87	36	steps	step	NOUN
chd-73	87	37	of	of	ADP
chd-73	87	38	antigen	antigen	ADJ
chd-73	87	39	encounter	encounter	NOUN
chd-73	87	40	by	by	ADP
chd-73	87	41	t	t	PROPN
chd-73	87	42	cells	cell	NOUN
chd-73	87	43	(	(	PUNCT
chd-73	87	44	laky	laky	PROPN
chd-73	87	45	et	et	PROPN
chd-73	87	46	al	al	PROPN
chd-73	87	47	.	.	PROPN
chd-73	87	48	,	,	PUNCT
chd-73	87	49	2015	2015	NUM
chd-73	87	50	)	)	PUNCT
chd-73	87	51	.	.	PUNCT
chd-73	88	1	also	also	ADV
chd-73	88	2	,	,	PUNCT
chd-73	88	3	it	it	PRON
chd-73	88	4	is	be	AUX
chd-73	88	5	known	know	VERB
chd-73	88	6	that	that	SCONJ
chd-73	88	7	a	a	DET
chd-73	88	8	transient	transient	ADJ
chd-73	88	9	pulse	pulse	NOUN
chd-73	88	10	of	of	ADP
chd-73	88	11	a	a	DET
chd-73	88	12	high	high	ADJ
chd-73	88	13	level	level	NOUN
chd-73	88	14	of	of	ADP
chd-73	88	15	notch	notch	ADJ
chd-73	88	16	1/2	1/2	NUM
chd-73	88	17	cognate	cognate	NOUN
chd-73	88	18	delta	delta	NOUN
chd-73	88	19	-	-	PUNCT
chd-73	88	20	like	like	ADJ
chd-73	88	21	ligand	ligand	NOUN
chd-73	88	22	is	be	AUX
chd-73	88	23	capable	capable	ADJ
chd-73	88	24	of	of	ADP
chd-73	88	25	inducing	induce	VERB
chd-73	88	26	hes1	hes1	ADJ
chd-73	88	27	expression	expression	NOUN
chd-73	88	28	for	for	ADP
chd-73	88	29	a	a	DET
chd-73	88	30	duration	duration	NOUN
chd-73	88	31	that	that	PRON
chd-73	88	32	is	be	AUX
chd-73	88	33	sufficient	sufficient	ADJ
chd-73	88	34	to	to	PART
chd-73	88	35	induce	induce	VERB
chd-73	88	36	a	a	DET
chd-73	88	37	binary	binary	ADJ
chd-73	88	38	cell	cell	NOUN
chd-73	88	39	fate	fate	NOUN
chd-73	88	40	switch	switch	NOUN
chd-73	88	41	.	.	PUNCT
chd-73	89	1	for	for	ADP
chd-73	89	2	example	example	NOUN
chd-73	89	3	,	,	PUNCT
chd-73	89	4	transient	transient	ADJ
chd-73	89	5	dll	dll	NOUN
chd-73	89	6	-	-	PUNCT
chd-73	89	7	notch	notch	NOUN
chd-73	89	8	signaling	signaling	NOUN
chd-73	89	9	has	have	AUX
chd-73	89	10	been	be	AUX
chd-73	89	11	shown	show	VERB
chd-73	89	12	to	to	PART
chd-73	89	13	be	be	AUX
chd-73	89	14	sufficient	sufficient	ADJ
chd-73	89	15	to	to	PART
chd-73	89	16	induce	induce	VERB
chd-73	89	17	t	t	NOUN
chd-73	89	18	cell	cell	NOUN
chd-73	89	19	(	(	PUNCT
chd-73	89	20	lefort	lefort	NOUN
chd-73	89	21	et	et	PROPN
chd-73	89	22	al	al	PROPN
chd-73	89	23	.	.	PROPN
chd-73	89	24	,	,	PUNCT
chd-73	89	25	2006	2006	NUM
chd-73	89	26	)	)	PUNCT
chd-73	89	27	or	or	CCONJ
chd-73	89	28	nk	nk	PROPN
chd-73	89	29	cell	cell	NOUN
chd-73	89	30	differentiation	differentiation	NOUN
chd-73	89	31	(	(	PUNCT
chd-73	89	32	carotta	carotta	NOUN
chd-73	89	33	et	et	PROPN
chd-73	89	34	al	al	PROPN
chd-73	89	35	.	.	PROPN
chd-73	89	36	,	,	PUNCT
chd-73	89	37	2006	2006	NUM
chd-73	89	38	)	)	PUNCT
chd-73	89	39	.	.	PUNCT
chd-73	90	1	notch	notch	NOUN
chd-73	90	2	signaling	signal	VERB
chd-73	90	3	in	in	ADP
chd-73	90	4	nk	nk	PROPN
chd-73	90	5	cells	cell	NOUN
chd-73	90	6	human	human	ADJ
chd-73	90	7	studies	study	NOUN
chd-73	90	8	indicate	indicate	VERB
chd-73	90	9	that	that	SCONJ
chd-73	90	10	notch	notch	NOUN
chd-73	90	11	1	1	NUM
chd-73	90	12	signaling	signal	VERB
chd-73	90	13	is	be	AUX
chd-73	90	14	crucial	crucial	ADJ
chd-73	90	15	for	for	ADP
chd-73	90	16	nk	nk	PROPN
chd-73	90	17	cell	cell	NOUN
chd-73	90	18	maturation	maturation	NOUN
chd-73	90	19	and	and	CCONJ
chd-73	90	20	effector	effector	NOUN
chd-73	90	21	function	function	NOUN
chd-73	90	22	as	as	ADV
chd-73	90	23	well	well	ADV
chd-73	90	24	,	,	PUNCT
chd-73	90	25	with	with	ADP
chd-73	90	26	an	an	DET
chd-73	90	27	increase	increase	NOUN
chd-73	90	28	in	in	ADP
chd-73	90	29	notch	notch	NOUN
chd-73	90	30	1	1	NUM
chd-73	90	31	signaling	signal	VERB
chd-73	90	32	leading	lead	VERB
chd-73	90	33	to	to	ADP
chd-73	90	34	an	an	DET
chd-73	90	35	enhanced	enhanced	ADJ
chd-73	90	36	inhibitory	inhibitory	ADJ
chd-73	90	37	killer	killer	NOUN
chd-73	90	38	immunoglobulin	immunoglobulin	NOUN
chd-73	90	39	-	-	PUNCT
chd-73	90	40	like	like	ADJ
chd-73	90	41	receptor	receptor	NOUN
chd-73	90	42	(	(	PUNCT
chd-73	90	43	kir	kir	PROPN
chd-73	90	44	)	)	PUNCT
chd-73	90	45	expression	expression	NOUN
chd-73	90	46	on	on	ADP
chd-73	90	47	nk	nk	PROPN
chd-73	90	48	cells	cell	NOUN
chd-73	90	49	.	.	PUNCT
chd-73	91	1	augmented	augment	VERB
chd-73	91	2	notch	notch	NOUN
chd-73	91	3	1	1	NUM
chd-73	91	4	signaling	signal	VERB
chd-73	91	5	also	also	ADV
chd-73	91	6	induces	induce	VERB
chd-73	91	7	increased	increase	VERB
chd-73	91	8	cytolytic	cytolytic	ADJ
chd-73	91	9	effector	effector	NOUN
chd-73	91	10	capacity	capacity	NOUN
chd-73	91	11	and	and	CCONJ
chd-73	91	12	cytokine	cytokine	VERB
chd-73	91	13	secretion	secretion	NOUN
chd-73	91	14	of	of	ADP
chd-73	91	15	human	human	ADJ
chd-73	91	16	peripheral	peripheral	ADJ
chd-73	91	17	nk	nk	PROPN
chd-73	91	18	cells	cell	NOUN
chd-73	91	19	,	,	PUNCT
chd-73	91	20	enhancing	enhance	VERB
chd-73	91	21	their	their	PRON
chd-73	91	22	antitumor	antitumor	PROPN
chd-73	91	23	functions	function	NOUN
chd-73	91	24	(	(	PUNCT
chd-73	91	25	felices	felice	NOUN
chd-73	91	26	et	et	PROPN
chd-73	91	27	al	al	PROPN
chd-73	91	28	.	.	PROPN
chd-73	91	29	,	,	PUNCT
chd-73	91	30	2014	2014	NUM
chd-73	91	31	)	)	PUNCT
chd-73	91	32	.	.	PUNCT
chd-73	92	1	furthermore	furthermore	ADV
chd-73	92	2	,	,	PUNCT
chd-73	92	3	an	an	DET
chd-73	92	4	increase	increase	NOUN
chd-73	92	5	in	in	ADP
chd-73	92	6	notch	notch	NOUN
chd-73	92	7	signaling	signal	VERB
chd-73	92	8	by	by	ADP
chd-73	92	9	mir-181	mir-181	NOUN
chd-73	92	10	increases	increase	NOUN
chd-73	92	11	production	production	NOUN
chd-73	92	12	of	of	ADP
chd-73	92	13	ifn-	ifn-	PROPN
chd-73	92	14	in	in	ADP
chd-73	92	15	primary	primary	ADJ
chd-73	92	16	nk	nk	PROPN
chd-73	92	17	cells	cell	NOUN
chd-73	92	18	(	(	PUNCT
chd-73	92	19	cichocki	cichocki	PROPN
chd-73	92	20	et	et	PROPN
chd-73	92	21	al	al	PROPN
chd-73	92	22	.	.	PROPN
chd-73	92	23	,	,	PUNCT
chd-73	92	24	2011	2011	NUM
chd-73	92	25	)	)	PUNCT
chd-73	92	26	.	.	PUNCT
chd-73	93	1	in	in	ADP
chd-73	93	2	murine	murine	ADJ
chd-73	93	3	studies	study	NOUN
chd-73	93	4	,	,	PUNCT
chd-73	93	5	dendritic	dendritic	ADJ
chd-73	93	6	cell	cell	NOUN
chd-73	93	7	overexpression	overexpression	NOUN
chd-73	93	8	of	of	ADP
chd-73	93	9	notch	notch	ADJ
chd-73	93	10	ligand	ligand	ADJ
chd-73	93	11	jag2	jag2	NOUN
chd-73	93	12	,	,	PUNCT
chd-73	93	13	which	which	PRON
chd-73	93	14	signals	signal	VERB
chd-73	93	15	through	through	ADP
chd-73	93	16	notch	notch	NOUN
chd-73	93	17	2	2	NUM
chd-73	93	18	,	,	PUNCT
chd-73	93	19	directly	directly	ADV
chd-73	93	20	enhances	enhance	VERB
chd-73	93	21	nk	nk	PROPN
chd-73	93	22	cytotoxicity	cytotoxicity	NOUN
chd-73	93	23	,	,	PUNCT
chd-73	93	24	ifn-production	ifn-production	NOUN
chd-73	93	25	,	,	PUNCT
chd-73	93	26	and	and	CCONJ
chd-73	93	27	proliferation	proliferation	NOUN
chd-73	93	28	(	(	PUNCT
chd-73	93	29	kijima	kijima	PROPN
chd-73	93	30	et	et	PROPN
chd-73	93	31	al	al	PROPN
chd-73	93	32	.	.	PROPN
chd-73	93	33	,	,	PUNCT
chd-73	93	34	2008	2008	NUM
chd-73	93	35	)	)	PUNCT
chd-73	93	36	.	.	PUNCT
chd-73	94	1	from	from	ADP
chd-73	94	2	these	these	DET
chd-73	94	3	studies	study	NOUN
chd-73	94	4	,	,	PUNCT
chd-73	94	5	it	it	PRON
chd-73	94	6	is	be	AUX
chd-73	94	7	evident	evident	ADJ
chd-73	94	8	that	that	SCONJ
chd-73	94	9	notch	notch	ADJ
chd-73	94	10	signaling	signal	VERB
chd-73	94	11	apparatus	apparatus	NOUN
chd-73	94	12	is	be	AUX
chd-73	94	13	critical	critical	ADJ
chd-73	94	14	not	not	PART
chd-73	94	15	only	only	ADV
chd-73	94	16	for	for	ADP
chd-73	94	17	t	t	PROPN
chd-73	94	18	cell	cell	NOUN
chd-73	94	19	effector	effector	NOUN
chd-73	94	20	and	and	CCONJ
chd-73	94	21	memory	memory	NOUN
chd-73	94	22	functions	function	NOUN
chd-73	94	23	but	but	CCONJ
chd-73	94	24	also	also	ADV
chd-73	94	25	for	for	ADP
chd-73	94	26	nk	nk	PROPN
chd-73	94	27	cell	cell	NOUN
chd-73	94	28	function	function	NOUN
chd-73	94	29	.	.	PUNCT
chd-73	95	1	overcoming	overcome	VERB
chd-73	95	2	tumor	tumor	NOUN
chd-73	95	3	interference	interference	NOUN
chd-73	95	4	with	with	ADP
chd-73	95	5	lymphopoietic	lymphopoietic	ADJ
chd-73	95	6	notch	notch	NOUN
chd-73	95	7	given	give	VERB
chd-73	95	8	the	the	DET
chd-73	95	9	critical	critical	ADJ
chd-73	95	10	roles	role	NOUN
chd-73	95	11	of	of	ADP
chd-73	95	12	notch	notch	NOUN
chd-73	95	13	in	in	ADP
chd-73	95	14	providing	provide	VERB
chd-73	95	15	instructive	instructive	ADJ
chd-73	95	16	signals	signal	NOUN
chd-73	95	17	for	for	ADP
chd-73	95	18	t	t	NOUN
chd-73	95	19	cell	cell	NOUN
chd-73	95	20	and	and	CCONJ
chd-73	95	21	nk	nk	PROPN
chd-73	95	22	cell	cell	NOUN
chd-73	95	23	differentiation	differentiation	NOUN
chd-73	95	24	and	and	CCONJ
chd-73	95	25	function	function	NOUN
chd-73	95	26	,	,	PUNCT
chd-73	95	27	it	it	PRON
chd-73	95	28	is	be	AUX
chd-73	95	29	logical	logical	ADJ
chd-73	95	30	to	to	PART
chd-73	95	31	consider	consider	VERB
chd-73	95	32	that	that	SCONJ
chd-73	95	33	tumors	tumor	NOUN
chd-73	95	34	will	will	AUX
chd-73	95	35	interfere	interfere	VERB
chd-73	95	36	with	with	ADP
chd-73	95	37	notch	notch	NOUN
chd-73	95	38	signaling	signal	VERB
chd-73	95	39	in	in	ADP
chd-73	95	40	lymphocytes	lymphocyte	NOUN
chd-73	95	41	to	to	PART
chd-73	95	42	promote	promote	VERB
chd-73	95	43	and	and	CCONJ
chd-73	95	44	sustain	sustain	VERB
chd-73	95	45	tumor	tumor	NOUN
chd-73	95	46	growth	growth	NOUN
chd-73	95	47	.	.	PUNCT
chd-73	96	1	indeed	indeed	ADV
chd-73	96	2	,	,	PUNCT
chd-73	96	3	tumors	tumor	NOUN
chd-73	96	4	downregulate	downregulate	VERB
chd-73	96	5	or	or	CCONJ
chd-73	96	6	perturb	perturb	VERB
chd-73	96	7	notch	notch	NOUN
chd-73	96	8	signaling	signal	VERB
chd-73	96	9	in	in	ADP
chd-73	96	10	lymphocytes	lymphocyte	NOUN
chd-73	96	11	to	to	PART
chd-73	96	12	escape	escape	VERB
chd-73	96	13	immune	immune	ADJ
chd-73	96	14	surveillance	surveillance	NOUN
chd-73	96	15	.	.	PUNCT
chd-73	97	1	moreover	moreover	ADV
chd-73	97	2	,	,	PUNCT
chd-73	97	3	tumors	tumor	NOUN
chd-73	97	4	tend	tend	VERB
chd-73	97	5	to	to	PART
chd-73	97	6	alter	alter	VERB
chd-73	97	7	the	the	DET
chd-73	97	8	expression	expression	NOUN
chd-73	97	9	of	of	ADP
chd-73	97	10	notch	notch	ADJ
chd-73	97	11	ligands	ligand	NOUN
chd-73	97	12	as	as	ADP
chd-73	97	13	a	a	DET
chd-73	97	14	prominent	prominent	ADJ
chd-73	97	15	mechanism	mechanism	NOUN
chd-73	97	16	of	of	ADP
chd-73	97	17	immunosuppression	immunosuppression	NOUN
chd-73	97	18	in	in	ADP
chd-73	97	19	conjunction	conjunction	NOUN
chd-73	97	20	with	with	ADP
chd-73	97	21	elevated	elevated	ADJ
chd-73	97	22	circulating	circulate	VERB
chd-73	97	23	levels	level	NOUN
chd-73	97	24	of	of	ADP
chd-73	97	25	vascular	vascular	ADJ
chd-73	97	26	endothelial	endothelial	ADJ
chd-73	97	27	growth	growth	NOUN
chd-73	97	28	factor	factor	NOUN
chd-73	97	29	(	(	PUNCT
chd-73	97	30	vegf	vegf	PROPN
chd-73	97	31	)	)	PUNCT
chd-73	98	1	(	(	PUNCT
chd-73	98	2	huang	huang	PROPN
chd-73	98	3	et	et	PROPN
chd-73	98	4	al	al	PROPN
chd-73	98	5	.	.	PROPN
chd-73	98	6	,	,	PUNCT
chd-73	98	7	2011	2011	NUM
chd-73	98	8	;	;	PUNCT
chd-73	98	9	novitskiy	novitskiy	PROPN
chd-73	98	10	et	et	PROPN
chd-73	98	11	al	al	PROPN
chd-73	98	12	.	.	PROPN
chd-73	98	13	,	,	PUNCT
chd-73	98	14	2010	2010	NUM
chd-73	98	15	)	)	PUNCT
chd-73	98	16	.	.	PUNCT
chd-73	99	1	in	in	ADP
chd-73	99	2	particular	particular	ADJ
chd-73	99	3	,	,	PUNCT
chd-73	99	4	tumors	tumor	NOUN
chd-73	99	5	specifically	specifically	ADV
chd-73	99	6	downregulate	downregulate	VERB
chd-73	99	7	expression	expression	NOUN
chd-73	99	8	of	of	ADP
chd-73	99	9	delta	delta	NOUN
chd-73	99	10	-	-	PUNCT
chd-73	99	11	like	like	ADJ
chd-73	99	12	ligands	ligand	NOUN
chd-73	99	13	dll1	dll1	PROPN
chd-73	99	14	and	and	CCONJ
chd-73	99	15	dll4	dll4	PROPN
chd-73	99	16	in	in	ADP
chd-73	99	17	the	the	DET
chd-73	99	18	tumor	tumor	NOUN
chd-73	99	19	microenvironment	microenvironment	NOUN
chd-73	99	20	to	to	PART
chd-73	99	21	escape	escape	VERB
chd-73	99	22	from	from	ADP
chd-73	99	23	t	t	NOUN
chd-73	99	24	cellmediated	cellmediate	VERB
chd-73	99	25	immunity	immunity	NOUN
chd-73	99	26	(	(	PUNCT
chd-73	99	27	biktasova	biktasova	PROPN
chd-73	99	28	et	et	PROPN
chd-73	99	29	al	al	PROPN
chd-73	99	30	.	.	PROPN
chd-73	99	31	,	,	PUNCT
chd-73	99	32	2015	2015	NUM
chd-73	99	33	;	;	PUNCT
chd-73	99	34	huang	huang	PROPN
chd-73	99	35	et	et	PROPN
chd-73	99	36	al	al	PROPN
chd-73	99	37	.	.	PROPN
chd-73	99	38	,	,	PUNCT
chd-73	99	39	2011	2011	NUM
chd-73	99	40	;	;	PUNCT
chd-73	99	41	thounaojam	thounaojam	NOUN
chd-73	99	42	et	et	NOUN
chd-73	99	43	al	al	PROPN
chd-73	99	44	.	.	PROPN
chd-73	99	45	,	,	PUNCT
chd-73	99	46	2015	2015	NUM
chd-73	99	47	)	)	PUNCT
chd-73	99	48	.	.	PUNCT
chd-73	100	1	restoring	restore	VERB
chd-73	100	2	the	the	DET
chd-73	100	3	cognate	cognate	NOUN
chd-73	100	4	notch	notch	NOUN
chd-73	100	5	receptor	receptor	NOUN
chd-73	100	6	signaling	signal	VERB
chd-73	100	7	by	by	ADP
chd-73	100	8	enhancing	enhance	VERB
chd-73	100	9	the	the	DET
chd-73	100	10	availability	availability	NOUN
chd-73	100	11	of	of	ADP
chd-73	100	12	dll1	dll1	NOUN
chd-73	100	13	by	by	ADP
chd-73	100	14	endogenous	endogenous	ADJ
chd-73	100	15	overexpression	overexpression	NOUN
chd-73	100	16	or	or	CCONJ
chd-73	100	17	pharmacological	pharmacological	ADJ
chd-73	100	18	administration	administration	NOUN
chd-73	100	19	of	of	ADP
chd-73	100	20	clustered	clustered	ADJ
chd-73	100	21	multivalent	multivalent	NOUN
chd-73	100	22	dll1	dll1	PROPN
chd-73	100	23	leads	lead	VERB
chd-73	100	24	to	to	ADP
chd-73	100	25	improved	improve	VERB
chd-73	100	26	tumor	tumor	NOUN
chd-73	100	27	rejection	rejection	NOUN
chd-73	100	28	(	(	PUNCT
chd-73	100	29	biktasova	biktasova	PROPN
chd-73	100	30	et	et	PROPN
chd-73	100	31	al	al	PROPN
chd-73	100	32	.	.	PROPN
chd-73	100	33	,	,	PUNCT
chd-73	100	34	2015	2015	NUM
chd-73	100	35	;	;	PUNCT
chd-73	100	36	huang	huang	PROPN
chd-73	100	37	et	et	PROPN
chd-73	100	38	al	al	PROPN
chd-73	100	39	.	.	PROPN
chd-73	100	40	,	,	PUNCT
chd-73	100	41	2011	2011	NUM
chd-73	100	42	)	)	PUNCT
chd-73	100	43	.	.	PUNCT
chd-73	101	1	furthermore	furthermore	ADV
chd-73	101	2	,	,	PUNCT
chd-73	101	3	tumor	tumor	NOUN
chd-73	101	4	-	-	PUNCT
chd-73	101	5	bearing	bear	VERB
chd-73	101	6	mice	mouse	NOUN
chd-73	101	7	following	follow	VERB
chd-73	101	8	treatment	treatment	NOUN
chd-73	101	9	with	with	ADP
chd-73	101	10	the	the	DET
chd-73	101	11	proteasome	proteasome	NOUN
chd-73	101	12	inhibitor	inhibitor	NOUN
chd-73	101	13	bortezomib	bortezomib	NOUN
chd-73	101	14	,	,	PUNCT
chd-73	101	15	showed	show	VERB
chd-73	101	16	increased	increased	ADJ
chd-73	101	17	cd8	cd8	PROPN
chd-73	101	18	+	+	PROPN
chd-73	101	19	t	t	PROPN
chd-73	101	20	lymphocyte	lymphocyte	ADJ
chd-73	101	21	ifn-	ifn-	PROPN
chd-73	101	22	secretion	secretion	NOUN
chd-73	101	23	and	and	CCONJ
chd-73	101	24	perforin	perforin	NOUN
chd-73	101	25	and	and	CCONJ
chd-73	101	26	granzyme	granzyme	NOUN
chd-73	101	27	b	b	NOUN
chd-73	101	28	expression	expression	NOUN
chd-73	101	29	by	by	ADP
chd-73	101	30	enhanced	enhance	VERB
chd-73	101	31	notch	notch	NOUN
chd-73	101	32	-	-	PUNCT
chd-73	101	33	nf-b	nf-b	NOUN
chd-73	101	34	signaling	signal	VERB
chd-73	101	35	crosstalk	crosstalk	NOUN
chd-73	101	36	(	(	PUNCT
chd-73	101	37	thounaojam	thounaojam	NOUN
chd-73	101	38	et	et	NOUN
chd-73	101	39	al	al	PROPN
chd-73	101	40	.	.	PROPN
chd-73	101	41	,	,	PUNCT
chd-73	101	42	2015	2015	NUM
chd-73	101	43	;	;	PUNCT
chd-73	101	44	uzhachenko	uzhachenko	PROPN
chd-73	101	45	and	and	CCONJ
chd-73	101	46	shanker	shanker	NOUN
chd-73	101	47	,	,	PUNCT
chd-73	101	48	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-73	101	49	e7	e7	PROPN
chd-73	101	50	cancer	cancer	NOUN
chd-73	101	51	health	health	NOUN
chd-73	101	52	disparities	disparity	NOUN
chd-73	101	53	research	research	VERB
chd-73	101	54	2016	2016	NUM
chd-73	101	55	)	)	PUNCT
chd-73	101	56	.	.	PUNCT
chd-73	102	1	thus	thus	ADV
chd-73	102	2	,	,	PUNCT
chd-73	102	3	for	for	ADP
chd-73	102	4	effective	effective	ADJ
chd-73	102	5	treatments	treatment	NOUN
chd-73	102	6	and	and	CCONJ
chd-73	102	7	addressal	addressal	NOUN
chd-73	102	8	of	of	ADP
chd-73	102	9	disparities	disparity	NOUN
chd-73	102	10	in	in	ADP
chd-73	102	11	cancers	cancer	NOUN
chd-73	102	12	,	,	PUNCT
chd-73	102	13	immunotherapeutic	immunotherapeutic	ADJ
chd-73	102	14	strategies	strategy	NOUN
chd-73	102	15	would	would	AUX
chd-73	102	16	need	need	VERB
chd-73	102	17	to	to	PART
chd-73	102	18	overcome	overcome	VERB
chd-73	102	19	tumor	tumor	NOUN
chd-73	102	20	-	-	PUNCT
chd-73	102	21	induced	induce	VERB
chd-73	102	22	notchbased	notchbase	VERB
chd-73	102	23	immunosuppression	immunosuppression	NOUN
chd-73	102	24	.	.	PUNCT
chd-73	103	1	concluding	conclude	VERB
chd-73	103	2	remarks	remark	NOUN
chd-73	103	3	and	and	CCONJ
chd-73	103	4	future	future	ADJ
chd-73	103	5	perspectives	perspective	NOUN
chd-73	103	6	although	although	SCONJ
chd-73	103	7	much	much	ADJ
chd-73	103	8	remains	remain	VERB
chd-73	103	9	to	to	PART
chd-73	103	10	be	be	AUX
chd-73	103	11	learned	learn	VERB
chd-73	103	12	about	about	ADP
chd-73	103	13	key	key	ADJ
chd-73	103	14	aspects	aspect	NOUN
chd-73	103	15	of	of	ADP
chd-73	103	16	notch	notch	ADJ
chd-73	103	17	basis	basis	NOUN
chd-73	103	18	of	of	ADP
chd-73	103	19	cancer	cancer	NOUN
chd-73	103	20	disparities	disparity	NOUN
chd-73	103	21	,	,	PUNCT
chd-73	103	22	available	available	ADJ
chd-73	103	23	evidence	evidence	NOUN
chd-73	103	24	is	be	AUX
chd-73	103	25	clear	clear	ADJ
chd-73	103	26	to	to	PART
chd-73	103	27	suggest	suggest	VERB
chd-73	103	28	that	that	SCONJ
chd-73	103	29	notch	notch	ADJ
chd-73	103	30	signaling	signal	VERB
chd-73	103	31	is	be	AUX
chd-73	103	32	crucial	crucial	ADJ
chd-73	103	33	for	for	ADP
chd-73	103	34	antitumor	antitumor	PROPN
chd-73	103	35	lymphocyte	lymphocyte	ADJ
chd-73	103	36	effector	effector	NOUN
chd-73	103	37	and	and	CCONJ
chd-73	103	38	memory	memory	NOUN
chd-73	103	39	functions	function	NOUN
chd-73	103	40	.	.	PUNCT
chd-73	104	1	notch	notch	ADJ
chd-73	104	2	signaling	signal	VERB
chd-73	104	3	is	be	AUX
chd-73	104	4	perturbed	perturb	VERB
chd-73	104	5	in	in	ADP
chd-73	104	6	hematopoietic	hematopoietic	ADJ
chd-73	104	7	cells	cell	NOUN
chd-73	104	8	by	by	ADP
chd-73	104	9	tumor	tumor	NOUN
chd-73	104	10	growth	growth	NOUN
chd-73	104	11	for	for	ADP
chd-73	104	12	its	its	PRON
chd-73	104	13	advantage	advantage	NOUN
chd-73	104	14	,	,	PUNCT
chd-73	104	15	and	and	CCONJ
chd-73	104	16	there	there	PRON
chd-73	104	17	are	be	VERB
chd-73	104	18	indications	indication	NOUN
chd-73	104	19	that	that	SCONJ
chd-73	104	20	differences	difference	NOUN
chd-73	104	21	in	in	ADP
chd-73	104	22	notch	notch	ADJ
chd-73	104	23	components	component	NOUN
chd-73	104	24	could	could	AUX
chd-73	104	25	underlie	underlie	VERB
chd-73	104	26	poor	poor	ADJ
chd-73	104	27	cancer	cancer	NOUN
chd-73	104	28	prognosis	prognosis	NOUN
chd-73	104	29	in	in	ADP
chd-73	104	30	certain	certain	ADJ
chd-73	104	31	racial	racial	ADJ
chd-73	104	32	/	/	SYM
chd-73	104	33	ethnic	ethnic	ADJ
chd-73	104	34	populations	population	NOUN
chd-73	104	35	.	.	PUNCT
chd-73	105	1	due	due	ADP
chd-73	105	2	to	to	ADP
chd-73	105	3	the	the	DET
chd-73	105	4	heterogeneity	heterogeneity	NOUN
chd-73	105	5	of	of	ADP
chd-73	105	6	notch	notch	NOUN
chd-73	105	7	signaling	signal	VERB
chd-73	105	8	in	in	ADP
chd-73	105	9	tumors	tumor	NOUN
chd-73	105	10	and	and	CCONJ
chd-73	105	11	the	the	DET
chd-73	105	12	potential	potential	NOUN
chd-73	105	13	for	for	ADP
chd-73	105	14	notch	notch	NOUN
chd-73	105	15	to	to	PART
chd-73	105	16	be	be	AUX
chd-73	105	17	oncoand	oncoand	NOUN
chd-73	105	18	tumorigenic	tumorigenic	NOUN
chd-73	105	19	on	on	ADP
chd-73	105	20	one	one	NUM
chd-73	105	21	hand	hand	NOUN
chd-73	105	22	and	and	CCONJ
chd-73	105	23	lymphostimulatory	lymphostimulatory	NOUN
chd-73	105	24	on	on	ADP
chd-73	105	25	the	the	DET
chd-73	105	26	other	other	ADJ
chd-73	105	27	,	,	PUNCT
chd-73	105	28	racial	racial	ADJ
chd-73	105	29	disparities	disparity	NOUN
chd-73	105	30	in	in	ADP
chd-73	105	31	cancer	cancer	NOUN
chd-73	105	32	may	may	AUX
chd-73	105	33	be	be	AUX
chd-73	105	34	addressed	address	VERB
chd-73	105	35	through	through	ADP
chd-73	105	36	systematic	systematic	ADJ
chd-73	105	37	elucidation	elucidation	NOUN
chd-73	105	38	of	of	ADP
chd-73	105	39	following	follow	VERB
chd-73	105	40	profiles	profile	NOUN
chd-73	105	41	.	.	PUNCT
chd-73	106	1	(	(	PUNCT
chd-73	106	2	1	1	X
chd-73	106	3	)	)	PUNCT
chd-73	106	4	characterizing	characterize	VERB
chd-73	106	5	the	the	DET
chd-73	106	6	notch	notch	ADJ
chd-73	106	7	profiles	profile	NOUN
chd-73	106	8	of	of	ADP
chd-73	106	9	various	various	ADJ
chd-73	106	10	cancer	cancer	NOUN
chd-73	106	11	subtypes	subtype	NOUN
chd-73	106	12	and	and	CCONJ
chd-73	106	13	tumor	tumor	NOUN
chd-73	106	14	-	-	PUNCT
chd-73	106	15	infiltrating	infiltrating	ADJ
chd-73	106	16	immune	immune	ADJ
chd-73	106	17	cells	cell	NOUN
chd-73	106	18	in	in	ADP
chd-73	106	19	various	various	ADJ
chd-73	106	20	racial	racial	ADJ
chd-73	106	21	/	/	SYM
chd-73	106	22	ethnic	ethnic	ADJ
chd-73	106	23	populations	population	NOUN
chd-73	106	24	should	should	AUX
chd-73	106	25	serve	serve	VERB
chd-73	106	26	to	to	PART
chd-73	106	27	provide	provide	VERB
chd-73	106	28	a	a	DET
chd-73	106	29	useful	useful	ADJ
chd-73	106	30	resource	resource	NOUN
chd-73	106	31	for	for	ADP
chd-73	106	32	understanding	understand	VERB
chd-73	106	33	notchbased	notchbase	VERB
chd-73	106	34	tumor	tumor	NOUN
chd-73	106	35	-	-	PUNCT
chd-73	106	36	immune	immune	ADJ
chd-73	106	37	interactions	interaction	NOUN
chd-73	106	38	in	in	ADP
chd-73	106	39	the	the	DET
chd-73	106	40	tumor	tumor	NOUN
chd-73	106	41	microenvironment	microenvironment	NOUN
chd-73	106	42	.	.	PUNCT
chd-73	107	1	(	(	PUNCT
chd-73	107	2	2	2	X
chd-73	107	3	)	)	PUNCT
chd-73	107	4	understanding	understand	VERB
chd-73	107	5	the	the	DET
chd-73	107	6	interindividual	interindividual	ADJ
chd-73	107	7	host	host	NOUN
chd-73	107	8	factors	factor	NOUN
chd-73	107	9	that	that	PRON
chd-73	107	10	influence	influence	NOUN
chd-73	107	11	naturally	naturally	ADV
chd-73	107	12	occurring	occur	VERB
chd-73	107	13	lymphocyte	lymphocyte	ADJ
chd-73	107	14	responses	response	NOUN
chd-73	107	15	will	will	AUX
chd-73	107	16	also	also	ADV
chd-73	107	17	be	be	AUX
chd-73	107	18	an	an	DET
chd-73	107	19	important	important	ADJ
chd-73	107	20	prerequisite	prerequisite	NOUN
chd-73	107	21	to	to	PART
chd-73	107	22	understand	understand	VERB
chd-73	107	23	the	the	DET
chd-73	107	24	host	host	NOUN
chd-73	107	25	immune	immune	ADJ
chd-73	107	26	responsiveness	responsiveness	NOUN
chd-73	107	27	and	and	CCONJ
chd-73	107	28	design	design	VERB
chd-73	107	29	a	a	DET
chd-73	107	30	successful	successful	ADJ
chd-73	107	31	immunotherapeutic	immunotherapeutic	ADJ
chd-73	107	32	modality	modality	NOUN
chd-73	107	33	.	.	PUNCT
chd-73	108	1	in	in	ADP
chd-73	108	2	contrast	contrast	NOUN
chd-73	108	3	to	to	ADP
chd-73	108	4	our	our	PRON
chd-73	108	5	understanding	understanding	NOUN
chd-73	108	6	of	of	ADP
chd-73	108	7	the	the	DET
chd-73	108	8	naturally	naturally	ADV
chd-73	108	9	occurring	occur	VERB
chd-73	108	10	immune	immune	ADJ
chd-73	108	11	responses	response	NOUN
chd-73	108	12	to	to	ADP
chd-73	108	13	many	many	ADJ
chd-73	108	14	infectious	infectious	ADJ
chd-73	108	15	agents	agent	NOUN
chd-73	108	16	,	,	PUNCT
chd-73	108	17	our	our	PRON
chd-73	108	18	knowledge	knowledge	NOUN
chd-73	108	19	of	of	ADP
chd-73	108	20	the	the	DET
chd-73	108	21	immunogenetic	immunogenetic	ADJ
chd-73	108	22	factors	factor	NOUN
chd-73	108	23	that	that	PRON
chd-73	108	24	influence	influence	VERB
chd-73	108	25	immune	immune	ADJ
chd-73	108	26	responsiveness	responsiveness	NOUN
chd-73	108	27	to	to	ADP
chd-73	108	28	tumor	tumor	NOUN
chd-73	108	29	-	-	PUNCT
chd-73	108	30	associated	associate	VERB
chd-73	108	31	antigens	antigen	NOUN
chd-73	108	32	is	be	AUX
chd-73	108	33	vastly	vastly	ADV
chd-73	108	34	incomplete	incomplete	ADJ
chd-73	108	35	.	.	PUNCT
chd-73	109	1	(	(	PUNCT
chd-73	109	2	3	3	X
chd-73	109	3	)	)	PUNCT
chd-73	109	4	an	an	DET
chd-73	109	5	improved	improved	ADJ
chd-73	109	6	understanding	understanding	NOUN
chd-73	109	7	of	of	ADP
chd-73	109	8	the	the	DET
chd-73	109	9	immunogenetic	immunogenetic	ADJ
chd-73	109	10	mechanisms	mechanism	NOUN
chd-73	109	11	underlying	underlie	VERB
chd-73	109	12	t	t	NOUN
chd-73	109	13	cell	cell	NOUN
chd-73	109	14	and	and	CCONJ
chd-73	109	15	nk	nk	PROPN
chd-73	109	16	cell	cell	NOUN
chd-73	109	17	immunity	immunity	NOUN
chd-73	109	18	in	in	ADP
chd-73	109	19	disparate	disparate	ADJ
chd-73	109	20	racial	racial	ADJ
chd-73	109	21	/	/	SYM
chd-73	109	22	ethnic	ethnic	ADJ
chd-73	109	23	populations	population	NOUN
chd-73	109	24	will	will	AUX
chd-73	109	25	be	be	AUX
chd-73	109	26	helpful	helpful	ADJ
chd-73	109	27	in	in	ADP
chd-73	109	28	designing	design	VERB
chd-73	109	29	efficient	efficient	ADJ
chd-73	109	30	personalized	personalized	ADJ
chd-73	109	31	immune	immune	ADJ
chd-73	109	32	strategies	strategy	NOUN
chd-73	109	33	against	against	ADP
chd-73	109	34	cancer	cancer	NOUN
chd-73	109	35	.	.	PUNCT
chd-73	110	1	this	this	DET
chd-73	110	2	knowledge	knowledge	NOUN
chd-73	110	3	would	would	AUX
chd-73	110	4	also	also	ADV
chd-73	110	5	be	be	AUX
chd-73	110	6	instrumental	instrumental	ADJ
chd-73	110	7	in	in	ADP
chd-73	110	8	the	the	DET
chd-73	110	9	proper	proper	ADJ
chd-73	110	10	evaluation	evaluation	NOUN
chd-73	110	11	of	of	ADP
chd-73	110	12	lymphocyte	lymphocyte	NOUN
chd-73	110	13	-	-	PUNCT
chd-73	110	14	based	base	VERB
chd-73	110	15	immunotherapy	immunotherapy	NOUN
chd-73	110	16	trials	trial	NOUN
chd-73	110	17	as	as	SCONJ
chd-73	110	18	some	some	DET
chd-73	110	19	people	people	NOUN
chd-73	110	20	could	could	AUX
chd-73	110	21	be	be	AUX
chd-73	110	22	naturally	naturally	ADV
chd-73	110	23	high	high	ADJ
chd-73	110	24	responders	responder	NOUN
chd-73	110	25	to	to	ADP
chd-73	110	26	adoptive	adoptive	ADJ
chd-73	110	27	cell	cell	NOUN
chd-73	110	28	immunotherapy	immunotherapy	NOUN
chd-73	110	29	,	,	PUNCT
chd-73	110	30	while	while	SCONJ
chd-73	110	31	others	other	NOUN
chd-73	110	32	could	could	AUX
chd-73	110	33	be	be	AUX
chd-73	110	34	low	low	ADJ
chd-73	110	35	responders	responder	NOUN
chd-73	110	36	.	.	PUNCT
chd-73	111	1	this	this	DET
chd-73	111	2	possibility	possibility	NOUN
chd-73	111	3	,	,	PUNCT
chd-73	111	4	unless	unless	SCONJ
chd-73	111	5	taken	take	VERB
chd-73	111	6	into	into	ADP
chd-73	111	7	account	account	NOUN
chd-73	111	8	,	,	PUNCT
chd-73	111	9	could	could	AUX
chd-73	111	10	confound	confound	VERB
chd-73	111	11	the	the	DET
chd-73	111	12	evaluation	evaluation	NOUN
chd-73	111	13	of	of	ADP
chd-73	111	14	immunotherapy	immunotherapy	NOUN
chd-73	111	15	trials	trial	NOUN
chd-73	111	16	.	.	PUNCT
chd-73	112	1	(	(	PUNCT
chd-73	112	2	4	4	X
chd-73	112	3	)	)	PUNCT
chd-73	112	4	based	base	VERB
chd-73	112	5	on	on	ADP
chd-73	112	6	the	the	DET
chd-73	112	7	outcomes	outcome	NOUN
chd-73	112	8	of	of	ADP
chd-73	112	9	these	these	DET
chd-73	112	10	studies	study	NOUN
chd-73	112	11	,	,	PUNCT
chd-73	112	12	it	it	PRON
chd-73	112	13	will	will	AUX
chd-73	112	14	,	,	PUNCT
chd-73	112	15	then	then	ADV
chd-73	112	16	,	,	PUNCT
chd-73	112	17	be	be	AUX
chd-73	112	18	important	important	ADJ
chd-73	112	19	to	to	PART
chd-73	112	20	develop	develop	VERB
chd-73	112	21	an	an	DET
chd-73	112	22	immunogenetic	immunogenetic	ADJ
chd-73	112	23	signature	signature	NOUN
chd-73	112	24	of	of	ADP
chd-73	112	25	notch	notch	ADJ
chd-73	112	26	signaling	signal	VERB
chd-73	112	27	components	component	NOUN
chd-73	112	28	,	,	PUNCT
chd-73	112	29	their	their	PRON
chd-73	112	30	receptors	receptor	NOUN
chd-73	112	31	,	,	PUNCT
chd-73	112	32	ligands	ligand	NOUN
chd-73	112	33	and	and	CCONJ
chd-73	112	34	downstream	downstream	ADJ
chd-73	112	35	targets	target	NOUN
chd-73	112	36	,	,	PUNCT
chd-73	112	37	in	in	ADP
chd-73	112	38	various	various	ADJ
chd-73	112	39	racial	racial	ADJ
chd-73	112	40	/	/	SYM
chd-73	112	41	ethnic	ethnic	ADJ
chd-73	112	42	populations	population	NOUN
chd-73	112	43	and	and	CCONJ
chd-73	112	44	establish	establish	VERB
chd-73	112	45	their	their	PRON
chd-73	112	46	association	association	NOUN
chd-73	112	47	with	with	ADP
chd-73	112	48	antitumor	antitumor	PROPN
chd-73	112	49	immune	immune	ADJ
chd-73	112	50	response	response	NOUN
chd-73	112	51	patterns	pattern	NOUN
chd-73	112	52	impacting	impact	VERB
chd-73	112	53	cancer	cancer	NOUN
chd-73	112	54	etiology	etiology	NOUN
chd-73	112	55	.	.	PUNCT
chd-73	113	1	the	the	DET
chd-73	113	2	studies	study	NOUN
chd-73	113	3	could	could	AUX
chd-73	113	4	also	also	ADV
chd-73	113	5	shed	shed	VERB
chd-73	113	6	light	light	NOUN
chd-73	113	7	on	on	ADP
chd-73	113	8	the	the	DET
chd-73	113	9	prognostic	prognostic	ADJ
chd-73	113	10	aspects	aspect	NOUN
chd-73	113	11	of	of	ADP
chd-73	113	12	notch	notch	NOUN
chd-73	113	13	in	in	ADP
chd-73	113	14	predicting	predict	VERB
chd-73	113	15	possible	possible	ADJ
chd-73	113	16	cancer	cancer	NOUN
chd-73	113	17	health	health	NOUN
chd-73	113	18	disparities	disparity	NOUN
chd-73	113	19	and	and	CCONJ
chd-73	113	20	the	the	DET
chd-73	113	21	outcome	outcome	NOUN
chd-73	113	22	of	of	ADP
chd-73	113	23	immunotherapy	immunotherapy	NOUN
chd-73	113	24	.	.	PUNCT
chd-73	114	1	findings	finding	NOUN
chd-73	114	2	of	of	ADP
chd-73	114	3	these	these	DET
chd-73	114	4	prospective	prospective	ADJ
chd-73	114	5	studies	study	NOUN
chd-73	114	6	would	would	AUX
chd-73	114	7	be	be	AUX
chd-73	114	8	critical	critical	ADJ
chd-73	114	9	to	to	PART
chd-73	114	10	devise	devise	VERB
chd-73	114	11	strategies	strategy	NOUN
chd-73	114	12	to	to	PART
chd-73	114	13	reverse	reverse	VERB
chd-73	114	14	notch	notch	ADJ
chd-73	114	15	dysfunction	dysfunction	NOUN
chd-73	114	16	in	in	ADP
chd-73	114	17	lymphocytes	lymphocyte	NOUN
chd-73	114	18	for	for	ADP
chd-73	114	19	effective	effective	ADJ
chd-73	114	20	tumor	tumor	NOUN
chd-73	114	21	eradication	eradication	NOUN
chd-73	114	22	and	and	CCONJ
chd-73	114	23	durable	durable	ADJ
chd-73	114	24	remission	remission	NOUN
chd-73	114	25	in	in	ADP
chd-73	114	26	cancer	cancer	NOUN
chd-73	114	27	patients	patient	NOUN
chd-73	114	28	of	of	ADP
chd-73	114	29	varied	varied	ADJ
chd-73	114	30	ethnic	ethnic	ADJ
chd-73	114	31	backgrounds	background	NOUN
chd-73	114	32	.	.	PUNCT
chd-73	115	1	acknowledgements	acknowledgement	NOUN
chd-73	115	2	the	the	DET
chd-73	115	3	authors	author	NOUN
chd-73	115	4	are	be	AUX
chd-73	115	5	thankful	thankful	ADJ
chd-73	115	6	to	to	ADP
chd-73	115	7	the	the	DET
chd-73	115	8	editorial	editorial	ADJ
chd-73	115	9	board	board	NOUN
chd-73	115	10	of	of	ADP
chd-73	115	11	cancer	cancer	NOUN
chd-73	115	12	health	health	NOUN
chd-73	115	13	disparities	disparity	NOUN
chd-73	115	14	for	for	ADP
chd-73	115	15	inviting	invite	VERB
chd-73	115	16	this	this	DET
chd-73	115	17	article	article	NOUN
chd-73	115	18	.	.	PUNCT
chd-73	116	1	they	they	PRON
chd-73	116	2	are	be	AUX
chd-73	116	3	also	also	ADV
chd-73	116	4	thankful	thankful	ADJ
chd-73	116	5	to	to	PART
chd-73	116	6	gladys	gladys	PROPN
chd-73	116	7	simiyu	simiyu	PROPN
chd-73	116	8	,	,	PUNCT
chd-73	116	9	phd	phd	NOUN
chd-73	116	10	and	and	CCONJ
chd-73	116	11	siddharth	siddharth	PROPN
chd-73	116	12	pratap	pratap	PROPN
chd-73	116	13	,	,	PUNCT
chd-73	116	14	phd	phd	NOUN
chd-73	116	15	for	for	ADP
chd-73	116	16	help	help	NOUN
chd-73	116	17	with	with	ADP
chd-73	116	18	the	the	DET
chd-73	116	19	tcga	tcga	PROPN
chd-73	116	20	data	data	NOUN
chd-73	116	21	sets	set	NOUN
chd-73	116	22	.	.	PUNCT
chd-73	117	1	funding	funding	NOUN
chd-73	117	2	as	as	SCONJ
chd-73	117	3	is	be	AUX
chd-73	117	4	supported	support	VERB
chd-73	117	5	by	by	ADP
chd-73	117	6	funds	fund	NOUN
chd-73	117	7	from	from	ADP
chd-73	117	8	the	the	DET
chd-73	117	9	following	follow	VERB
chd-73	117	10	national	national	ADJ
chd-73	117	11	institutes	institutes	PROPN
chd-73	117	12	of	of	ADP
chd-73	117	13	health	health	PROPN
chd-73	117	14	(	(	PUNCT
chd-73	117	15	nih	nih	NOUN
chd-73	117	16	)	)	PUNCT
chd-73	117	17	grants	grant	NOUN
chd-73	117	18	u54	u54	ADP
chd-73	117	19	ca163069	ca163069	PROPN
chd-73	117	20	-	-	PUNCT
chd-73	117	21	6963	6963	NUM
chd-73	117	22	,	,	PUNCT
chd-73	117	23	u54	u54	PROPN
chd-73	117	24	md007593	md007593	PROPN
chd-73	117	25	,	,	PUNCT
chd-73	117	26	sc1	sc1	PROPN
chd-73	117	27	ca182843	ca182843	PROPN
chd-73	117	28	,	,	PUNCT
chd-73	117	29	and	and	CCONJ
chd-73	117	30	r01	r01	PROPN
chd-73	117	31	ca175370	ca175370	PROPN
chd-73	117	32	.	.	PUNCT
chd-73	118	1	plt	plt	NOUN
chd-73	118	2	is	be	AUX
chd-73	118	3	an	an	DET
chd-73	118	4	md	md	PROPN
chd-73	118	5	phd	phd	NOUN
chd-73	118	6	candidate	candidate	NOUN
chd-73	118	7	supported	support	VERB
chd-73	118	8	by	by	ADP
chd-73	118	9	grant	grant	PROPN
chd-73	118	10	s21md000104	s21md000104	PROPN
chd-73	118	11	.	.	PUNCT
chd-73	119	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PROPN
chd-73	119	2	e8	e8	PROPN
chd-73	119	3	cancer	cancer	PROPN
chd-73	119	4	health	health	NOUN
chd-73	119	5	disparities	disparity	NOUN
chd-73	119	6	research	research	VERB
chd-73	119	7	conflict	conflict	NOUN
chd-73	119	8	of	of	ADP
chd-73	119	9	interest	interest	NOUN
chd-73	119	10	the	the	DET
chd-73	119	11	authors	author	NOUN
chd-73	119	12	declare	declare	VERB
chd-73	119	13	that	that	SCONJ
chd-73	119	14	no	no	DET
chd-73	119	15	competing	compete	VERB
chd-73	119	16	or	or	CCONJ
chd-73	119	17	conflict	conflict	NOUN
chd-73	119	18	of	of	ADP
chd-73	119	19	interests	interest	NOUN
chd-73	119	20	exist	exist	VERB
chd-73	119	21	.	.	PUNCT
chd-73	120	1	the	the	DET
chd-73	120	2	funders	funder	NOUN
chd-73	120	3	had	have	VERB
chd-73	120	4	no	no	DET
chd-73	120	5	role	role	NOUN
chd-73	120	6	in	in	ADP
chd-73	120	7	study	study	NOUN
chd-73	120	8	design	design	NOUN
chd-73	120	9	,	,	PUNCT
chd-73	120	10	writing	writing	NOUN
chd-73	120	11	of	of	ADP
chd-73	120	12	the	the	DET
chd-73	120	13	manuscript	manuscript	NOUN
chd-73	120	14	,	,	PUNCT
chd-73	120	15	or	or	CCONJ
chd-73	120	16	decision	decision	NOUN
chd-73	120	17	to	to	PART
chd-73	120	18	publish	publish	VERB
chd-73	120	19	.	.	PUNCT
chd-73	121	1	authors	author	NOUN
chd-73	121	2	’	’	PART
chd-73	121	3	contributions	contribution	NOUN
chd-73	121	4	conception	conception	NOUN
chd-73	121	5	and	and	CCONJ
chd-73	121	6	design	design	NOUN
chd-73	121	7	:	:	PUNCT
chd-73	121	8	as	as	SCONJ
chd-73	121	9	literature	literature	NOUN
chd-73	121	10	review	review	NOUN
chd-73	121	11	and	and	CCONJ
chd-73	121	12	manuscript	manuscript	NOUN
chd-73	121	13	writing	writing	NOUN
chd-73	121	14	:	:	PUNCT
chd-73	121	15	plt	plt	NOUN
chd-73	121	16	,	,	PUNCT
chd-73	121	17	as	as	ADP
chd-73	121	18	references	reference	NOUN
chd-73	121	19	adler	adler	PROPN
chd-73	121	20	,	,	PUNCT
chd-73	121	21	s.h	s.h	PROPN
chd-73	121	22	.	.	PROPN
chd-73	121	23	,	,	PUNCT
chd-73	121	24	chiffoleau	chiffoleau	PROPN
chd-73	121	25	,	,	PUNCT
chd-73	121	26	e.	e.	PROPN
chd-73	121	27	,	,	PUNCT
chd-73	121	28	xu	xu	PROPN
chd-73	121	29	,	,	PUNCT
chd-73	121	30	l.	l.	PROPN
chd-73	121	31	,	,	PUNCT
chd-73	121	32	dalton	dalton	PROPN
chd-73	121	33	,	,	PUNCT
chd-73	121	34	n.m	n.m	PROPN
chd-73	121	35	.	.	PROPN
chd-73	121	36	,	,	PUNCT
chd-73	121	37	burg	burg	PROPN
chd-73	121	38	,	,	PUNCT
chd-73	121	39	j.m	j.m	PROPN
chd-73	121	40	.	.	PROPN
chd-73	121	41	,	,	PUNCT
chd-73	121	42	wells	wells	PROPN
chd-73	121	43	,	,	PUNCT
chd-73	121	44	a.d	a.d	PROPN
chd-73	121	45	.	.	PROPN
chd-73	121	46	,	,	PUNCT
chd-73	121	47	wolfe	wolfe	PROPN
chd-73	121	48	,	,	PUNCT
chd-73	121	49	m.s	m.s	PROPN
chd-73	121	50	.	.	PROPN
chd-73	121	51	,	,	PUNCT
chd-73	121	52	turka	turka	PROPN
chd-73	121	53	,	,	PUNCT
chd-73	121	54	l.a	l.a	PROPN
chd-73	121	55	.	.	PROPN
chd-73	121	56	,	,	PUNCT
chd-73	121	57	and	and	CCONJ
chd-73	121	58	pear	pear	NOUN
chd-73	121	59	,	,	PUNCT
chd-73	121	60	w.s	w.s	PROPN
chd-73	121	61	.	.	PROPN
chd-73	121	62	(	(	PUNCT
chd-73	121	63	2003	2003	NUM
chd-73	121	64	)	)	PUNCT
chd-73	121	65	.	.	PUNCT
chd-73	122	1	notch	notch	NOUN
chd-73	122	2	signaling	signal	VERB
chd-73	122	3	augments	augment	NOUN
chd-73	122	4	t	t	PROPN
chd-73	122	5	cell	cell	NOUN
chd-73	122	6	responsiveness	responsiveness	NOUN
chd-73	122	7	by	by	ADP
chd-73	122	8	enhancing	enhance	VERB
chd-73	122	9	cd25	cd25	PROPN
chd-73	122	10	expression	expression	NOUN
chd-73	122	11	.	.	PUNCT
chd-73	123	1	j	j	PROPN
chd-73	123	2	immunol	immunol	NOUN
chd-73	123	3	171	171	NUM
chd-73	123	4	,	,	PUNCT
chd-73	123	5	28962903	28962903	NUM
chd-73	123	6	.	.	PUNCT
chd-73	124	1	amsen	amsen	VERB
chd-73	124	2	,	,	PUNCT
chd-73	124	3	d.	d.	PROPN
chd-73	124	4	,	,	PUNCT
chd-73	124	5	antov	antov	PROPN
chd-73	124	6	,	,	PUNCT
chd-73	124	7	a.	a.	NOUN
chd-73	124	8	,	,	PUNCT
chd-73	124	9	and	and	CCONJ
chd-73	124	10	flavell	flavell	ADJ
chd-73	124	11	,	,	PUNCT
chd-73	124	12	r.a	r.a	PROPN
chd-73	124	13	.	.	PROPN
chd-73	124	14	(	(	PUNCT
chd-73	124	15	2009	2009	NUM
chd-73	124	16	)	)	PUNCT
chd-73	124	17	.	.	PUNCT
chd-73	125	1	the	the	DET
chd-73	125	2	different	different	ADJ
chd-73	125	3	faces	face	NOUN
chd-73	125	4	of	of	ADP
chd-73	125	5	notch	notch	NOUN
chd-73	125	6	in	in	ADP
chd-73	125	7	t	t	PROPN
chd-73	125	8	-	-	PUNCT
chd-73	125	9	helper	helper	NOUN
chd-73	125	10	-	-	PUNCT
chd-73	125	11	cell	cell	NOUN
chd-73	125	12	differentiation	differentiation	NOUN
chd-73	125	13	.	.	PUNCT
chd-73	126	1	nat	nat	PROPN
chd-73	126	2	rev	rev	VERB
chd-73	126	3	immunol	immunol	NOUN
chd-73	126	4	9	9	NUM
chd-73	126	5	,	,	PUNCT
chd-73	126	6	116	116	NUM
chd-73	126	7	-	-	SYM
chd-73	126	8	124	124	NUM
chd-73	126	9	.	.	PUNCT
chd-73	127	1	amsen	amsen	PROPN
chd-73	127	2	,	,	PUNCT
chd-73	127	3	d.	d.	PROPN
chd-73	127	4	,	,	PUNCT
chd-73	127	5	blander	bland	ADJ
chd-73	127	6	,	,	PUNCT
chd-73	127	7	j.m	j.m	PROPN
chd-73	127	8	.	.	PROPN
chd-73	127	9	,	,	PUNCT
chd-73	127	10	lee	lee	PROPN
chd-73	127	11	,	,	PUNCT
chd-73	127	12	g.r	g.r	PROPN
chd-73	127	13	.	.	PROPN
chd-73	127	14	,	,	PUNCT
chd-73	127	15	tanigaki	tanigaki	PROPN
chd-73	127	16	,	,	PUNCT
chd-73	127	17	k.	k.	PROPN
chd-73	127	18	,	,	PUNCT
chd-73	127	19	honjo	honjo	PROPN
chd-73	127	20	,	,	PUNCT
chd-73	127	21	t.	t.	PROPN
chd-73	127	22	,	,	PUNCT
chd-73	127	23	and	and	CCONJ
chd-73	127	24	flavell	flavell	ADJ
chd-73	127	25	,	,	PUNCT
chd-73	127	26	r.a	r.a	PROPN
chd-73	127	27	.	.	PROPN
chd-73	127	28	(	(	PUNCT
chd-73	127	29	2004	2004	NUM
chd-73	127	30	)	)	PUNCT
chd-73	127	31	.	.	PUNCT
chd-73	128	1	instruction	instruction	NOUN
chd-73	128	2	of	of	ADP
chd-73	128	3	distinct	distinct	ADJ
chd-73	128	4	cd4	cd4	PROPN
chd-73	128	5	t	t	PROPN
chd-73	128	6	helper	helper	NOUN
chd-73	128	7	cell	cell	NOUN
chd-73	128	8	fates	fate	NOUN
chd-73	128	9	by	by	ADP
chd-73	128	10	different	different	ADJ
chd-73	128	11	notch	notch	ADJ
chd-73	128	12	ligands	ligand	NOUN
chd-73	128	13	on	on	ADP
chd-73	128	14	antigenpresenting	antigenpresente	VERB
chd-73	128	15	cells	cell	NOUN
chd-73	128	16	.	.	PUNCT
chd-73	129	1	cell	cell	NOUN
chd-73	129	2	117	117	NUM
chd-73	129	3	,	,	PUNCT
chd-73	129	4	515	515	NUM
chd-73	129	5	-	-	SYM
chd-73	129	6	526	526	NUM
chd-73	129	7	.	.	PUNCT
chd-73	130	1	andersson	andersson	PROPN
chd-73	130	2	,	,	PUNCT
chd-73	130	3	e.r	e.r	PROPN
chd-73	130	4	.	.	PROPN
chd-73	130	5	,	,	PUNCT
chd-73	130	6	sandberg	sandberg	PROPN
chd-73	130	7	,	,	PUNCT
chd-73	130	8	r.	r.	PROPN
chd-73	130	9	,	,	PUNCT
chd-73	130	10	and	and	CCONJ
chd-73	130	11	lendahl	lendahl	PROPN
chd-73	130	12	,	,	PUNCT
chd-73	130	13	u.	u.	PROPN
chd-73	130	14	(	(	PUNCT
chd-73	130	15	2011	2011	NUM
chd-73	130	16	)	)	PUNCT
chd-73	130	17	.	.	PUNCT
chd-73	131	1	notch	notch	ADJ
chd-73	131	2	signaling	signal	VERB
chd-73	131	3	:	:	PUNCT
chd-73	131	4	simplicity	simplicity	NOUN
chd-73	131	5	in	in	ADP
chd-73	131	6	design	design	NOUN
chd-73	131	7	,	,	PUNCT
chd-73	131	8	versatility	versatility	NOUN
chd-73	131	9	in	in	ADP
chd-73	131	10	function	function	NOUN
chd-73	131	11	.	.	PUNCT
chd-73	132	1	development	development	NOUN
chd-73	132	2	138	138	NUM
chd-73	132	3	,	,	PUNCT
chd-73	132	4	3593	3593	NUM
chd-73	132	5	-	-	SYM
chd-73	132	6	3612	3612	NUM
chd-73	132	7	.	.	PUNCT
chd-73	133	1	auderset	auderset	NOUN
chd-73	133	2	,	,	PUNCT
chd-73	133	3	f.	f.	PROPN
chd-73	133	4	,	,	PUNCT
chd-73	133	5	schuster	schuster	PROPN
chd-73	133	6	,	,	PUNCT
chd-73	133	7	s.	s.	PROPN
chd-73	133	8	,	,	PUNCT
chd-73	133	9	coutaz	coutaz	NOUN
chd-73	133	10	,	,	PUNCT
chd-73	133	11	m.	m.	NOUN
chd-73	133	12	,	,	PUNCT
chd-73	133	13	koch	koch	PROPN
chd-73	133	14	,	,	PUNCT
chd-73	133	15	u.	u.	PROPN
chd-73	133	16	,	,	PUNCT
chd-73	133	17	desgranges	desgrange	NOUN
chd-73	133	18	,	,	PUNCT
chd-73	133	19	f.	f.	PROPN
chd-73	133	20	,	,	PUNCT
chd-73	133	21	merck	merck	PROPN
chd-73	133	22	,	,	PUNCT
chd-73	133	23	e.	e.	PROPN
chd-73	133	24	,	,	PUNCT
chd-73	133	25	macdonald	macdonald	PROPN
chd-73	133	26	,	,	PUNCT
chd-73	133	27	h.r	h.r	PROPN
chd-73	133	28	.	.	PROPN
chd-73	133	29	,	,	PUNCT
chd-73	133	30	radtke	radtke	PROPN
chd-73	133	31	,	,	PUNCT
chd-73	133	32	f.	f.	PROPN
chd-73	133	33	,	,	PUNCT
chd-73	133	34	and	and	CCONJ
chd-73	133	35	tacchinicottier	tacchinicottier	PROPN
chd-73	133	36	,	,	PUNCT
chd-73	133	37	f.	f.	PROPN
chd-73	133	38	(	(	PUNCT
chd-73	133	39	2012	2012	NUM
chd-73	133	40	)	)	PUNCT
chd-73	133	41	.	.	PUNCT
chd-73	134	1	redundant	redundant	ADJ
chd-73	134	2	notch1	notch1	NOUN
chd-73	134	3	and	and	CCONJ
chd-73	134	4	notch2	notch2	NOUN
chd-73	134	5	signaling	signal	VERB
chd-73	134	6	is	be	AUX
chd-73	134	7	necessary	necessary	ADJ
chd-73	134	8	for	for	ADP
chd-73	134	9	ifngamma	ifngamma	PROPN
chd-73	134	10	secretion	secretion	NOUN
chd-73	134	11	by	by	ADP
chd-73	134	12	t	t	PROPN
chd-73	134	13	helper	helper	NOUN
chd-73	134	14	1	1	NUM
chd-73	134	15	cells	cell	NOUN
chd-73	134	16	during	during	ADP
chd-73	134	17	infection	infection	NOUN
chd-73	134	18	with	with	ADP
chd-73	134	19	leishmania	leishmania	PROPN
chd-73	134	20	major	major	PROPN
chd-73	134	21	.	.	PUNCT
chd-73	135	1	plos	plos	PROPN
chd-73	135	2	pathogens	pathogen	NOUN
chd-73	135	3	8	8	NUM
chd-73	135	4	,	,	PUNCT
chd-73	135	5	e1002560	e1002560	PROPN
chd-73	135	6	.	.	PUNCT
chd-73	135	7	backer	backer	NOUN
chd-73	135	8	,	,	PUNCT
chd-73	135	9	r.a	r.a	PROPN
chd-73	135	10	.	.	PROPN
chd-73	135	11	,	,	PUNCT
chd-73	135	12	helbig	helbig	PROPN
chd-73	135	13	,	,	PUNCT
chd-73	135	14	c.	c.	PROPN
chd-73	135	15	,	,	PUNCT
chd-73	135	16	gentek	gentek	PROPN
chd-73	135	17	,	,	PUNCT
chd-73	135	18	r.	r.	PROPN
chd-73	135	19	,	,	PUNCT
chd-73	135	20	kent	kent	PROPN
chd-73	135	21	,	,	PUNCT
chd-73	135	22	a.	a.	PROPN
chd-73	135	23	,	,	PUNCT
chd-73	135	24	laidlaw	laidlaw	PROPN
chd-73	135	25	,	,	PUNCT
chd-73	135	26	b.j	b.j	PROPN
chd-73	135	27	.	.	PROPN
chd-73	135	28	,	,	PUNCT
chd-73	135	29	dominguez	dominguez	PROPN
chd-73	135	30	,	,	PUNCT
chd-73	135	31	c.x	c.x	PROPN
chd-73	135	32	.	.	PROPN
chd-73	135	33	,	,	PUNCT
chd-73	135	34	de	de	PROPN
chd-73	135	35	souza	souza	PROPN
chd-73	135	36	,	,	PUNCT
chd-73	135	37	y.s	y.s	PROPN
chd-73	135	38	.	.	PROPN
chd-73	135	39	,	,	PUNCT
chd-73	135	40	van	van	PROPN
chd-73	135	41	trierum	trierum	PROPN
chd-73	135	42	,	,	PUNCT
chd-73	135	43	s.e	s.e	PROPN
chd-73	135	44	.	.	PROPN
chd-73	135	45	,	,	PUNCT
chd-73	135	46	van	van	PROPN
chd-73	135	47	beek	beek	PROPN
chd-73	135	48	,	,	PUNCT
chd-73	135	49	r.	r.	PROPN
chd-73	135	50	,	,	PUNCT
chd-73	135	51	rimmelzwaan	rimmelzwaan	PROPN
chd-73	135	52	,	,	PUNCT
chd-73	135	53	g.f	g.f	PROPN
chd-73	135	54	.	.	PROPN
chd-73	135	55	,	,	PUNCT
chd-73	135	56	et	et	PROPN
chd-73	135	57	al	al	PROPN
chd-73	135	58	.	.	PUNCT
chd-73	136	1	(	(	PUNCT
chd-73	136	2	2014	2014	NUM
chd-73	136	3	)	)	PUNCT
chd-73	136	4	.	.	PUNCT
chd-73	137	1	a	a	DET
chd-73	137	2	central	central	ADJ
chd-73	137	3	role	role	NOUN
chd-73	137	4	for	for	ADP
chd-73	137	5	notch	notch	NOUN
chd-73	137	6	in	in	ADP
chd-73	137	7	effector	effector	NOUN
chd-73	137	8	cd8(+	cd8(+	PROPN
chd-73	137	9	)	)	PUNCT
chd-73	137	10	t	t	NOUN
chd-73	137	11	cell	cell	NOUN
chd-73	137	12	differentiation	differentiation	NOUN
chd-73	137	13	.	.	PUNCT
chd-73	138	1	nat	nat	PROPN
chd-73	138	2	immunol	immunol	NOUN
chd-73	138	3	15	15	NUM
chd-73	138	4	,	,	PUNCT
chd-73	138	5	1143	1143	NUM
chd-73	138	6	-	-	SYM
chd-73	138	7	1151	1151	NUM
chd-73	138	8	.	.	PUNCT
chd-73	139	1	biktasova	biktasova	PROPN
chd-73	139	2	,	,	PUNCT
chd-73	139	3	a.k	a.k	PROPN
chd-73	139	4	.	.	PROPN
chd-73	139	5	,	,	PUNCT
chd-73	139	6	dudimah	dudimah	PROPN
chd-73	139	7	,	,	PUNCT
chd-73	139	8	d.f	d.f	PROPN
chd-73	139	9	.	.	PROPN
chd-73	139	10	,	,	PUNCT
chd-73	139	11	uzhachenko	uzhachenko	PROPN
chd-73	139	12	,	,	PUNCT
chd-73	139	13	r.v	r.v	PROPN
chd-73	139	14	.	.	PROPN
chd-73	139	15	,	,	PUNCT
chd-73	139	16	park	park	PROPN
chd-73	139	17	,	,	PUNCT
chd-73	139	18	k.	k.	PROPN
chd-73	139	19	,	,	PUNCT
chd-73	139	20	akhter	akhter	PROPN
chd-73	139	21	,	,	PUNCT
chd-73	139	22	a.	a.	PROPN
chd-73	139	23	,	,	PUNCT
chd-73	139	24	arasada	arasada	PROPN
chd-73	139	25	,	,	PUNCT
chd-73	139	26	r.r	r.r	PROPN
chd-73	139	27	.	.	PROPN
chd-73	139	28	,	,	PUNCT
chd-73	139	29	evans	evans	PROPN
chd-73	139	30	,	,	PUNCT
chd-73	139	31	j.v	j.v	PROPN
chd-73	139	32	.	.	PROPN
chd-73	139	33	,	,	PUNCT
chd-73	139	34	novitskiy	novitskiy	PROPN
chd-73	139	35	,	,	PUNCT
chd-73	139	36	s.v	s.v	PROPN
chd-73	139	37	.	.	PROPN
chd-73	139	38	,	,	PUNCT
chd-73	139	39	tchekneva	tchekneva	PROPN
chd-73	139	40	,	,	PUNCT
chd-73	139	41	e.e	e.e	PROPN
chd-73	139	42	.	.	PROPN
chd-73	139	43	,	,	PUNCT
chd-73	139	44	carbone	carbone	PROPN
chd-73	139	45	,	,	PUNCT
chd-73	139	46	d.p	d.p	PROPN
chd-73	139	47	.	.	PROPN
chd-73	139	48	,	,	PUNCT
chd-73	139	49	et	et	PROPN
chd-73	139	50	al	al	PROPN
chd-73	139	51	.	.	PUNCT
chd-73	139	52	(	(	PUNCT
chd-73	139	53	2015	2015	NUM
chd-73	139	54	)	)	PUNCT
chd-73	139	55	.	.	PUNCT
chd-73	140	1	multivalent	multivalent	NOUN
chd-73	140	2	forms	form	NOUN
chd-73	140	3	of	of	ADP
chd-73	140	4	the	the	DET
chd-73	140	5	notch	notch	ADJ
chd-73	140	6	ligand	ligand	NOUN
chd-73	140	7	dll-1	dll-1	PUNCT
chd-73	140	8	enhance	enhance	VERB
chd-73	140	9	antitumor	antitumor	PROPN
chd-73	140	10	tcell	tcell	NOUN
chd-73	140	11	immunity	immunity	NOUN
chd-73	140	12	in	in	ADP
chd-73	140	13	lung	lung	NOUN
chd-73	140	14	cancer	cancer	NOUN
chd-73	140	15	and	and	CCONJ
chd-73	140	16	improve	improve	VERB
chd-73	140	17	efficacy	efficacy	NOUN
chd-73	140	18	of	of	ADP
chd-73	140	19	egfr	egfr	NOUN
chd-73	140	20	-	-	PUNCT
chd-73	140	21	targeted	target	VERB
chd-73	140	22	therapy	therapy	NOUN
chd-73	140	23	.	.	PUNCT
chd-73	141	1	cancer	cancer	NOUN
chd-73	141	2	res	re	NOUN
chd-73	141	3	75	75	NUM
chd-73	141	4	,	,	PUNCT
chd-73	141	5	4728	4728	NUM
chd-73	141	6	-	-	SYM
chd-73	141	7	4741	4741	NUM
chd-73	141	8	.	.	PUNCT
chd-73	142	1	busch	busch	PROPN
chd-73	142	2	,	,	PUNCT
chd-73	142	3	r.	r.	PROPN
chd-73	142	4	,	,	PUNCT
chd-73	142	5	qiu	qiu	PROPN
chd-73	142	6	,	,	PUNCT
chd-73	142	7	w.	w.	PROPN
chd-73	142	8	,	,	PUNCT
chd-73	142	9	lasky	lasky	PROPN
chd-73	142	10	-	-	PUNCT
chd-73	142	11	su	su	PROPN
chd-73	142	12	,	,	PUNCT
chd-73	142	13	j.	j.	PROPN
chd-73	142	14	,	,	PUNCT
chd-73	142	15	morrow	morrow	PROPN
chd-73	142	16	,	,	PUNCT
chd-73	142	17	j.	j.	PROPN
chd-73	142	18	,	,	PUNCT
chd-73	142	19	criner	criner	NOUN
chd-73	142	20	,	,	PUNCT
chd-73	142	21	g.	g.	PROPN
chd-73	142	22	,	,	PUNCT
chd-73	142	23	and	and	CCONJ
chd-73	142	24	demeo	demeo	PROPN
chd-73	142	25	,	,	PUNCT
chd-73	142	26	d.	d.	PROPN
chd-73	142	27	(	(	PUNCT
chd-73	142	28	2016	2016	NUM
chd-73	142	29	)	)	PUNCT
chd-73	142	30	.	.	PUNCT
chd-73	143	1	differential	differential	PROPN
chd-73	143	2	dna	dna	PROPN
chd-73	143	3	methylation	methylation	NOUN
chd-73	143	4	marks	mark	NOUN
chd-73	143	5	and	and	CCONJ
chd-73	143	6	gene	gene	NOUN
chd-73	143	7	comethylation	comethylation	NOUN
chd-73	143	8	of	of	ADP
chd-73	143	9	copd	copd	PROPN
chd-73	143	10	in	in	ADP
chd-73	143	11	african	african	PROPN
chd-73	143	12	-	-	PUNCT
chd-73	143	13	americans	americans	PROPN
chd-73	143	14	with	with	ADP
chd-73	143	15	copd	copd	NOUN
chd-73	143	16	exacerbations	exacerbation	NOUN
chd-73	143	17	.	.	PUNCT
chd-73	144	1	respir	respir	VERB
chd-73	144	2	res	re	NOUN
chd-73	144	3	17	17	NUM
chd-73	144	4	,	,	PUNCT
chd-73	144	5	143	143	NUM
chd-73	144	6	.	.	PUNCT
chd-73	145	1	carotta	carotta	PROPN
chd-73	145	2	,	,	PUNCT
chd-73	145	3	s.	s.	PROPN
chd-73	145	4	,	,	PUNCT
chd-73	145	5	brady	brady	PROPN
chd-73	145	6	,	,	PUNCT
chd-73	145	7	j.	j.	PROPN
chd-73	145	8	,	,	PUNCT
chd-73	145	9	wu	wu	PROPN
chd-73	145	10	,	,	PUNCT
chd-73	145	11	l.	l.	PROPN
chd-73	145	12	,	,	PUNCT
chd-73	145	13	and	and	CCONJ
chd-73	145	14	nutt	nutt	NOUN
chd-73	145	15	,	,	PUNCT
chd-73	145	16	s.l	s.l	PROPN
chd-73	145	17	.	.	PROPN
chd-73	145	18	(	(	PUNCT
chd-73	145	19	2006	2006	NUM
chd-73	145	20	)	)	PUNCT
chd-73	145	21	.	.	PUNCT
chd-73	146	1	transient	transient	ADJ
chd-73	146	2	notch	notch	NOUN
chd-73	146	3	signaling	signal	VERB
chd-73	146	4	induces	induce	NOUN
chd-73	146	5	nk	nk	PROPN
chd-73	146	6	cell	cell	NOUN
chd-73	146	7	potential	potential	NOUN
chd-73	146	8	in	in	ADP
chd-73	146	9	pax5deficient	pax5deficient	PROPN
chd-73	146	10	pro	pro	ADJ
chd-73	146	11	-	-	ADJ
chd-73	146	12	b	b	ADJ
chd-73	146	13	cells	cell	NOUN
chd-73	146	14	.	.	PUNCT
chd-73	147	1	eur	eur	PROPN
chd-73	147	2	j	j	PROPN
chd-73	147	3	immunol	immunol	NOUN
chd-73	147	4	36	36	NUM
chd-73	147	5	,	,	PUNCT
chd-73	147	6	3294	3294	NUM
chd-73	147	7	-	-	SYM
chd-73	147	8	3304	3304	NUM
chd-73	147	9	.	.	PUNCT
chd-73	148	1	cichocki	cichocki	PROPN
chd-73	148	2	,	,	PUNCT
chd-73	148	3	f.	f.	PROPN
chd-73	148	4	,	,	PUNCT
chd-73	148	5	felices	felice	NOUN
chd-73	148	6	,	,	PUNCT
chd-73	148	7	m.	m.	NOUN
chd-73	148	8	,	,	PUNCT
chd-73	148	9	mccullar	mccullar	PROPN
chd-73	148	10	,	,	PUNCT
chd-73	148	11	v.	v.	ADV
chd-73	148	12	,	,	PUNCT
chd-73	148	13	presnell	presnell	PROPN
chd-73	148	14	,	,	PUNCT
chd-73	148	15	s.r	s.r	PROPN
chd-73	148	16	.	.	PROPN
chd-73	148	17	,	,	PUNCT
chd-73	148	18	al	al	PROPN
chd-73	148	19	-	-	PUNCT
chd-73	148	20	attar	attar	PROPN
chd-73	148	21	,	,	PUNCT
chd-73	148	22	a.	a.	PROPN
chd-73	148	23	,	,	PUNCT
chd-73	148	24	lutz	lutz	PROPN
chd-73	148	25	,	,	PUNCT
chd-73	148	26	c.t	c.t	PROPN
chd-73	148	27	.	.	PROPN
chd-73	148	28	,	,	PUNCT
chd-73	148	29	and	and	CCONJ
chd-73	148	30	miller	miller	PROPN
chd-73	148	31	,	,	PUNCT
chd-73	148	32	j.s	j.s	PROPN
chd-73	148	33	.	.	PUNCT
chd-73	148	34	(	(	PUNCT
chd-73	148	35	2011	2011	NUM
chd-73	148	36	)	)	PUNCT
chd-73	148	37	.	.	PUNCT
chd-73	149	1	cutting	cut	VERB
chd-73	149	2	edge	edge	NOUN
chd-73	149	3	:	:	PUNCT
chd-73	149	4	microrna181	microrna181	PROPN
chd-73	149	5	promotes	promote	VERB
chd-73	149	6	human	human	PROPN
chd-73	149	7	nk	nk	PROPN
chd-73	149	8	cell	cell	NOUN
chd-73	149	9	development	development	NOUN
chd-73	149	10	by	by	ADP
chd-73	149	11	regulating	regulate	VERB
chd-73	149	12	notch	notch	ADJ
chd-73	149	13	signaling	signal	VERB
chd-73	149	14	.	.	PUNCT
chd-73	150	1	j	j	PROPN
chd-73	150	2	immunol	immunol	NOUN
chd-73	150	3	187	187	NUM
chd-73	150	4	,	,	PUNCT
chd-73	150	5	6171	6171	NUM
chd-73	150	6	-	-	SYM
chd-73	150	7	6175	6175	NUM
chd-73	150	8	.	.	PUNCT
chd-73	151	1	crabtree	crabtree	PROPN
chd-73	151	2	,	,	PUNCT
chd-73	151	3	j.s	j.s	PROPN
chd-73	151	4	.	.	PROPN
chd-73	151	5	,	,	PUNCT
chd-73	151	6	singleton	singleton	PROPN
chd-73	151	7	,	,	PUNCT
chd-73	151	8	c.s	c.s	PROPN
chd-73	151	9	.	.	PROPN
chd-73	151	10	,	,	PUNCT
chd-73	151	11	and	and	CCONJ
chd-73	151	12	miele	miele	PROPN
chd-73	151	13	,	,	PUNCT
chd-73	151	14	l.	l.	PROPN
chd-73	151	15	(	(	PUNCT
chd-73	151	16	2016	2016	NUM
chd-73	151	17	)	)	PUNCT
chd-73	151	18	.	.	PUNCT
chd-73	152	1	notch	notch	NOUN
chd-73	152	2	signaling	signal	VERB
chd-73	152	3	in	in	ADP
chd-73	152	4	neuroendocrine	neuroendocrine	ADJ
chd-73	152	5	tumors	tumor	NOUN
chd-73	152	6	.	.	PUNCT
chd-73	153	1	front	front	ADJ
chd-73	153	2	oncol	oncol	ADJ
chd-73	153	3	6	6	NUM
chd-73	153	4	,	,	PUNCT
chd-73	153	5	94	94	NUM
chd-73	153	6	.	.	PUNCT
chd-73	154	1	duan	duan	PROPN
chd-73	154	2	,	,	PUNCT
chd-73	154	3	z.	z.	PROPN
chd-73	154	4	,	,	PUNCT
chd-73	154	5	li	li	PROPN
chd-73	154	6	,	,	PUNCT
chd-73	154	7	f.q	f.q	PROPN
chd-73	154	8	.	.	PROPN
chd-73	154	9	,	,	PUNCT
chd-73	154	10	wechsler	wechsler	PROPN
chd-73	154	11	,	,	PUNCT
chd-73	154	12	j.	j.	PROPN
chd-73	154	13	,	,	PUNCT
chd-73	154	14	meade	meade	PROPN
chd-73	154	15	-	-	PUNCT
chd-73	154	16	white	white	PROPN
chd-73	154	17	,	,	PUNCT
chd-73	154	18	k.	k.	PROPN
chd-73	154	19	,	,	PUNCT
chd-73	154	20	williams	williams	PROPN
chd-73	154	21	,	,	PUNCT
chd-73	154	22	k.	k.	PROPN
chd-73	154	23	,	,	PUNCT
chd-73	154	24	benson	benson	PROPN
chd-73	154	25	,	,	PUNCT
chd-73	154	26	k.f	k.f	PROPN
chd-73	154	27	.	.	PROPN
chd-73	154	28	,	,	PUNCT
chd-73	154	29	and	and	CCONJ
chd-73	154	30	horwitz	horwitz	PROPN
chd-73	154	31	,	,	PUNCT
chd-73	154	32	m.	m.	NOUN
chd-73	154	33	(	(	PUNCT
chd-73	154	34	2004	2004	NUM
chd-73	154	35	)	)	PUNCT
chd-73	154	36	.	.	PUNCT
chd-73	155	1	a	a	DET
chd-73	155	2	novel	novel	ADJ
chd-73	155	3	notch	notch	NOUN
chd-73	155	4	protein	protein	NOUN
chd-73	155	5	,	,	PUNCT
chd-73	155	6	n2n	n2n	NOUN
chd-73	155	7	,	,	PUNCT
chd-73	155	8	targeted	target	VERB
chd-73	155	9	by	by	ADP
chd-73	155	10	neutrophil	neutrophil	ADJ
chd-73	155	11	elastase	elastase	NOUN
chd-73	155	12	and	and	CCONJ
chd-73	155	13	implicated	implicate	VERB
chd-73	155	14	in	in	ADP
chd-73	155	15	hereditary	hereditary	ADJ
chd-73	155	16	neutropenia	neutropenia	NOUN
chd-73	155	17	.	.	PUNCT
chd-73	156	1	mol	mol	ADP
chd-73	156	2	cell	cell	NOUN
chd-73	156	3	biol	biol	NOUN
chd-73	156	4	24	24	NUM
chd-73	156	5	,	,	PUNCT
chd-73	156	6	58	58	NUM
chd-73	156	7	-	-	SYM
chd-73	156	8	70	70	NUM
chd-73	156	9	.	.	PUNCT
chd-73	157	1	felices	felice	NOUN
chd-73	157	2	,	,	PUNCT
chd-73	157	3	m.	m.	NOUN
chd-73	157	4	,	,	PUNCT
chd-73	157	5	ankarlo	ankarlo	NOUN
chd-73	157	6	,	,	PUNCT
chd-73	157	7	d.e	d.e	PROPN
chd-73	157	8	.	.	PROPN
chd-73	157	9	,	,	PUNCT
chd-73	157	10	lenvik	lenvik	PROPN
chd-73	157	11	,	,	PUNCT
chd-73	157	12	t.r	t.r	PROPN
chd-73	157	13	.	.	PROPN
chd-73	157	14	,	,	PUNCT
chd-73	157	15	nelson	nelson	PROPN
chd-73	157	16	,	,	PUNCT
chd-73	157	17	h.h	h.h	PROPN
chd-73	157	18	.	.	PROPN
chd-73	157	19	,	,	PUNCT
chd-73	157	20	blazar	blazar	PROPN
chd-73	157	21	,	,	PUNCT
chd-73	157	22	b.r	b.r	PROPN
chd-73	157	23	.	.	PROPN
chd-73	157	24	,	,	PUNCT
chd-73	157	25	verneris	verneris	PROPN
chd-73	157	26	,	,	PUNCT
chd-73	157	27	m.r	m.r	PROPN
chd-73	157	28	.	.	PROPN
chd-73	157	29	,	,	PUNCT
chd-73	157	30	and	and	CCONJ
chd-73	157	31	miller	miller	PROPN
chd-73	157	32	,	,	PUNCT
chd-73	157	33	j.s	j.s	PROPN
chd-73	157	34	.	.	PROPN
chd-73	157	35	(	(	PUNCT
chd-73	157	36	2014	2014	NUM
chd-73	157	37	)	)	PUNCT
chd-73	157	38	.	.	PUNCT
chd-73	158	1	notch	notch	NOUN
chd-73	158	2	signaling	signal	VERB
chd-73	158	3	at	at	ADP
chd-73	158	4	later	later	ADJ
chd-73	158	5	stages	stage	NOUN
chd-73	158	6	of	of	ADP
chd-73	158	7	nk	nk	PROPN
chd-73	158	8	cell	cell	NOUN
chd-73	158	9	development	development	NOUN
chd-73	158	10	enhances	enhance	VERB
chd-73	158	11	kir	kir	NOUN
chd-73	158	12	expression	expression	NOUN
chd-73	158	13	and	and	CCONJ
chd-73	158	14	functional	functional	ADJ
chd-73	158	15	maturation	maturation	NOUN
chd-73	158	16	.	.	PUNCT
chd-73	159	1	j	j	PROPN
chd-73	159	2	immunol	immunol	NOUN
chd-73	159	3	193	193	NUM
chd-73	159	4	,	,	PUNCT
chd-73	159	5	3344	3344	NUM
chd-73	159	6	-	-	SYM
chd-73	159	7	3354	3354	NUM
chd-73	159	8	.	.	PUNCT
chd-73	160	1	fregene	fregene	NOUN
chd-73	160	2	,	,	PUNCT
chd-73	160	3	a.	a.	NOUN
chd-73	160	4	,	,	PUNCT
chd-73	160	5	and	and	CCONJ
chd-73	160	6	newman	newman	PROPN
chd-73	160	7	,	,	PUNCT
chd-73	160	8	l.a	l.a	PROPN
chd-73	160	9	.	.	PROPN
chd-73	160	10	(	(	PUNCT
chd-73	160	11	2005	2005	NUM
chd-73	160	12	)	)	PUNCT
chd-73	160	13	.	.	PUNCT
chd-73	161	1	breast	breast	NOUN
chd-73	161	2	cancer	cancer	NOUN
chd-73	161	3	in	in	ADP
chd-73	161	4	subsaharan	subsaharan	PROPN
chd-73	161	5	africa	africa	PROPN
chd-73	161	6	:	:	PUNCT
chd-73	161	7	how	how	SCONJ
chd-73	161	8	does	do	AUX
chd-73	161	9	it	it	PRON
chd-73	161	10	relate	relate	VERB
chd-73	161	11	to	to	ADP
chd-73	161	12	breast	breast	NOUN
chd-73	161	13	cancer	cancer	NOUN
chd-73	161	14	in	in	ADP
chd-73	161	15	african	african	ADJ
chd-73	161	16	-	-	PUNCT
chd-73	161	17	american	american	ADJ
chd-73	161	18	women	woman	NOUN
chd-73	161	19	?	?	PUNCT
chd-73	162	1	cancer	cancer	NOUN
chd-73	162	2	103	103	NUM
chd-73	162	3	,	,	PUNCT
chd-73	162	4	1540	1540	NUM
chd-73	162	5	-	-	SYM
chd-73	162	6	1550	1550	NUM
chd-73	162	7	.	.	PUNCT
chd-73	163	1	howlader	howlader	PROPN
chd-73	163	2	,	,	PUNCT
chd-73	163	3	n.	n.	PROPN
chd-73	163	4	,	,	PUNCT
chd-73	163	5	cronin	cronin	PROPN
chd-73	163	6	,	,	PUNCT
chd-73	163	7	k.a	k.a	PROPN
chd-73	163	8	.	.	PROPN
chd-73	163	9	,	,	PUNCT
chd-73	163	10	kurian	kurian	PROPN
chd-73	163	11	,	,	PUNCT
chd-73	163	12	a.w	a.w	PROPN
chd-73	163	13	.	.	PROPN
chd-73	163	14	,	,	PUNCT
chd-73	163	15	and	and	CCONJ
chd-73	163	16	andridge	andridge	VERB
chd-73	163	17	,	,	PUNCT
chd-73	163	18	r.	r.	PROPN
chd-73	163	19	(	(	PUNCT
chd-73	163	20	2018	2018	NUM
chd-73	163	21	)	)	PUNCT
chd-73	163	22	.	.	PUNCT
chd-73	164	1	differences	difference	NOUN
chd-73	164	2	in	in	ADP
chd-73	164	3	breast	breast	NOUN
chd-73	164	4	cancer	cancer	NOUN
chd-73	164	5	survival	survival	NOUN
chd-73	164	6	by	by	ADP
chd-73	164	7	molecular	molecular	ADJ
chd-73	164	8	subtypes	subtype	NOUN
chd-73	164	9	in	in	ADP
chd-73	164	10	the	the	DET
chd-73	164	11	united	united	PROPN
chd-73	164	12	states	states	PROPN
chd-73	164	13	.	.	PUNCT
chd-73	165	1	cancer	cancer	NOUN
chd-73	165	2	epidemiol	epidemiol	PROPN
chd-73	165	3	biomarkers	biomarkers	PROPN
chd-73	165	4	prev	prev	VERB
chd-73	165	5	27	27	NUM
chd-73	165	6	,	,	PUNCT
chd-73	165	7	619	619	NUM
chd-73	165	8	-	-	SYM
chd-73	165	9	626	626	NUM
chd-73	165	10	.	.	PUNCT
chd-73	166	1	huang	huang	PROPN
chd-73	166	2	,	,	PUNCT
chd-73	166	3	y.	y.	PROPN
chd-73	166	4	,	,	PUNCT
chd-73	166	5	lin	lin	PROPN
chd-73	166	6	,	,	PUNCT
chd-73	166	7	l.	l.	PROPN
chd-73	166	8	,	,	PUNCT
chd-73	166	9	shanker	shanker	PROPN
chd-73	166	10	,	,	PUNCT
chd-73	166	11	a.	a.	PROPN
chd-73	166	12	,	,	PUNCT
chd-73	166	13	malhotra	malhotra	PROPN
chd-73	166	14	,	,	PUNCT
chd-73	166	15	a.	a.	PROPN
chd-73	166	16	,	,	PUNCT
chd-73	166	17	yang	yang	PROPN
chd-73	166	18	,	,	PUNCT
chd-73	166	19	l.	l.	PROPN
chd-73	166	20	,	,	PUNCT
chd-73	166	21	dikov	dikov	PROPN
chd-73	166	22	,	,	PUNCT
chd-73	166	23	m.m	m.m	PROPN
chd-73	166	24	.	.	PROPN
chd-73	166	25	,	,	PUNCT
chd-73	166	26	and	and	CCONJ
chd-73	166	27	carbone	carbone	NOUN
chd-73	166	28	,	,	PUNCT
chd-73	166	29	d.p	d.p	PROPN
chd-73	166	30	.	.	PUNCT
chd-73	166	31	(	(	PUNCT
chd-73	166	32	2011	2011	NUM
chd-73	166	33	)	)	PUNCT
chd-73	166	34	.	.	PUNCT
chd-73	167	1	resuscitating	resuscitate	VERB
chd-73	167	2	cancer	cancer	NOUN
chd-73	167	3	immunosurveillance	immunosurveillance	NOUN
chd-73	167	4	:	:	PUNCT
chd-73	167	5	selective	selective	ADJ
chd-73	167	6	stimulation	stimulation	NOUN
chd-73	167	7	of	of	ADP
chd-73	167	8	dll1	dll1	NOUN
chd-73	167	9	-	-	PUNCT
chd-73	167	10	notch	notch	NOUN
chd-73	167	11	signaling	signal	VERB
chd-73	167	12	in	in	ADP
chd-73	167	13	t	t	PROPN
chd-73	167	14	cells	cell	NOUN
chd-73	167	15	rescues	rescue	VERB
chd-73	167	16	t	t	PROPN
chd-73	167	17	-	-	PUNCT
chd-73	167	18	cell	cell	NOUN
chd-73	167	19	function	function	NOUN
chd-73	167	20	and	and	CCONJ
chd-73	167	21	inhibits	inhibit	VERB
chd-73	167	22	tumor	tumor	NOUN
chd-73	167	23	growth	growth	NOUN
chd-73	167	24	.	.	PUNCT
chd-73	168	1	cancer	cancer	NOUN
chd-73	168	2	res	re	NOUN
chd-73	168	3	71	71	NUM
chd-73	168	4	,	,	PUNCT
chd-73	168	5	6122	6122	NUM
chd-73	168	6	-	-	SYM
chd-73	168	7	6131	6131	NUM
chd-73	168	8	.	.	PUNCT
chd-73	169	1	kared	kare	VERB
chd-73	169	2	,	,	PUNCT
chd-73	169	3	h.	h.	PROPN
chd-73	169	4	,	,	PUNCT
chd-73	169	5	adle	adle	NOUN
chd-73	169	6	-	-	PUNCT
chd-73	169	7	biassette	biassette	PROPN
chd-73	169	8	,	,	PUNCT
chd-73	169	9	h.	h.	PROPN
chd-73	169	10	,	,	PUNCT
chd-73	169	11	fois	fois	PROPN
chd-73	169	12	,	,	PUNCT
chd-73	169	13	e.	e.	PROPN
chd-73	169	14	,	,	PUNCT
chd-73	169	15	masson	masson	PROPN
chd-73	169	16	,	,	PUNCT
chd-73	169	17	a.	a.	PROPN
chd-73	169	18	,	,	PUNCT
chd-73	169	19	bach	bach	PROPN
chd-73	169	20	,	,	PUNCT
chd-73	169	21	j.f	j.f	PROPN
chd-73	169	22	.	.	PROPN
chd-73	169	23	,	,	PUNCT
chd-73	169	24	chatenoud	chatenoud	PROPN
chd-73	169	25	,	,	PUNCT
chd-73	169	26	l.	l.	PROPN
chd-73	169	27	,	,	PUNCT
chd-73	169	28	schneider	schneider	PROPN
chd-73	169	29	,	,	PUNCT
chd-73	169	30	e.	e.	PROPN
chd-73	169	31	,	,	PUNCT
chd-73	169	32	and	and	CCONJ
chd-73	169	33	zavala	zavala	NOUN
chd-73	169	34	,	,	PUNCT
chd-73	169	35	f.	f.	PROPN
chd-73	169	36	(	(	PUNCT
chd-73	169	37	2006	2006	NUM
chd-73	169	38	)	)	PUNCT
chd-73	169	39	.	.	PUNCT
chd-73	170	1	jagged2	jagged2	NOUN
chd-73	170	2	-	-	PUNCT
chd-73	170	3	expressing	express	VERB
chd-73	170	4	hematopoietic	hematopoietic	ADJ
chd-73	170	5	progenitors	progenitor	NOUN
chd-73	170	6	promote	promote	VERB
chd-73	170	7	regulatory	regulatory	ADJ
chd-73	170	8	t	t	NOUN
chd-73	170	9	cell	cell	NOUN
chd-73	170	10	expansion	expansion	NOUN
chd-73	170	11	in	in	ADP
chd-73	170	12	the	the	DET
chd-73	170	13	periphery	periphery	NOUN
chd-73	170	14	through	through	ADP
chd-73	170	15	notch	notch	ADJ
chd-73	170	16	signaling	signal	VERB
chd-73	170	17	.	.	PUNCT
chd-73	171	1	immunity	immunity	NOUN
chd-73	171	2	25	25	NUM
chd-73	171	3	,	,	PUNCT
chd-73	171	4	823	823	NUM
chd-73	171	5	-	-	SYM
chd-73	171	6	834	834	NUM
chd-73	171	7	.	.	PUNCT
chd-73	172	1	keerthivasan	keerthivasan	PROPN
chd-73	172	2	,	,	PUNCT
chd-73	172	3	s.	s.	PROPN
chd-73	172	4	,	,	PUNCT
chd-73	172	5	suleiman	suleiman	PROPN
chd-73	172	6	,	,	PUNCT
chd-73	172	7	r.	r.	PROPN
chd-73	172	8	,	,	PUNCT
chd-73	172	9	lawlor	lawlor	PROPN
chd-73	172	10	,	,	PUNCT
chd-73	172	11	r.	r.	PROPN
chd-73	172	12	,	,	PUNCT
chd-73	172	13	roderick	roderick	PROPN
chd-73	172	14	,	,	PUNCT
chd-73	172	15	j.	j.	PROPN
chd-73	172	16	,	,	PUNCT
chd-73	172	17	bates	bate	NOUN
chd-73	172	18	,	,	PUNCT
chd-73	172	19	t.	t.	PROPN
chd-73	172	20	,	,	PUNCT
chd-73	172	21	minter	minter	PROPN
chd-73	172	22	,	,	PUNCT
chd-73	172	23	l.	l.	PROPN
chd-73	172	24	,	,	PUNCT
chd-73	172	25	anguita	anguita	PROPN
chd-73	172	26	,	,	PUNCT
chd-73	172	27	j.	j.	PROPN
chd-73	172	28	,	,	PUNCT
chd-73	172	29	juncadella	juncadella	PROPN
chd-73	172	30	,	,	PUNCT
chd-73	172	31	i.	i.	PROPN
chd-73	172	32	,	,	PUNCT
chd-73	172	33	nickoloff	nickoloff	PROPN
chd-73	172	34	,	,	PUNCT
chd-73	172	35	b.j	b.j	PROPN
chd-73	172	36	.	.	PROPN
chd-73	172	37	,	,	PUNCT
chd-73	172	38	le	le	PROPN
chd-73	172	39	poole	poole	PROPN
chd-73	172	40	,	,	PUNCT
chd-73	172	41	i.c	i.c	PROPN
chd-73	172	42	.	.	PROPN
chd-73	172	43	,	,	PUNCT
chd-73	172	44	et	et	PROPN
chd-73	172	45	al	al	PROPN
chd-73	172	46	.	.	PUNCT
chd-73	172	47	(	(	PUNCT
chd-73	172	48	2011	2011	NUM
chd-73	172	49	)	)	PUNCT
chd-73	172	50	.	.	PUNCT
chd-73	173	1	notch	notch	NOUN
chd-73	173	2	signaling	signal	VERB
chd-73	173	3	regulates	regulate	VERB
chd-73	173	4	mouse	mouse	NOUN
chd-73	173	5	and	and	CCONJ
chd-73	173	6	human	human	ADJ
chd-73	173	7	th17	th17	PROPN
chd-73	173	8	differentiation	differentiation	NOUN
chd-73	173	9	.	.	PUNCT
chd-73	174	1	j	j	PROPN
chd-73	174	2	immunol	immunol	NOUN
chd-73	174	3	187	187	NUM
chd-73	174	4	,	,	PUNCT
chd-73	174	5	692	692	NUM
chd-73	174	6	-	-	SYM
chd-73	174	7	701	701	NUM
chd-73	174	8	.	.	PUNCT
chd-73	175	1	kijima	kijima	PROPN
chd-73	175	2	,	,	PUNCT
chd-73	175	3	m.	m.	NOUN
chd-73	175	4	,	,	PUNCT
chd-73	175	5	yamaguchi	yamaguchi	PROPN
chd-73	175	6	,	,	PUNCT
chd-73	175	7	t.	t.	PROPN
chd-73	175	8	,	,	PUNCT
chd-73	175	9	ishifune	ishifune	PROPN
chd-73	175	10	,	,	PUNCT
chd-73	175	11	c.	c.	PROPN
chd-73	175	12	,	,	PUNCT
chd-73	175	13	maekawa	maekawa	PROPN
chd-73	175	14	,	,	PUNCT
chd-73	175	15	y.	y.	PROPN
chd-73	175	16	,	,	PUNCT
chd-73	175	17	koyanagi	koyanagi	PROPN
chd-73	175	18	,	,	PUNCT
chd-73	175	19	a.	a.	PROPN
chd-73	175	20	,	,	PUNCT
chd-73	175	21	yagita	yagita	PROPN
chd-73	175	22	,	,	PUNCT
chd-73	175	23	h.	h.	PROPN
chd-73	175	24	,	,	PUNCT
chd-73	175	25	chiba	chiba	PROPN
chd-73	175	26	,	,	PUNCT
chd-73	175	27	s.	s.	PROPN
chd-73	175	28	,	,	PUNCT
chd-73	175	29	kishihara	kishihara	PROPN
chd-73	175	30	,	,	PUNCT
chd-73	175	31	k.	k.	PROPN
chd-73	175	32	,	,	PUNCT
chd-73	175	33	shimada	shimada	PROPN
chd-73	175	34	,	,	PUNCT
chd-73	175	35	m.	m.	NOUN
chd-73	175	36	,	,	PUNCT
chd-73	175	37	and	and	CCONJ
chd-73	175	38	yasutomo	yasutomo	PROPN
chd-73	175	39	,	,	PUNCT
chd-73	175	40	k.	k.	PROPN
chd-73	175	41	(	(	PUNCT
chd-73	175	42	2008	2008	NUM
chd-73	175	43	)	)	PUNCT
chd-73	175	44	.	.	PUNCT
chd-73	176	1	dendritic	dendritic	ADJ
chd-73	176	2	cell	cell	NOUN
chd-73	176	3	-	-	PUNCT
chd-73	176	4	mediated	mediate	VERB
chd-73	176	5	nk	nk	NOUN
chd-73	176	6	cell	cell	NOUN
chd-73	176	7	activation	activation	NOUN
chd-73	176	8	is	be	AUX
chd-73	176	9	controlled	control	VERB
chd-73	176	10	by	by	ADP
chd-73	176	11	jagged2	jagged2	NOUN
chd-73	176	12	-	-	PUNCT
chd-73	176	13	notch	notch	NOUN
chd-73	176	14	interaction	interaction	NOUN
chd-73	176	15	.	.	PUNCT
chd-73	177	1	proc	proc	PROPN
chd-73	177	2	natl	natl	PROPN
chd-73	177	3	acad	acad	PROPN
chd-73	177	4	sci	sci	PROPN
chd-73	177	5	u	u	PROPN
chd-73	177	6	s	s	PROPN
chd-73	177	7	a	a	DET
chd-73	177	8	105	105	NUM
chd-73	177	9	,	,	PUNCT
chd-73	177	10	7010	7010	NUM
chd-73	177	11	-	-	SYM
chd-73	177	12	7015	7015	NUM
chd-73	177	13	.	.	PUNCT
chd-73	178	1	klinakis	klinakis	PROPN
chd-73	178	2	,	,	PUNCT
chd-73	178	3	a.	a.	NOUN
chd-73	178	4	,	,	PUNCT
chd-73	178	5	lobry	lobry	NOUN
chd-73	178	6	,	,	PUNCT
chd-73	178	7	c.	c.	PROPN
chd-73	178	8	,	,	PUNCT
chd-73	178	9	abdel	abdel	PROPN
chd-73	178	10	-	-	PUNCT
chd-73	178	11	wahab	wahab	PROPN
chd-73	178	12	,	,	PUNCT
chd-73	178	13	o.	o.	PROPN
chd-73	178	14	,	,	PUNCT
chd-73	178	15	oh	oh	INTJ
chd-73	178	16	,	,	PUNCT
chd-73	178	17	p.	p.	NOUN
chd-73	178	18	,	,	PUNCT
chd-73	178	19	haeno	haeno	PROPN
chd-73	178	20	,	,	PUNCT
chd-73	178	21	h.	h.	PROPN
chd-73	178	22	,	,	PUNCT
chd-73	178	23	buonamici	buonamici	PROPN
chd-73	178	24	,	,	PUNCT
chd-73	178	25	s.	s.	PROPN
chd-73	178	26	,	,	PUNCT
chd-73	178	27	van	van	PROPN
chd-73	178	28	de	de	PROPN
chd-73	178	29	walle	walle	PROPN
chd-73	178	30	,	,	PUNCT
chd-73	178	31	i.	i.	PROPN
chd-73	178	32	,	,	PUNCT
chd-73	178	33	cathelin	cathelin	PROPN
chd-73	178	34	,	,	PUNCT
chd-73	178	35	s.	s.	PROPN
chd-73	178	36	,	,	PUNCT
chd-73	178	37	trimarchi	trimarchi	NOUN
chd-73	178	38	,	,	PUNCT
chd-73	178	39	t.	t.	PROPN
chd-73	178	40	,	,	PUNCT
chd-73	178	41	araldi	araldi	PROPN
chd-73	178	42	,	,	PUNCT
chd-73	178	43	e.	e.	PROPN
chd-73	178	44	,	,	PUNCT
chd-73	178	45	et	et	PROPN
chd-73	178	46	al	al	PROPN
chd-73	178	47	.	.	PUNCT
chd-73	178	48	(	(	PUNCT
chd-73	178	49	2011	2011	NUM
chd-73	178	50	)	)	PUNCT
chd-73	178	51	.	.	PUNCT
chd-73	179	1	a	a	DET
chd-73	179	2	novel	novel	ADJ
chd-73	179	3	tumour	tumour	NOUN
chd-73	179	4	-	-	PUNCT
chd-73	179	5	suppressor	suppressor	NOUN
chd-73	179	6	function	function	NOUN
chd-73	179	7	for	for	ADP
chd-73	179	8	the	the	DET
chd-73	179	9	notch	notch	ADJ
chd-73	179	10	pathway	pathway	NOUN
chd-73	179	11	in	in	ADP
chd-73	179	12	myeloid	myeloid	ADJ
chd-73	179	13	leukaemia	leukaemia	NOUN
chd-73	179	14	.	.	PUNCT
chd-73	180	1	nature	nature	NOUN
chd-73	180	2	473	473	NUM
chd-73	180	3	,	,	PUNCT
chd-73	180	4	230	230	NUM
chd-73	180	5	-	-	SYM
chd-73	180	6	233	233	NUM
chd-73	180	7	.	.	PUNCT
chd-73	181	1	krawczyk	krawczyk	PROPN
chd-73	181	2	,	,	PUNCT
chd-73	181	3	c.m	c.m	PROPN
chd-73	181	4	.	.	PROPN
chd-73	181	5	,	,	PUNCT
chd-73	181	6	sun	sun	PROPN
chd-73	181	7	,	,	PUNCT
chd-73	181	8	j.	j.	PROPN
chd-73	181	9	,	,	PUNCT
chd-73	181	10	and	and	CCONJ
chd-73	181	11	pearce	pearce	PROPN
chd-73	181	12	,	,	PUNCT
chd-73	181	13	e.j	e.j	PROPN
chd-73	181	14	.	.	PROPN
chd-73	181	15	(	(	PUNCT
chd-73	181	16	2008	2008	NUM
chd-73	181	17	)	)	PUNCT
chd-73	181	18	.	.	PUNCT
chd-73	182	1	th2	th2	PROPN
chd-73	182	2	differentiation	differentiation	NOUN
chd-73	182	3	is	be	AUX
chd-73	182	4	unaffected	unaffected	ADJ
chd-73	182	5	by	by	ADP
chd-73	182	6	jagged2	jagged2	NOUN
chd-73	182	7	expression	expression	NOUN
chd-73	182	8	on	on	ADP
chd-73	182	9	dendritic	dendritic	ADJ
chd-73	182	10	cells	cell	NOUN
chd-73	182	11	.	.	PUNCT
chd-73	183	1	j	j	PROPN
chd-73	183	2	immunol	immunol	NOUN
chd-73	183	3	180	180	NUM
chd-73	183	4	,	,	PUNCT
chd-73	183	5	7931	7931	NUM
chd-73	183	6	-	-	SYM
chd-73	183	7	7937	7937	NUM
chd-73	183	8	.	.	PUNCT
chd-73	184	1	kuijk	kuijk	PROPN
chd-73	184	2	,	,	PUNCT
chd-73	184	3	l.m	l.m	PROPN
chd-73	184	4	.	.	PROPN
chd-73	184	5	,	,	PUNCT
chd-73	184	6	verstege	verstege	NOUN
chd-73	184	7	,	,	PUNCT
chd-73	184	8	m.i	m.i	PROPN
chd-73	184	9	.	.	PROPN
chd-73	184	10	,	,	PUNCT
chd-73	184	11	rekers	reker	NOUN
chd-73	184	12	,	,	PUNCT
chd-73	184	13	n.v	n.v	PROPN
chd-73	184	14	.	.	PROPN
chd-73	184	15	,	,	PUNCT
chd-73	184	16	bruijns	bruijns	PROPN
chd-73	184	17	,	,	PUNCT
chd-73	184	18	s.c	s.c	PROPN
chd-73	184	19	.	.	PROPN
chd-73	184	20	,	,	PUNCT
chd-73	184	21	hooijberg	hooijberg	PROPN
chd-73	184	22	,	,	PUNCT
chd-73	184	23	e.	e.	PROPN
chd-73	184	24	,	,	PUNCT
chd-73	184	25	roep	roep	PROPN
chd-73	184	26	,	,	PUNCT
chd-73	184	27	b.o	b.o	PROPN
chd-73	184	28	.	.	PROPN
chd-73	184	29	,	,	PUNCT
chd-73	184	30	de	de	X
chd-73	184	31	gruijl	gruijl	PROPN
chd-73	184	32	,	,	PUNCT
chd-73	184	33	t.d	t.d	PROPN
chd-73	184	34	.	.	PROPN
chd-73	184	35	,	,	PUNCT
chd-73	184	36	van	van	PROPN
chd-73	184	37	kooyk	kooyk	PROPN
chd-73	184	38	,	,	PUNCT
chd-73	184	39	y.	y.	NOUN
chd-73	184	40	,	,	PUNCT
chd-73	184	41	and	and	CCONJ
chd-73	184	42	unger	unger	NOUN
chd-73	184	43	,	,	PUNCT
chd-73	184	44	w.w	w.w	PROPN
chd-73	184	45	.	.	PROPN
chd-73	184	46	(	(	PUNCT
chd-73	184	47	2013	2013	NUM
chd-73	184	48	)	)	PUNCT
chd-73	184	49	.	.	PUNCT
chd-73	185	1	notch	notch	ADJ
chd-73	185	2	controls	control	NOUN
chd-73	185	3	generation	generation	NOUN
chd-73	185	4	and	and	CCONJ
chd-73	185	5	function	function	NOUN
chd-73	185	6	of	of	ADP
chd-73	185	7	human	human	PROPN
chd-73	185	8	effector	effector	NOUN
chd-73	185	9	cd8	cd8	PROPN
chd-73	185	10	+	+	PROPN
chd-73	185	11	t	t	NOUN
chd-73	185	12	cells	cell	NOUN
chd-73	185	13	.	.	PUNCT
chd-73	186	1	blood	blood	NOUN
chd-73	186	2	121	121	NUM
chd-73	186	3	,	,	PUNCT
chd-73	186	4	2638	2638	NUM
chd-73	186	5	-	-	SYM
chd-73	186	6	2646	2646	NUM
chd-73	186	7	.	.	PUNCT
chd-73	187	1	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	PUNCT
chd-73	187	2	e9	e9	PROPN
chd-73	187	3	cancer	cancer	NOUN
chd-73	187	4	health	health	NOUN
chd-73	187	5	disparities	disparity	NOUN
chd-73	187	6	research	research	PROPN
chd-73	187	7	kulkarni	kulkarni	PROPN
chd-73	187	8	,	,	PUNCT
chd-73	187	9	h.	h.	PROPN
chd-73	187	10	,	,	PUNCT
chd-73	187	11	marconi	marconi	PROPN
chd-73	187	12	,	,	PUNCT
chd-73	187	13	v.c	v.c	PROPN
chd-73	187	14	.	.	PROPN
chd-73	187	15	,	,	PUNCT
chd-73	187	16	he	he	PRON
chd-73	187	17	,	,	PUNCT
chd-73	187	18	w.	w.	PROPN
chd-73	187	19	,	,	PUNCT
chd-73	187	20	landrum	landrum	PROPN
chd-73	187	21	,	,	PUNCT
chd-73	187	22	m.l	m.l	PROPN
chd-73	187	23	.	.	PROPN
chd-73	187	24	,	,	PUNCT
chd-73	187	25	okulicz	okulicz	VERB
chd-73	187	26	,	,	PUNCT
chd-73	187	27	j.f	j.f	PROPN
chd-73	187	28	.	.	PROPN
chd-73	187	29	,	,	PUNCT
chd-73	187	30	delmar	delmar	PROPN
chd-73	187	31	,	,	PUNCT
chd-73	187	32	j.	j.	PROPN
chd-73	187	33	,	,	PUNCT
chd-73	187	34	kazandjian	kazandjian	PROPN
chd-73	187	35	,	,	PUNCT
chd-73	187	36	d.	d.	PROPN
chd-73	187	37	,	,	PUNCT
chd-73	187	38	castiblanco	castiblanco	PROPN
chd-73	187	39	,	,	PUNCT
chd-73	187	40	j.	j.	PROPN
chd-73	187	41	,	,	PUNCT
chd-73	187	42	ahuja	ahuja	PROPN
chd-73	187	43	,	,	PUNCT
chd-73	187	44	s.s	s.s	PROPN
chd-73	187	45	.	.	PROPN
chd-73	187	46	,	,	PUNCT
chd-73	187	47	wright	wright	PROPN
chd-73	187	48	,	,	PUNCT
chd-73	187	49	e.j	e.j	PROPN
chd-73	187	50	.	.	PROPN
chd-73	187	51	,	,	PUNCT
chd-73	187	52	et	et	PROPN
chd-73	187	53	al	al	PROPN
chd-73	187	54	.	.	PUNCT
chd-73	188	1	(	(	PUNCT
chd-73	188	2	2009	2009	NUM
chd-73	188	3	)	)	PUNCT
chd-73	188	4	.	.	PUNCT
chd-73	189	1	the	the	DET
chd-73	189	2	duffy	duffy	PROPN
chd-73	189	3	-	-	PUNCT
chd-73	189	4	null	null	ADJ
chd-73	189	5	state	state	NOUN
chd-73	189	6	is	be	AUX
chd-73	189	7	associated	associate	VERB
chd-73	189	8	with	with	ADP
chd-73	189	9	a	a	DET
chd-73	189	10	survival	survival	NOUN
chd-73	189	11	advantage	advantage	NOUN
chd-73	189	12	in	in	ADP
chd-73	189	13	leukopenic	leukopenic	ADJ
chd-73	189	14	hivinfected	hivinfecte	VERB
chd-73	189	15	persons	person	NOUN
chd-73	189	16	of	of	ADP
chd-73	189	17	african	african	ADJ
chd-73	189	18	ancestry	ancestry	NOUN
chd-73	189	19	.	.	PUNCT
chd-73	190	1	blood	blood	NOUN
chd-73	190	2	114	114	NUM
chd-73	190	3	,	,	PUNCT
chd-73	190	4	27832792	27832792	NUM
chd-73	190	5	.	.	PUNCT
chd-73	191	1	laky	laky	PROPN
chd-73	191	2	,	,	PUNCT
chd-73	191	3	k.	k.	PROPN
chd-73	191	4	,	,	PUNCT
chd-73	191	5	evans	evans	PROPN
chd-73	191	6	,	,	PUNCT
chd-73	191	7	s.	s.	PROPN
chd-73	191	8	,	,	PUNCT
chd-73	191	9	perez	perez	PROPN
chd-73	191	10	-	-	PUNCT
chd-73	191	11	diez	diez	PROPN
chd-73	191	12	,	,	PUNCT
chd-73	191	13	a.	a.	NOUN
chd-73	191	14	,	,	PUNCT
chd-73	191	15	and	and	CCONJ
chd-73	191	16	fowlkes	fowlke	NOUN
chd-73	191	17	,	,	PUNCT
chd-73	191	18	b.j	b.j	PROPN
chd-73	191	19	.	.	PROPN
chd-73	191	20	(	(	PUNCT
chd-73	191	21	2015	2015	NUM
chd-73	191	22	)	)	PUNCT
chd-73	191	23	.	.	PUNCT
chd-73	192	1	notch	notch	NOUN
chd-73	192	2	signaling	signal	VERB
chd-73	192	3	regulates	regulate	VERB
chd-73	192	4	antigen	antigen	ADJ
chd-73	192	5	sensitivity	sensitivity	NOUN
chd-73	192	6	of	of	ADP
chd-73	192	7	naive	naive	ADJ
chd-73	192	8	cd4	cd4	PROPN
chd-73	192	9	+	+	PROPN
chd-73	192	10	t	t	NOUN
chd-73	192	11	cells	cell	NOUN
chd-73	192	12	by	by	ADP
chd-73	192	13	tuning	tune	VERB
chd-73	192	14	co	co	NOUN
chd-73	192	15	-	-	NOUN
chd-73	192	16	stimulation	stimulation	NOUN
chd-73	192	17	.	.	PUNCT
chd-73	193	1	immunity	immunity	NOUN
chd-73	193	2	42	42	NUM
chd-73	193	3	,	,	PUNCT
chd-73	193	4	8094	8094	NUM
chd-73	193	5	.	.	PUNCT
chd-73	194	1	lefort	lefort	NOUN
chd-73	194	2	,	,	PUNCT
chd-73	194	3	n.	n.	NOUN
chd-73	194	4	,	,	PUNCT
chd-73	194	5	benne	benne	PROPN
chd-73	194	6	,	,	PUNCT
chd-73	194	7	c.	c.	PROPN
chd-73	194	8	,	,	PUNCT
chd-73	194	9	lelievre	lelievre	NOUN
chd-73	194	10	,	,	PUNCT
chd-73	194	11	j.d	j.d	PROPN
chd-73	194	12	.	.	PROPN
chd-73	194	13	,	,	PUNCT
chd-73	194	14	dorival	dorival	PROPN
chd-73	194	15	,	,	PUNCT
chd-73	194	16	c.	c.	PROPN
chd-73	194	17	,	,	PUNCT
chd-73	194	18	balbo	balbo	PROPN
chd-73	194	19	,	,	PUNCT
chd-73	194	20	m.	m.	NOUN
chd-73	194	21	,	,	PUNCT
chd-73	194	22	sakano	sakano	PROPN
chd-73	194	23	,	,	PUNCT
chd-73	194	24	s.	s.	PROPN
chd-73	194	25	,	,	PUNCT
chd-73	194	26	coulombel	coulombel	NOUN
chd-73	194	27	,	,	PUNCT
chd-73	194	28	l.	l.	PROPN
chd-73	194	29	,	,	PUNCT
chd-73	194	30	and	and	CCONJ
chd-73	194	31	levy	levy	NOUN
chd-73	194	32	,	,	PUNCT
chd-73	194	33	y.	y.	PROPN
chd-73	194	34	(	(	PUNCT
chd-73	194	35	2006	2006	NUM
chd-73	194	36	)	)	PUNCT
chd-73	194	37	.	.	PUNCT
chd-73	195	1	short	short	ADJ
chd-73	195	2	exposure	exposure	NOUN
chd-73	195	3	to	to	ADP
chd-73	195	4	notch	notch	ADJ
chd-73	195	5	ligand	ligand	NOUN
chd-73	195	6	delta-4	delta-4	NUM
chd-73	195	7	is	be	AUX
chd-73	195	8	sufficient	sufficient	ADJ
chd-73	195	9	to	to	PART
chd-73	195	10	induce	induce	VERB
chd-73	195	11	t	t	NOUN
chd-73	195	12	-	-	PUNCT
chd-73	195	13	cell	cell	NOUN
chd-73	195	14	differentiation	differentiation	NOUN
chd-73	195	15	program	program	NOUN
chd-73	195	16	and	and	CCONJ
chd-73	195	17	to	to	PART
chd-73	195	18	increase	increase	VERB
chd-73	195	19	the	the	DET
chd-73	195	20	t	t	NOUN
chd-73	195	21	cell	cell	NOUN
chd-73	195	22	potential	potential	NOUN
chd-73	195	23	of	of	ADP
chd-73	195	24	primary	primary	ADJ
chd-73	195	25	human	human	ADJ
chd-73	195	26	cd34	cd34	PROPN
chd-73	195	27	+	+	NUM
chd-73	195	28	cells	cell	NOUN
chd-73	195	29	.	.	PUNCT
chd-73	196	1	exp	exp	NOUN
chd-73	196	2	hematol	hematol	NOUN
chd-73	196	3	34	34	NUM
chd-73	196	4	,	,	PUNCT
chd-73	196	5	1720	1720	NUM
chd-73	196	6	-	-	SYM
chd-73	196	7	1729	1729	NUM
chd-73	196	8	.	.	PUNCT
chd-73	197	1	lobry	lobry	PROPN
chd-73	197	2	,	,	PUNCT
chd-73	197	3	c.	c.	PROPN
chd-73	197	4	,	,	PUNCT
chd-73	197	5	oh	oh	INTJ
chd-73	197	6	,	,	PUNCT
chd-73	197	7	p.	p.	NOUN
chd-73	197	8	,	,	PUNCT
chd-73	197	9	and	and	CCONJ
chd-73	197	10	aifantis	aifantis	PROPN
chd-73	197	11	,	,	PUNCT
chd-73	197	12	i.	i.	PROPN
chd-73	197	13	(	(	PUNCT
chd-73	197	14	2011	2011	NUM
chd-73	197	15	)	)	PUNCT
chd-73	197	16	.	.	PUNCT
chd-73	198	1	oncogenic	oncogenic	NOUN
chd-73	198	2	and	and	CCONJ
chd-73	198	3	tumor	tumor	NOUN
chd-73	198	4	suppressor	suppressor	NOUN
chd-73	198	5	functions	function	NOUN
chd-73	198	6	of	of	ADP
chd-73	198	7	notch	notch	NOUN
chd-73	198	8	in	in	ADP
chd-73	198	9	cancer	cancer	NOUN
chd-73	198	10	:	:	PUNCT
chd-73	198	11	it	it	PRON
chd-73	198	12	's	be	AUX
chd-73	198	13	notch	notch	ADJ
chd-73	198	14	what	what	PRON
chd-73	198	15	you	you	PRON
chd-73	198	16	think	think	VERB
chd-73	198	17	.	.	PUNCT
chd-73	199	1	j	j	PROPN
chd-73	199	2	exp	exp	NOUN
chd-73	199	3	med	me	VERB
chd-73	199	4	208	208	NUM
chd-73	199	5	,	,	PUNCT
chd-73	199	6	1931	1931	NUM
chd-73	199	7	-	-	SYM
chd-73	199	8	1935	1935	NUM
chd-73	199	9	.	.	PUNCT
chd-73	200	1	martin	martin	PROPN
chd-73	200	2	,	,	PUNCT
chd-73	200	3	m.p	m.p	PROPN
chd-73	200	4	.	.	PROPN
chd-73	200	5	,	,	PUNCT
chd-73	200	6	naranbhai	naranbhai	NOUN
chd-73	200	7	,	,	PUNCT
chd-73	200	8	v.	v.	PROPN
chd-73	200	9	,	,	PUNCT
chd-73	200	10	shea	shea	PROPN
chd-73	200	11	,	,	PUNCT
chd-73	200	12	p.r	p.r	PROPN
chd-73	200	13	.	.	PROPN
chd-73	200	14	,	,	PUNCT
chd-73	200	15	qi	qi	PROPN
chd-73	200	16	,	,	PUNCT
chd-73	200	17	y.	y.	PROPN
chd-73	200	18	,	,	PUNCT
chd-73	200	19	ramsuran	ramsuran	VERB
chd-73	200	20	,	,	PUNCT
chd-73	200	21	v.	v.	ADV
chd-73	200	22	,	,	PUNCT
chd-73	200	23	vince	vince	NOUN
chd-73	200	24	,	,	PUNCT
chd-73	200	25	n.	n.	PROPN
chd-73	200	26	,	,	PUNCT
chd-73	200	27	gao	gao	PROPN
chd-73	200	28	,	,	PUNCT
chd-73	200	29	x.	x.	PROPN
chd-73	200	30	,	,	PUNCT
chd-73	200	31	thomas	thomas	PROPN
chd-73	200	32	,	,	PUNCT
chd-73	200	33	r.	r.	PROPN
chd-73	200	34	,	,	PUNCT
chd-73	200	35	brumme	brumme	PROPN
chd-73	200	36	,	,	PUNCT
chd-73	200	37	z.l	z.l	PROPN
chd-73	200	38	.	.	PROPN
chd-73	200	39	,	,	PUNCT
chd-73	200	40	carlson	carlson	PROPN
chd-73	200	41	,	,	PUNCT
chd-73	200	42	j.m	j.m	PROPN
chd-73	200	43	.	.	PROPN
chd-73	200	44	,	,	PUNCT
chd-73	200	45	et	et	PROPN
chd-73	200	46	al	al	PROPN
chd-73	200	47	.	.	PUNCT
chd-73	201	1	(	(	PUNCT
chd-73	201	2	2018	2018	NUM
chd-73	201	3	)	)	PUNCT
chd-73	201	4	.	.	PUNCT
chd-73	202	1	killer	killer	NOUN
chd-73	202	2	cell	cell	NOUN
chd-73	202	3	immunoglobulin	immunoglobulin	NOUN
chd-73	202	4	-	-	PUNCT
chd-73	202	5	like	like	ADJ
chd-73	202	6	receptor	receptor	NOUN
chd-73	202	7	3dl1	3dl1	NUM
chd-73	202	8	variation	variation	NOUN
chd-73	202	9	modifies	modify	VERB
chd-73	202	10	hla	hla	PROPN
chd-73	202	11	-	-	PUNCT
chd-73	202	12	b*57	b*57	PROPN
chd-73	202	13	protection	protection	NOUN
chd-73	202	14	against	against	ADP
chd-73	202	15	hiv-1	hiv-1	NOUN
chd-73	202	16	.	.	PUNCT
chd-73	203	1	j	j	PROPN
chd-73	203	2	clin	clin	PROPN
chd-73	203	3	invest	invest	PROPN
chd-73	203	4	.	.	PUNCT
chd-73	204	1	novitskiy	novitskiy	PROPN
chd-73	204	2	,	,	PUNCT
chd-73	204	3	s.v	s.v	PROPN
chd-73	204	4	.	.	PROPN
chd-73	204	5	,	,	PUNCT
chd-73	204	6	csiki	csiki	PROPN
chd-73	204	7	,	,	PUNCT
chd-73	204	8	i.	i.	PROPN
chd-73	204	9	,	,	PUNCT
chd-73	204	10	huang	huang	PROPN
chd-73	204	11	,	,	PUNCT
chd-73	204	12	y.	y.	PROPN
chd-73	204	13	,	,	PUNCT
chd-73	204	14	johnson	johnson	PROPN
chd-73	204	15	,	,	PUNCT
chd-73	204	16	d.h	d.h	PROPN
chd-73	204	17	.	.	PROPN
chd-73	204	18	,	,	PUNCT
chd-73	204	19	harth	harth	PROPN
chd-73	204	20	,	,	PUNCT
chd-73	204	21	e.m	e.m	PROPN
chd-73	204	22	.	.	PROPN
chd-73	204	23	,	,	PUNCT
chd-73	204	24	carbone	carbone	PROPN
chd-73	204	25	,	,	PUNCT
chd-73	204	26	d.p	d.p	PROPN
chd-73	204	27	.	.	PROPN
chd-73	204	28	,	,	PUNCT
chd-73	204	29	and	and	CCONJ
chd-73	204	30	dikov	dikov	PROPN
chd-73	204	31	,	,	PUNCT
chd-73	204	32	m.m	m.m	PROPN
chd-73	204	33	.	.	PROPN
chd-73	204	34	(	(	PUNCT
chd-73	204	35	2010	2010	NUM
chd-73	204	36	)	)	PUNCT
chd-73	204	37	.	.	PUNCT
chd-73	205	1	anti	anti	ADJ
chd-73	205	2	-	-	ADJ
chd-73	205	3	vascular	vascular	ADJ
chd-73	205	4	endothelial	endothelial	ADJ
chd-73	205	5	growth	growth	NOUN
chd-73	205	6	factor	factor	NOUN
chd-73	205	7	treatment	treatment	NOUN
chd-73	205	8	in	in	ADP
chd-73	205	9	combination	combination	NOUN
chd-73	205	10	with	with	ADP
chd-73	205	11	chemotherapy	chemotherapy	NOUN
chd-73	205	12	delays	delay	NOUN
chd-73	205	13	hematopoietic	hematopoietic	ADJ
chd-73	205	14	recovery	recovery	NOUN
chd-73	205	15	due	due	ADP
chd-73	205	16	to	to	ADP
chd-73	205	17	decreased	decrease	VERB
chd-73	205	18	proliferation	proliferation	NOUN
chd-73	205	19	of	of	ADP
chd-73	205	20	bone	bone	NOUN
chd-73	205	21	marrow	marrow	NOUN
chd-73	205	22	hematopoietic	hematopoietic	ADJ
chd-73	205	23	progenitor	progenitor	NOUN
chd-73	205	24	cells	cell	NOUN
chd-73	205	25	.	.	PUNCT
chd-73	206	1	j	j	PROPN
chd-73	206	2	thorac	thorac	NOUN
chd-73	206	3	oncol	oncol	ADJ
chd-73	206	4	5	5	NUM
chd-73	206	5	,	,	PUNCT
chd-73	206	6	1410	1410	NUM
chd-73	206	7	-	-	SYM
chd-73	206	8	1415	1415	NUM
chd-73	206	9	.	.	PUNCT
chd-73	207	1	ntziachristos	ntziachristos	NOUN
chd-73	207	2	,	,	PUNCT
chd-73	207	3	p.	p.	NOUN
chd-73	207	4	,	,	PUNCT
chd-73	207	5	lim	lim	PROPN
chd-73	207	6	,	,	PUNCT
chd-73	207	7	j.s	j.s	PROPN
chd-73	207	8	.	.	PROPN
chd-73	207	9	,	,	PUNCT
chd-73	207	10	sage	sage	NOUN
chd-73	207	11	,	,	PUNCT
chd-73	207	12	j.	j.	PROPN
chd-73	207	13	,	,	PUNCT
chd-73	207	14	and	and	CCONJ
chd-73	207	15	aifantis	aifantis	PROPN
chd-73	207	16	,	,	PUNCT
chd-73	207	17	i.	i.	PROPN
chd-73	207	18	(	(	PUNCT
chd-73	207	19	2014	2014	NUM
chd-73	207	20	)	)	PUNCT
chd-73	207	21	.	.	PUNCT
chd-73	208	1	from	from	ADP
chd-73	208	2	fly	fly	VERB
chd-73	208	3	wings	wing	NOUN
chd-73	208	4	to	to	ADP
chd-73	208	5	targeted	target	VERB
chd-73	208	6	cancer	cancer	NOUN
chd-73	208	7	therapies	therapy	NOUN
chd-73	208	8	:	:	PUNCT
chd-73	208	9	a	a	DET
chd-73	208	10	centennial	centennial	NOUN
chd-73	208	11	for	for	ADP
chd-73	208	12	notch	notch	ADJ
chd-73	208	13	signaling	signal	VERB
chd-73	208	14	.	.	PUNCT
chd-73	209	1	cancer	cancer	NOUN
chd-73	209	2	cell	cell	NOUN
chd-73	209	3	25	25	NUM
chd-73	209	4	,	,	PUNCT
chd-73	209	5	318	318	NUM
chd-73	209	6	-	-	SYM
chd-73	209	7	334	334	NUM
chd-73	209	8	.	.	PUNCT
chd-73	210	1	orzechowska	orzechowska	PROPN
chd-73	210	2	,	,	PUNCT
chd-73	210	3	m.	m.	NOUN
chd-73	210	4	,	,	PUNCT
chd-73	210	5	jedroszka	jedroszka	PROPN
chd-73	210	6	,	,	PUNCT
chd-73	210	7	d.	d.	PROPN
chd-73	210	8	,	,	PUNCT
chd-73	210	9	and	and	CCONJ
chd-73	210	10	bednarek	bednarek	NOUN
chd-73	210	11	,	,	PUNCT
chd-73	210	12	a.k	a.k	PROPN
chd-73	210	13	.	.	PROPN
chd-73	211	1	(	(	PUNCT
chd-73	211	2	2017	2017	NUM
chd-73	211	3	)	)	PUNCT
chd-73	211	4	.	.	PUNCT
chd-73	212	1	common	common	ADJ
chd-73	212	2	profiles	profile	NOUN
chd-73	212	3	of	of	ADP
chd-73	212	4	notch	notch	NOUN
chd-73	212	5	signaling	signal	VERB
chd-73	212	6	differentiate	differentiate	ADJ
chd-73	212	7	disease	disease	NOUN
chd-73	212	8	-	-	PUNCT
chd-73	212	9	free	free	ADJ
chd-73	212	10	survival	survival	NOUN
chd-73	212	11	in	in	ADP
chd-73	212	12	luminal	luminal	ADJ
chd-73	212	13	type	type	NOUN
chd-73	212	14	a	a	DET
chd-73	212	15	and	and	CCONJ
chd-73	212	16	triple	triple	ADJ
chd-73	212	17	negative	negative	ADJ
chd-73	212	18	breast	breast	NOUN
chd-73	212	19	cancer	cancer	NOUN
chd-73	212	20	.	.	PUNCT
chd-73	213	1	oncotarget	oncotarget	NOUN
chd-73	213	2	8	8	NUM
chd-73	213	3	,	,	PUNCT
chd-73	213	4	6013	6013	NUM
chd-73	213	5	-	-	SYM
chd-73	213	6	6032	6032	NUM
chd-73	213	7	.	.	PUNCT
chd-73	214	1	palaga	palaga	NOUN
chd-73	214	2	,	,	PUNCT
chd-73	214	3	t.	t.	PROPN
chd-73	214	4	,	,	PUNCT
chd-73	214	5	miele	miele	PROPN
chd-73	214	6	,	,	PUNCT
chd-73	214	7	l.	l.	PROPN
chd-73	214	8	,	,	PUNCT
chd-73	214	9	golde	golde	PROPN
chd-73	214	10	,	,	PUNCT
chd-73	214	11	t.e	t.e	PROPN
chd-73	214	12	.	.	PROPN
chd-73	214	13	,	,	PUNCT
chd-73	214	14	and	and	CCONJ
chd-73	214	15	osborne	osborne	PROPN
chd-73	214	16	,	,	PUNCT
chd-73	214	17	b.a	b.a	PROPN
chd-73	214	18	.	.	PROPN
chd-73	214	19	(	(	PUNCT
chd-73	214	20	2003	2003	NUM
chd-73	214	21	)	)	PUNCT
chd-73	214	22	.	.	PUNCT
chd-73	215	1	tcr	tcr	PROPN
chd-73	215	2	-	-	PUNCT
chd-73	215	3	mediated	mediate	VERB
chd-73	215	4	notch	notch	NOUN
chd-73	215	5	signaling	signal	VERB
chd-73	215	6	regulates	regulate	VERB
chd-73	215	7	proliferation	proliferation	NOUN
chd-73	215	8	and	and	CCONJ
chd-73	215	9	ifn	ifn	PROPN
chd-73	215	10	-	-	PUNCT
chd-73	215	11	gamma	gamma	NOUN
chd-73	215	12	production	production	NOUN
chd-73	215	13	in	in	ADP
chd-73	215	14	peripheral	peripheral	ADJ
chd-73	215	15	t	t	NOUN
chd-73	215	16	cells	cell	NOUN
chd-73	215	17	.	.	PUNCT
chd-73	216	1	j	j	PROPN
chd-73	216	2	immunol	immunol	NOUN
chd-73	216	3	171	171	NUM
chd-73	216	4	,	,	PUNCT
chd-73	216	5	3019	3019	NUM
chd-73	216	6	-	-	SYM
chd-73	216	7	3024	3024	NUM
chd-73	216	8	.	.	PUNCT
chd-73	217	1	parr	parr	PROPN
chd-73	217	2	,	,	PUNCT
chd-73	217	3	c.	c.	PROPN
chd-73	217	4	,	,	PUNCT
chd-73	217	5	watkins	watkins	PROPN
chd-73	217	6	,	,	PUNCT
chd-73	217	7	g.	g.	PROPN
chd-73	217	8	,	,	PUNCT
chd-73	217	9	and	and	CCONJ
chd-73	217	10	jiang	jiang	PROPN
chd-73	217	11	,	,	PUNCT
chd-73	217	12	w.g	w.g	PROPN
chd-73	217	13	.	.	PROPN
chd-73	217	14	(	(	PUNCT
chd-73	217	15	2004	2004	NUM
chd-73	217	16	)	)	PUNCT
chd-73	217	17	.	.	PUNCT
chd-73	218	1	the	the	DET
chd-73	218	2	possible	possible	ADJ
chd-73	218	3	correlation	correlation	NOUN
chd-73	218	4	of	of	ADP
chd-73	218	5	notch-1	notch-1	NUM
chd-73	218	6	and	and	CCONJ
chd-73	218	7	notch-2	notch-2	NUM
chd-73	218	8	with	with	ADP
chd-73	218	9	clinical	clinical	ADJ
chd-73	218	10	outcome	outcome	NOUN
chd-73	218	11	and	and	CCONJ
chd-73	218	12	tumour	tumour	ADJ
chd-73	218	13	clinicopathological	clinicopathological	ADJ
chd-73	218	14	parameters	parameter	NOUN
chd-73	218	15	in	in	ADP
chd-73	218	16	human	human	ADJ
chd-73	218	17	breast	breast	NOUN
chd-73	218	18	cancer	cancer	NOUN
chd-73	218	19	.	.	PUNCT
chd-73	219	1	int	int	PROPN
chd-73	219	2	j	j	PROPN
chd-73	219	3	mol	mol	ADP
chd-73	219	4	med	med	PROPN
chd-73	219	5	14	14	NUM
chd-73	219	6	,	,	PUNCT
chd-73	219	7	779	779	NUM
chd-73	219	8	-	-	SYM
chd-73	219	9	786	786	NUM
chd-73	219	10	.	.	PUNCT
chd-73	220	1	previs	previs	PROPN
chd-73	220	2	,	,	PUNCT
chd-73	220	3	r.a	r.a	PROPN
chd-73	220	4	.	.	PROPN
chd-73	220	5	,	,	PUNCT
chd-73	220	6	coleman	coleman	PROPN
chd-73	220	7	,	,	PUNCT
chd-73	220	8	r.l	r.l	PROPN
chd-73	220	9	.	.	PROPN
chd-73	220	10	,	,	PUNCT
chd-73	220	11	harris	harris	PROPN
chd-73	220	12	,	,	PUNCT
chd-73	220	13	a.l	a.l	PROPN
chd-73	220	14	.	.	PROPN
chd-73	220	15	,	,	PUNCT
chd-73	220	16	and	and	CCONJ
chd-73	220	17	sood	sood	PROPN
chd-73	220	18	,	,	PUNCT
chd-73	220	19	a.k	a.k	PROPN
chd-73	220	20	.	.	PROPN
chd-73	220	21	(	(	PUNCT
chd-73	220	22	2015	2015	NUM
chd-73	220	23	)	)	PUNCT
chd-73	220	24	.	.	PUNCT
chd-73	221	1	molecular	molecular	ADJ
chd-73	221	2	pathways	pathway	NOUN
chd-73	221	3	:	:	PUNCT
chd-73	221	4	translational	translational	ADJ
chd-73	221	5	and	and	CCONJ
chd-73	221	6	therapeutic	therapeutic	ADJ
chd-73	221	7	implications	implication	NOUN
chd-73	221	8	of	of	ADP
chd-73	221	9	the	the	DET
chd-73	221	10	notch	notch	NOUN
chd-73	221	11	signaling	signal	VERB
chd-73	221	12	pathway	pathway	NOUN
chd-73	221	13	in	in	ADP
chd-73	221	14	cancer	cancer	NOUN
chd-73	221	15	.	.	PUNCT
chd-73	222	1	clin	clin	PROPN
chd-73	222	2	cancer	cancer	NOUN
chd-73	222	3	res	re	NOUN
chd-73	222	4	21	21	NUM
chd-73	222	5	,	,	PUNCT
chd-73	222	6	955	955	NUM
chd-73	222	7	-	-	SYM
chd-73	222	8	961	961	NUM
chd-73	222	9	.	.	PUNCT
chd-73	223	1	radtke	radtke	PROPN
chd-73	223	2	,	,	PUNCT
chd-73	223	3	f.	f.	PROPN
chd-73	223	4	,	,	PUNCT
chd-73	223	5	fasnacht	fasnacht	PROPN
chd-73	223	6	,	,	PUNCT
chd-73	223	7	n.	n.	NOUN
chd-73	223	8	,	,	PUNCT
chd-73	223	9	and	and	CCONJ
chd-73	223	10	macdonald	macdonald	PROPN
chd-73	223	11	,	,	PUNCT
chd-73	223	12	h.r	h.r	PROPN
chd-73	223	13	.	.	PROPN
chd-73	223	14	(	(	PUNCT
chd-73	223	15	2010	2010	NUM
chd-73	223	16	)	)	PUNCT
chd-73	223	17	.	.	PUNCT
chd-73	224	1	notch	notch	NOUN
chd-73	224	2	signaling	signal	VERB
chd-73	224	3	in	in	ADP
chd-73	224	4	the	the	DET
chd-73	224	5	immune	immune	ADJ
chd-73	224	6	system	system	NOUN
chd-73	224	7	.	.	PUNCT
chd-73	225	1	immunity	immunity	NOUN
chd-73	225	2	32	32	NUM
chd-73	225	3	,	,	PUNCT
chd-73	225	4	14	14	NUM
chd-73	225	5	-	-	SYM
chd-73	225	6	27	27	NUM
chd-73	225	7	.	.	PUNCT
chd-73	226	1	rakhra	rakhra	PROPN
chd-73	226	2	,	,	PUNCT
chd-73	226	3	k.	k.	PROPN
chd-73	226	4	,	,	PUNCT
chd-73	226	5	bachireddy	bachireddy	NOUN
chd-73	226	6	,	,	PUNCT
chd-73	226	7	p.	p.	PROPN
chd-73	226	8	,	,	PUNCT
chd-73	226	9	zabuawala	zabuawala	PROPN
chd-73	226	10	,	,	PUNCT
chd-73	226	11	t.	t.	PROPN
chd-73	226	12	,	,	PUNCT
chd-73	226	13	zeiser	zeiser	PROPN
chd-73	226	14	,	,	PUNCT
chd-73	226	15	r.	r.	PROPN
chd-73	226	16	,	,	PUNCT
chd-73	226	17	xu	xu	PROPN
chd-73	226	18	,	,	PUNCT
chd-73	226	19	l.	l.	PROPN
chd-73	226	20	,	,	PUNCT
chd-73	226	21	kopelman	kopelman	PROPN
chd-73	226	22	,	,	PUNCT
chd-73	226	23	a.	a.	NOUN
chd-73	226	24	,	,	PUNCT
chd-73	226	25	fan	fan	PROPN
chd-73	226	26	,	,	PUNCT
chd-73	226	27	a.c	a.c	PROPN
chd-73	226	28	.	.	PROPN
chd-73	226	29	,	,	PUNCT
chd-73	226	30	yang	yang	PROPN
chd-73	226	31	,	,	PUNCT
chd-73	226	32	q.	q.	PROPN
chd-73	226	33	,	,	PUNCT
chd-73	226	34	braunstein	braunstein	ADV
chd-73	226	35	,	,	PUNCT
chd-73	226	36	l.	l.	PROPN
chd-73	226	37	,	,	PUNCT
chd-73	226	38	crosby	crosby	PROPN
chd-73	226	39	,	,	PUNCT
chd-73	226	40	e.	e.	PROPN
chd-73	226	41	,	,	PUNCT
chd-73	226	42	et	et	PROPN
chd-73	226	43	al	al	PROPN
chd-73	226	44	.	.	PUNCT
chd-73	227	1	(	(	PUNCT
chd-73	227	2	2010	2010	NUM
chd-73	227	3	)	)	PUNCT
chd-73	227	4	.	.	PUNCT
chd-73	228	1	cd4(+	cd4(+	VERB
chd-73	228	2	)	)	PUNCT
chd-73	228	3	t	t	NOUN
chd-73	228	4	cells	cell	NOUN
chd-73	228	5	contribute	contribute	VERB
chd-73	228	6	to	to	ADP
chd-73	228	7	the	the	DET
chd-73	228	8	remodeling	remodeling	NOUN
chd-73	228	9	of	of	ADP
chd-73	228	10	the	the	DET
chd-73	228	11	microenvironment	microenvironment	NOUN
chd-73	228	12	required	require	VERB
chd-73	228	13	for	for	ADP
chd-73	228	14	sustained	sustained	ADJ
chd-73	228	15	tumor	tumor	NOUN
chd-73	228	16	regression	regression	NOUN
chd-73	228	17	upon	upon	SCONJ
chd-73	228	18	oncogene	oncogene	NOUN
chd-73	228	19	inactivation	inactivation	NOUN
chd-73	228	20	.	.	PUNCT
chd-73	229	1	cancer	cancer	NOUN
chd-73	229	2	cell	cell	NOUN
chd-73	229	3	18	18	NUM
chd-73	229	4	,	,	PUNCT
chd-73	229	5	485	485	NUM
chd-73	229	6	-	-	SYM
chd-73	229	7	498	498	NUM
chd-73	229	8	.	.	PUNCT
chd-73	230	1	ramsuran	ramsuran	ADJ
chd-73	230	2	,	,	PUNCT
chd-73	230	3	v.	v.	ADV
chd-73	230	4	,	,	PUNCT
chd-73	230	5	naranbhai	naranbhai	NOUN
chd-73	230	6	,	,	PUNCT
chd-73	230	7	v.	v.	PROPN
chd-73	230	8	,	,	PUNCT
chd-73	230	9	horowitz	horowitz	PROPN
chd-73	230	10	,	,	PUNCT
chd-73	230	11	a.	a.	PROPN
chd-73	230	12	,	,	PUNCT
chd-73	230	13	qi	qi	PROPN
chd-73	230	14	,	,	PUNCT
chd-73	230	15	y.	y.	PROPN
chd-73	230	16	,	,	PUNCT
chd-73	230	17	martin	martin	PROPN
chd-73	230	18	,	,	PUNCT
chd-73	230	19	m.p	m.p	PROPN
chd-73	230	20	.	.	PROPN
chd-73	230	21	,	,	PUNCT
chd-73	230	22	yuki	yuki	PROPN
chd-73	230	23	,	,	PUNCT
chd-73	230	24	y.	y.	PROPN
chd-73	230	25	,	,	PUNCT
chd-73	230	26	gao	gao	PROPN
chd-73	230	27	,	,	PUNCT
chd-73	230	28	x.	x.	PROPN
chd-73	230	29	,	,	PUNCT
chd-73	230	30	walker	walker	NOUN
chd-73	230	31	-	-	PUNCT
chd-73	230	32	sperling	sperling	PROPN
chd-73	230	33	,	,	PUNCT
chd-73	230	34	v.	v.	PROPN
chd-73	230	35	,	,	PUNCT
chd-73	230	36	del	del	PROPN
chd-73	230	37	prete	prete	NOUN
chd-73	230	38	,	,	PUNCT
chd-73	230	39	g.q	g.q	PROPN
chd-73	230	40	.	.	PROPN
chd-73	230	41	,	,	PUNCT
chd-73	230	42	schneider	schneider	PROPN
chd-73	230	43	,	,	PUNCT
chd-73	230	44	d.k	d.k	PROPN
chd-73	230	45	.	.	PROPN
chd-73	230	46	,	,	PUNCT
chd-73	230	47	et	et	PROPN
chd-73	230	48	al	al	PROPN
chd-73	230	49	.	.	PUNCT
chd-73	231	1	(	(	PUNCT
chd-73	231	2	2018	2018	NUM
chd-73	231	3	)	)	PUNCT
chd-73	231	4	.	.	PUNCT
chd-73	232	1	elevated	elevate	VERB
chd-73	232	2	hla	hla	PROPN
chd-73	232	3	-	-	PUNCT
chd-73	232	4	a	a	DET
chd-73	232	5	expression	expression	NOUN
chd-73	232	6	impairs	impair	VERB
chd-73	232	7	hiv	hiv	PROPN
chd-73	232	8	control	control	NOUN
chd-73	232	9	through	through	ADP
chd-73	232	10	inhibition	inhibition	NOUN
chd-73	232	11	of	of	ADP
chd-73	232	12	nkg2aexpressing	nkg2aexpresse	VERB
chd-73	232	13	cells	cell	NOUN
chd-73	232	14	.	.	PUNCT
chd-73	233	1	science	science	NOUN
chd-73	233	2	359	359	NUM
chd-73	233	3	,	,	PUNCT
chd-73	233	4	86	86	NUM
chd-73	233	5	-	-	SYM
chd-73	233	6	90	90	NUM
chd-73	233	7	.	.	PUNCT
chd-73	233	8	reedijk	reedijk	PROPN
chd-73	233	9	,	,	PUNCT
chd-73	233	10	m.	m.	NOUN
chd-73	233	11	,	,	PUNCT
chd-73	233	12	odorcic	odorcic	NOUN
chd-73	233	13	,	,	PUNCT
chd-73	233	14	s.	s.	PROPN
chd-73	233	15	,	,	PUNCT
chd-73	233	16	chang	chang	PROPN
chd-73	233	17	,	,	PUNCT
chd-73	233	18	l.	l.	PROPN
chd-73	233	19	,	,	PUNCT
chd-73	233	20	zhang	zhang	PROPN
chd-73	233	21	,	,	PUNCT
chd-73	233	22	h.	h.	PROPN
chd-73	233	23	,	,	PUNCT
chd-73	233	24	miller	miller	PROPN
chd-73	233	25	,	,	PUNCT
chd-73	233	26	n.	n.	NOUN
chd-73	233	27	,	,	PUNCT
chd-73	233	28	mccready	mccready	PROPN
chd-73	233	29	,	,	PUNCT
chd-73	233	30	d.r	d.r	PROPN
chd-73	233	31	.	.	PROPN
chd-73	233	32	,	,	PUNCT
chd-73	233	33	lockwood	lockwood	PROPN
chd-73	233	34	,	,	PUNCT
chd-73	233	35	g.	g.	PROPN
chd-73	233	36	,	,	PUNCT
chd-73	233	37	and	and	CCONJ
chd-73	233	38	egan	egan	PROPN
chd-73	233	39	,	,	PUNCT
chd-73	233	40	s.e	s.e	PROPN
chd-73	233	41	.	.	PROPN
chd-73	233	42	(	(	PUNCT
chd-73	233	43	2005	2005	NUM
chd-73	233	44	)	)	PUNCT
chd-73	233	45	.	.	PUNCT
chd-73	234	1	high	high	ADJ
chd-73	234	2	-	-	PUNCT
chd-73	234	3	level	level	NOUN
chd-73	234	4	coexpression	coexpression	NOUN
chd-73	234	5	of	of	ADP
chd-73	234	6	jag1	jag1	NOUN
chd-73	234	7	and	and	CCONJ
chd-73	234	8	notch1	notch1	NOUN
chd-73	234	9	is	be	AUX
chd-73	234	10	observed	observe	VERB
chd-73	234	11	in	in	ADP
chd-73	234	12	human	human	ADJ
chd-73	234	13	breast	breast	NOUN
chd-73	234	14	cancer	cancer	NOUN
chd-73	234	15	and	and	CCONJ
chd-73	234	16	is	be	AUX
chd-73	234	17	associated	associate	VERB
chd-73	234	18	with	with	ADP
chd-73	234	19	poor	poor	ADJ
chd-73	234	20	overall	overall	ADJ
chd-73	234	21	survival	survival	NOUN
chd-73	234	22	.	.	PUNCT
chd-73	235	1	cancer	cancer	NOUN
chd-73	235	2	res	re	NOUN
chd-73	235	3	65	65	NUM
chd-73	235	4	,	,	PUNCT
chd-73	235	5	8530	8530	NUM
chd-73	235	6	-	-	SYM
chd-73	235	7	8537	8537	NUM
chd-73	235	8	.	.	PUNCT
chd-73	236	1	sauma	sauma	PROPN
chd-73	236	2	,	,	PUNCT
chd-73	236	3	d.	d.	PROPN
chd-73	236	4	,	,	PUNCT
chd-73	236	5	ramirez	ramirez	PROPN
chd-73	236	6	,	,	PUNCT
chd-73	236	7	a.	a.	PROPN
chd-73	236	8	,	,	PUNCT
chd-73	236	9	alvarez	alvarez	PROPN
chd-73	236	10	,	,	PUNCT
chd-73	236	11	k.	k.	PROPN
chd-73	236	12	,	,	PUNCT
chd-73	236	13	rosemblatt	rosemblatt	PROPN
chd-73	236	14	,	,	PUNCT
chd-73	236	15	m.	m.	NOUN
chd-73	236	16	,	,	PUNCT
chd-73	236	17	and	and	CCONJ
chd-73	236	18	bono	bono	X
chd-73	236	19	,	,	PUNCT
chd-73	236	20	m.r	m.r	PROPN
chd-73	236	21	.	.	PROPN
chd-73	236	22	(	(	PUNCT
chd-73	236	23	2012	2012	NUM
chd-73	236	24	)	)	PUNCT
chd-73	236	25	.	.	PUNCT
chd-73	237	1	notch	notch	NOUN
chd-73	237	2	signalling	signal	VERB
chd-73	237	3	regulates	regulate	VERB
chd-73	237	4	cytokine	cytokine	ADJ
chd-73	237	5	production	production	NOUN
chd-73	237	6	by	by	ADP
chd-73	237	7	cd8	cd8	PROPN
chd-73	237	8	+	+	PROPN
chd-73	237	9	and	and	CCONJ
chd-73	237	10	cd4	cd4	PROPN
chd-73	237	11	+	+	PROPN
chd-73	237	12	t	t	NOUN
chd-73	237	13	cells	cell	NOUN
chd-73	237	14	.	.	PUNCT
chd-73	238	1	scand	scand	PROPN
chd-73	238	2	j	j	PROPN
chd-73	238	3	immunol	immunol	NOUN
chd-73	238	4	75	75	NUM
chd-73	238	5	,	,	PUNCT
chd-73	238	6	389	389	NUM
chd-73	238	7	-	-	SYM
chd-73	238	8	400	400	NUM
chd-73	238	9	.	.	PUNCT
chd-73	239	1	shen	shen	PROPN
chd-73	239	2	,	,	PUNCT
chd-73	239	3	q.	q.	PROPN
chd-73	239	4	,	,	PUNCT
chd-73	239	5	cohen	cohen	PROPN
chd-73	239	6	,	,	PUNCT
chd-73	239	7	b.	b.	PROPN
chd-73	239	8	,	,	PUNCT
chd-73	239	9	zheng	zheng	PROPN
chd-73	239	10	,	,	PUNCT
chd-73	239	11	w.	w.	PROPN
chd-73	239	12	,	,	PUNCT
chd-73	239	13	rahbar	rahbar	NOUN
chd-73	239	14	,	,	PUNCT
chd-73	239	15	r.	r.	PROPN
chd-73	239	16	,	,	PUNCT
chd-73	239	17	martin	martin	PROPN
chd-73	239	18	,	,	PUNCT
chd-73	239	19	b.	b.	PROPN
chd-73	239	20	,	,	PUNCT
chd-73	239	21	murakami	murakami	NOUN
chd-73	239	22	,	,	PUNCT
chd-73	239	23	k.	k.	PROPN
chd-73	239	24	,	,	PUNCT
chd-73	239	25	lamorte	lamorte	PROPN
chd-73	239	26	,	,	PUNCT
chd-73	239	27	s.	s.	PROPN
chd-73	239	28	,	,	PUNCT
chd-73	239	29	thompson	thompson	PROPN
chd-73	239	30	,	,	PUNCT
chd-73	239	31	p.	p.	NOUN
chd-73	239	32	,	,	PUNCT
chd-73	239	33	berman	berman	PROPN
chd-73	239	34	,	,	PUNCT
chd-73	239	35	h.	h.	PROPN
chd-73	239	36	,	,	PUNCT
chd-73	239	37	zuniga	zuniga	PROPN
chd-73	239	38	-	-	PUNCT
chd-73	239	39	pflucker	pflucker	PROPN
chd-73	239	40	,	,	PUNCT
chd-73	239	41	j.c	j.c	PROPN
chd-73	239	42	.	.	PROPN
chd-73	239	43	,	,	PUNCT
chd-73	239	44	et	et	PROPN
chd-73	239	45	al	al	PROPN
chd-73	239	46	.	.	PUNCT
chd-73	239	47	(	(	PUNCT
chd-73	239	48	2017	2017	NUM
chd-73	239	49	)	)	PUNCT
chd-73	239	50	.	.	PUNCT
chd-73	240	1	notch	notch	ADJ
chd-73	240	2	shapes	shape	VERB
chd-73	240	3	the	the	DET
chd-73	240	4	innate	innate	ADJ
chd-73	240	5	immunophenotype	immunophenotype	NOUN
chd-73	240	6	in	in	ADP
chd-73	240	7	breast	breast	NOUN
chd-73	240	8	cancer	cancer	NOUN
chd-73	240	9	.	.	PUNCT
chd-73	241	1	cancer	cancer	NOUN
chd-73	241	2	discov	discov	PROPN
chd-73	241	3	7	7	NUM
chd-73	241	4	,	,	PUNCT
chd-73	241	5	1320	1320	NUM
chd-73	241	6	-	-	SYM
chd-73	241	7	1335	1335	NUM
chd-73	241	8	.	.	PUNCT
chd-73	242	1	sierra	sierra	PROPN
chd-73	242	2	,	,	PUNCT
chd-73	242	3	r.a	r.a	PROPN
chd-73	242	4	.	.	PROPN
chd-73	242	5	,	,	PUNCT
chd-73	242	6	thevenot	thevenot	ADV
chd-73	242	7	,	,	PUNCT
chd-73	242	8	p.	p.	NOUN
chd-73	242	9	,	,	PUNCT
chd-73	242	10	raber	raber	PROPN
chd-73	242	11	,	,	PUNCT
chd-73	242	12	p.l	p.l	PROPN
chd-73	242	13	.	.	PROPN
chd-73	242	14	,	,	PUNCT
chd-73	242	15	cui	cui	PROPN
chd-73	242	16	,	,	PUNCT
chd-73	242	17	y.	y.	PROPN
chd-73	242	18	,	,	PUNCT
chd-73	242	19	parsons	parson	NOUN
chd-73	242	20	,	,	PUNCT
chd-73	242	21	c.	c.	PROPN
chd-73	242	22	,	,	PUNCT
chd-73	242	23	ochoa	ochoa	PROPN
chd-73	242	24	,	,	PUNCT
chd-73	242	25	a.c	a.c	PROPN
chd-73	242	26	.	.	PROPN
chd-73	242	27	,	,	PUNCT
chd-73	242	28	trillo	trillo	PROPN
chd-73	242	29	-	-	PUNCT
chd-73	242	30	tinoco	tinoco	PROPN
chd-73	242	31	,	,	PUNCT
chd-73	242	32	j.	j.	PROPN
chd-73	242	33	,	,	PUNCT
chd-73	242	34	del	del	PROPN
chd-73	242	35	valle	valle	PROPN
chd-73	242	36	,	,	PUNCT
chd-73	242	37	l.	l.	PROPN
chd-73	242	38	,	,	PUNCT
chd-73	242	39	and	and	CCONJ
chd-73	242	40	rodriguez	rodriguez	NOUN
chd-73	242	41	,	,	PUNCT
chd-73	242	42	p.c	p.c	PROPN
chd-73	242	43	.	.	PROPN
chd-73	242	44	(	(	PUNCT
chd-73	242	45	2014	2014	NUM
chd-73	242	46	)	)	PUNCT
chd-73	242	47	.	.	PUNCT
chd-73	243	1	rescue	rescue	NOUN
chd-73	243	2	of	of	ADP
chd-73	243	3	notch-1	notch-1	NUM
chd-73	243	4	signaling	signal	VERB
chd-73	243	5	in	in	ADP
chd-73	243	6	antigenspecific	antigenspecific	PROPN
chd-73	243	7	cd8	cd8	PROPN
chd-73	243	8	+	+	PROPN
chd-73	243	9	t	t	PROPN
chd-73	243	10	cells	cell	NOUN
chd-73	243	11	overcomes	overcome	VERB
chd-73	243	12	tumor	tumor	NOUN
chd-73	243	13	-	-	PUNCT
chd-73	243	14	induced	induce	VERB
chd-73	243	15	t	t	NOUN
chd-73	243	16	-	-	PUNCT
chd-73	243	17	cell	cell	NOUN
chd-73	243	18	suppression	suppression	NOUN
chd-73	243	19	and	and	CCONJ
chd-73	243	20	enhances	enhance	VERB
chd-73	243	21	immunotherapy	immunotherapy	NOUN
chd-73	243	22	in	in	ADP
chd-73	243	23	cancer	cancer	NOUN
chd-73	243	24	.	.	PUNCT
chd-73	244	1	cancer	cancer	NOUN
chd-73	244	2	immunol	immunol	NOUN
chd-73	244	3	res	re	NOUN
chd-73	244	4	2	2	NUM
chd-73	244	5	,	,	PUNCT
chd-73	244	6	800	800	NUM
chd-73	244	7	-	-	SYM
chd-73	244	8	811	811	NUM
chd-73	244	9	.	.	PUNCT
chd-73	245	1	sierra	sierra	PROPN
chd-73	245	2	,	,	PUNCT
chd-73	245	3	r.a	r.a	PROPN
chd-73	245	4	.	.	PROPN
chd-73	245	5	,	,	PUNCT
chd-73	245	6	trillo	trillo	PROPN
chd-73	245	7	-	-	PUNCT
chd-73	245	8	tinoco	tinoco	PROPN
chd-73	245	9	,	,	PUNCT
chd-73	245	10	j.	j.	PROPN
chd-73	245	11	,	,	PUNCT
chd-73	245	12	mohamed	mohamed	PROPN
chd-73	245	13	,	,	PUNCT
chd-73	245	14	e.	e.	PROPN
chd-73	245	15	,	,	PUNCT
chd-73	245	16	yu	yu	PROPN
chd-73	245	17	,	,	PUNCT
chd-73	245	18	l.	l.	PROPN
chd-73	245	19	,	,	PUNCT
chd-73	245	20	achyut	achyut	NOUN
chd-73	245	21	,	,	PUNCT
chd-73	245	22	b.r	b.r	PROPN
chd-73	245	23	.	.	PROPN
chd-73	245	24	,	,	PUNCT
chd-73	245	25	arbab	arbab	PROPN
chd-73	245	26	,	,	PUNCT
chd-73	245	27	a.	a.	PROPN
chd-73	245	28	,	,	PUNCT
chd-73	245	29	bradford	bradford	PROPN
chd-73	245	30	,	,	PUNCT
chd-73	245	31	j.w	j.w	PROPN
chd-73	245	32	.	.	PROPN
chd-73	245	33	,	,	PUNCT
chd-73	245	34	osborne	osborne	PROPN
chd-73	245	35	,	,	PUNCT
chd-73	245	36	b.a	b.a	PROPN
chd-73	245	37	.	.	PROPN
chd-73	245	38	,	,	PUNCT
chd-73	245	39	miele	miele	PROPN
chd-73	245	40	,	,	PUNCT
chd-73	245	41	l.	l.	PROPN
chd-73	245	42	,	,	PUNCT
chd-73	245	43	and	and	CCONJ
chd-73	245	44	rodriguez	rodriguez	NOUN
chd-73	245	45	,	,	PUNCT
chd-73	245	46	p.c	p.c	PROPN
chd-73	245	47	.	.	PROPN
chd-73	245	48	(	(	PUNCT
chd-73	245	49	2017	2017	NUM
chd-73	245	50	)	)	PUNCT
chd-73	245	51	.	.	PUNCT
chd-73	246	1	anti	anti	ADJ
chd-73	246	2	-	-	ADJ
chd-73	246	3	jagged	jagged	ADJ
chd-73	246	4	immunotherapy	immunotherapy	NOUN
chd-73	246	5	inhibits	inhibit	VERB
chd-73	246	6	mdscs	mdsc	NOUN
chd-73	246	7	and	and	CCONJ
chd-73	246	8	overcomes	overcome	VERB
chd-73	246	9	tumor	tumor	NOUN
chd-73	246	10	-	-	PUNCT
chd-73	246	11	induced	induce	VERB
chd-73	246	12	tolerance	tolerance	NOUN
chd-73	246	13	.	.	PUNCT
chd-73	247	1	cancer	cancer	NOUN
chd-73	247	2	res	re	NOUN
chd-73	247	3	77	77	NUM
chd-73	247	4	,	,	PUNCT
chd-73	247	5	5628	5628	NUM
chd-73	247	6	-	-	SYM
chd-73	247	7	5638	5638	NUM
chd-73	247	8	.	.	PUNCT
chd-73	248	1	sprinzak	sprinzak	NOUN
chd-73	248	2	,	,	PUNCT
chd-73	248	3	d.	d.	PROPN
chd-73	248	4	,	,	PUNCT
chd-73	248	5	lakhanpal	lakhanpal	PROPN
chd-73	248	6	,	,	PUNCT
chd-73	248	7	a.	a.	NOUN
chd-73	248	8	,	,	PUNCT
chd-73	248	9	lebon	lebon	PROPN
chd-73	248	10	,	,	PUNCT
chd-73	248	11	l.	l.	PROPN
chd-73	248	12	,	,	PUNCT
chd-73	248	13	santat	santat	PROPN
chd-73	248	14	,	,	PUNCT
chd-73	248	15	l.a	l.a	PROPN
chd-73	248	16	.	.	PROPN
chd-73	248	17	,	,	PUNCT
chd-73	248	18	fontes	fontes	PROPN
chd-73	248	19	,	,	PUNCT
chd-73	248	20	m.e	m.e	PROPN
chd-73	248	21	.	.	PROPN
chd-73	248	22	,	,	PUNCT
chd-73	248	23	anderson	anderson	PROPN
chd-73	248	24	,	,	PUNCT
chd-73	248	25	g.a	g.a	PROPN
chd-73	248	26	.	.	PROPN
chd-73	248	27	,	,	PUNCT
chd-73	248	28	garcia	garcia	PROPN
chd-73	248	29	-	-	PUNCT
chd-73	248	30	ojalvo	ojalvo	PROPN
chd-73	248	31	,	,	PUNCT
chd-73	248	32	j.	j.	PROPN
chd-73	248	33	,	,	PUNCT
chd-73	248	34	and	and	CCONJ
chd-73	248	35	elowitz	elowitz	PROPN
chd-73	248	36	,	,	PUNCT
chd-73	248	37	m.b	m.b	PROPN
chd-73	248	38	.	.	PROPN
chd-73	248	39	(	(	PUNCT
chd-73	248	40	2010	2010	NUM
chd-73	248	41	)	)	PUNCT
chd-73	248	42	.	.	PUNCT
chd-73	249	1	cis	cis	NOUN
chd-73	249	2	-	-	PUNCT
chd-73	249	3	interactions	interaction	NOUN
chd-73	249	4	between	between	ADP
chd-73	249	5	notch	notch	NOUN
chd-73	249	6	and	and	CCONJ
chd-73	249	7	delta	delta	NOUN
chd-73	249	8	generate	generate	VERB
chd-73	249	9	mutually	mutually	ADV
chd-73	249	10	exclusive	exclusive	ADJ
chd-73	249	11	signalling	signal	VERB
chd-73	249	12	states	state	NOUN
chd-73	249	13	.	.	PUNCT
chd-73	250	1	nature	nature	NOUN
chd-73	250	2	465	465	NUM
chd-73	250	3	,	,	PUNCT
chd-73	250	4	86	86	NUM
chd-73	250	5	-	-	SYM
chd-73	250	6	90	90	NUM
chd-73	250	7	.	.	PUNCT
chd-73	251	1	steinbuck	steinbuck	NOUN
chd-73	251	2	,	,	PUNCT
chd-73	251	3	m.p	m.p	PROPN
chd-73	251	4	.	.	PROPN
chd-73	251	5	,	,	PUNCT
chd-73	251	6	arakcheeva	arakcheeva	PROPN
chd-73	251	7	,	,	PUNCT
chd-73	251	8	k.	k.	PROPN
chd-73	251	9	,	,	PUNCT
chd-73	251	10	and	and	CCONJ
chd-73	251	11	winandy	winandy	ADJ
chd-73	251	12	,	,	PUNCT
chd-73	251	13	s.	s.	PROPN
chd-73	251	14	(	(	PUNCT
chd-73	251	15	2018	2018	NUM
chd-73	251	16	)	)	PUNCT
chd-73	251	17	.	.	PUNCT
chd-73	252	1	novel	novel	PROPN
chd-73	252	2	tcr	tcr	PROPN
chd-73	252	3	-	-	PUNCT
chd-73	252	4	mediated	mediate	VERB
chd-73	252	5	mechanisms	mechanism	NOUN
chd-73	252	6	of	of	ADP
chd-73	252	7	notch	notch	ADJ
chd-73	252	8	activation	activation	NOUN
chd-73	252	9	and	and	CCONJ
chd-73	252	10	signaling	signaling	NOUN
chd-73	252	11	.	.	PUNCT
chd-73	253	1	j	j	PROPN
chd-73	253	2	immunol	immunol	NOUN
chd-73	253	3	200	200	NUM
chd-73	253	4	,	,	PUNCT
chd-73	253	5	997	997	NUM
chd-73	253	6	-	-	SYM
chd-73	253	7	1007	1007	NUM
chd-73	253	8	.	.	PUNCT
chd-73	254	1	stoeck	stoeck	PROPN
chd-73	254	2	,	,	PUNCT
chd-73	254	3	a.	a.	PROPN
chd-73	254	4	,	,	PUNCT
chd-73	254	5	lejnine	lejnine	NOUN
chd-73	254	6	,	,	PUNCT
chd-73	254	7	s.	s.	PROPN
chd-73	254	8	,	,	PUNCT
chd-73	254	9	truong	truong	PROPN
chd-73	254	10	,	,	PUNCT
chd-73	254	11	a.	a.	PROPN
chd-73	254	12	,	,	PUNCT
chd-73	254	13	pan	pan	PROPN
chd-73	254	14	,	,	PUNCT
chd-73	254	15	l.	l.	PROPN
chd-73	254	16	,	,	PUNCT
chd-73	254	17	wang	wang	PROPN
chd-73	254	18	,	,	PUNCT
chd-73	254	19	h.	h.	PROPN
chd-73	254	20	,	,	PUNCT
chd-73	254	21	zang	zang	PROPN
chd-73	254	22	,	,	PUNCT
chd-73	254	23	c.	c.	PROPN
chd-73	254	24	,	,	PUNCT
chd-73	254	25	yuan	yuan	PROPN
chd-73	254	26	,	,	PUNCT
chd-73	254	27	j.	j.	PROPN
chd-73	254	28	,	,	PUNCT
chd-73	254	29	ware	ware	PROPN
chd-73	254	30	,	,	PUNCT
chd-73	254	31	c.	c.	PROPN
chd-73	254	32	,	,	PUNCT
chd-73	254	33	maclean	maclean	PROPN
chd-73	254	34	,	,	PUNCT
chd-73	254	35	j.	j.	PROPN
chd-73	254	36	,	,	PUNCT
chd-73	254	37	garrett	garrett	PROPN
chd-73	254	38	-	-	PUNCT
chd-73	254	39	engele	engele	PROPN
chd-73	254	40	,	,	PUNCT
chd-73	254	41	p.w	p.w	PROPN
chd-73	254	42	.	.	PROPN
chd-73	254	43	,	,	PUNCT
chd-73	254	44	et	et	PROPN
chd-73	254	45	al	al	PROPN
chd-73	254	46	.	.	PUNCT
chd-73	254	47	(	(	PUNCT
chd-73	254	48	2014	2014	NUM
chd-73	254	49	)	)	PUNCT
chd-73	254	50	.	.	PUNCT
chd-73	255	1	discovery	discovery	NOUN
chd-73	255	2	of	of	ADP
chd-73	255	3	biomarkers	biomarker	NOUN
chd-73	255	4	predictive	predictive	ADJ
chd-73	255	5	of	of	ADP
chd-73	255	6	gsi	gsi	PROPN
chd-73	255	7	response	response	NOUN
chd-73	255	8	in	in	ADP
chd-73	255	9	triple	triple	ADJ
chd-73	255	10	-	-	PUNCT
chd-73	255	11	negative	negative	ADJ
chd-73	255	12	breast	breast	NOUN
chd-73	255	13	cancer	cancer	NOUN
chd-73	255	14	and	and	CCONJ
chd-73	255	15	adenoid	adenoid	ADJ
chd-73	255	16	cystic	cystic	ADJ
chd-73	255	17	carcinoma	carcinoma	NOUN
chd-73	255	18	.	.	PUNCT
chd-73	256	1	cancer	cancer	NOUN
chd-73	256	2	discov	discov	PROPN
chd-73	256	3	4	4	NUM
chd-73	256	4	,	,	PUNCT
chd-73	256	5	1154	1154	NUM
chd-73	256	6	-	-	SYM
chd-73	256	7	1167	1167	NUM
chd-73	256	8	.	.	PUNCT
chd-73	257	1	sugimoto	sugimoto	PROPN
chd-73	257	2	,	,	PUNCT
chd-73	257	3	k.	k.	PROPN
chd-73	257	4	,	,	PUNCT
chd-73	257	5	maekawa	maekawa	PROPN
chd-73	257	6	,	,	PUNCT
chd-73	257	7	y.	y.	PROPN
chd-73	257	8	,	,	PUNCT
chd-73	257	9	kitamura	kitamura	PROPN
chd-73	257	10	,	,	PUNCT
chd-73	257	11	a.	a.	PROPN
chd-73	257	12	,	,	PUNCT
chd-73	257	13	nishida	nishida	PROPN
chd-73	257	14	,	,	PUNCT
chd-73	257	15	j.	j.	PROPN
chd-73	257	16	,	,	PUNCT
chd-73	257	17	koyanagi	koyanagi	PROPN
chd-73	257	18	,	,	PUNCT
chd-73	257	19	a.	a.	PROPN
chd-73	257	20	,	,	PUNCT
chd-73	257	21	yagita	yagita	PROPN
chd-73	257	22	,	,	PUNCT
chd-73	257	23	h.	h.	PROPN
chd-73	257	24	,	,	PUNCT
chd-73	257	25	kojima	kojima	PROPN
chd-73	257	26	,	,	PUNCT
chd-73	257	27	h.	h.	PROPN
chd-73	257	28	,	,	PUNCT
chd-73	257	29	chiba	chiba	PROPN
chd-73	257	30	,	,	PUNCT
chd-73	257	31	s.	s.	PROPN
chd-73	257	32	,	,	PUNCT
chd-73	257	33	shimada	shimada	PROPN
chd-73	257	34	,	,	PUNCT
chd-73	257	35	m.	m.	NOUN
chd-73	257	36	,	,	PUNCT
chd-73	257	37	and	and	CCONJ
chd-73	257	38	yasutomo	yasutomo	PROPN
chd-73	257	39	,	,	PUNCT
chd-73	257	40	k.	k.	PROPN
chd-73	257	41	(	(	PUNCT
chd-73	257	42	2010	2010	NUM
chd-73	257	43	)	)	PUNCT
chd-73	257	44	.	.	PUNCT
chd-73	258	1	notch2	notch2	NOUN
chd-73	259	1	signaling	signal	VERB
chd-73	259	2	is	be	AUX
chd-73	259	3	required	require	VERB
chd-73	259	4	for	for	ADP
chd-73	259	5	potent	potent	ADJ
chd-73	259	6	antitumor	antitumor	PROPN
chd-73	259	7	immunity	immunity	NOUN
chd-73	259	8	in	in	ADP
chd-73	259	9	vivo	vivo	NOUN
chd-73	259	10	.	.	PUNCT
chd-73	260	1	j	j	PROPN
chd-73	260	2	immunol	immunol	NOUN
chd-73	260	3	184	184	NUM
chd-73	260	4	,	,	PUNCT
chd-73	260	5	46734678	46734678	NUM
chd-73	260	6	.	.	PUNCT
chd-73	261	1	thounaojam	thounaojam	NOUN
chd-73	261	2	,	,	PUNCT
chd-73	261	3	m.c	m.c	PROPN
chd-73	261	4	.	.	PROPN
chd-73	261	5	,	,	PUNCT
chd-73	261	6	dudimah	dudimah	PROPN
chd-73	261	7	,	,	PUNCT
chd-73	261	8	d.f	d.f	PROPN
chd-73	261	9	.	.	PROPN
chd-73	261	10	,	,	PUNCT
chd-73	261	11	pellom	pellom	NOUN
chd-73	261	12	,	,	PUNCT
chd-73	261	13	s.t	s.t	PROPN
chd-73	261	14	.	.	PROPN
chd-73	261	15	,	,	PUNCT
chd-73	261	16	jr	jr	PROPN
chd-73	261	17	.	.	PROPN
chd-73	261	18	,	,	PUNCT
chd-73	261	19	uzhachenko	uzhachenko	PROPN
chd-73	261	20	,	,	PUNCT
chd-73	261	21	r.v	r.v	PROPN
chd-73	261	22	.	.	PROPN
chd-73	261	23	,	,	PUNCT
chd-73	261	24	carbone	carbone	PROPN
chd-73	261	25	,	,	PUNCT
chd-73	261	26	d.p	d.p	PROPN
chd-73	261	27	.	.	PROPN
chd-73	261	28	,	,	PUNCT
chd-73	261	29	dikov	dikov	PROPN
chd-73	261	30	,	,	PUNCT
chd-73	261	31	m.m	m.m	PROPN
chd-73	261	32	.	.	PROPN
chd-73	261	33	,	,	PUNCT
chd-73	261	34	and	and	CCONJ
chd-73	261	35	shanker	shanker	NOUN
chd-73	261	36	,	,	PUNCT
chd-73	261	37	a.	a.	NOUN
chd-73	261	38	(	(	PUNCT
chd-73	261	39	2015	2015	NUM
chd-73	261	40	)	)	PUNCT
chd-73	261	41	.	.	PUNCT
chd-73	262	1	bortezomib	bortezomib	NOUN
chd-73	262	2	enhances	enhance	VERB
chd-73	262	3	expression	expression	NOUN
chd-73	262	4	of	of	ADP
chd-73	262	5	effector	effector	NOUN
chd-73	262	6	molecules	molecule	NOUN
chd-73	262	7	in	in	ADP
chd-73	262	8	anti	anti	ADJ
chd-73	262	9	-	-	ADJ
chd-73	262	10	tumor	tumor	ADJ
chd-73	262	11	cd8	cd8	PROPN
chd-73	262	12	+	+	PROPN
chd-73	262	13	t	t	PROPN
chd-73	262	14	lymphocytes	lymphocyte	VERB
chd-73	262	15	by	by	ADP
chd-73	262	16	www.companyofscientists.com/index.php/chd	www.companyofscientists.com/index.php/chd	NUM
chd-73	262	17	e10	e10	NUM
chd-73	262	18	cancer	cancer	NOUN
chd-73	262	19	health	health	NOUN
chd-73	262	20	disparities	disparity	NOUN
chd-73	262	21	research	research	NOUN
chd-73	262	22	promoting	promote	VERB
chd-73	262	23	notch	notch	ADJ
chd-73	262	24	-	-	PUNCT
chd-73	262	25	nuclear	nuclear	ADJ
chd-73	262	26	factor	factor	NOUN
chd-73	262	27	-	-	PUNCT
chd-73	262	28	kappab	kappab	NOUN
chd-73	262	29	crosstalk	crosstalk	NOUN
chd-73	262	30	.	.	PUNCT
chd-73	263	1	oncotarget	oncotarget	VERB
chd-73	263	2	6	6	NUM
chd-73	263	3	,	,	PUNCT
chd-73	263	4	32439	32439	NUM
chd-73	263	5	-	-	SYM
chd-73	263	6	32455	32455	NUM
chd-73	263	7	.	.	PUNCT
chd-73	264	1	touplikioti	touplikioti	PROPN
chd-73	264	2	,	,	PUNCT
chd-73	264	3	p.	p.	NOUN
chd-73	264	4	(	(	PUNCT
chd-73	264	5	2012	2012	NUM
chd-73	264	6	)	)	PUNCT
chd-73	264	7	.	.	PUNCT
chd-73	265	1	expression	expression	NOUN
chd-73	265	2	of	of	ADP
chd-73	265	3	notch	notch	ADJ
chd-73	265	4	receptors	receptor	NOUN
chd-73	265	5	in	in	ADP
chd-73	265	6	primary	primary	ADJ
chd-73	265	7	breast	breast	NOUN
chd-73	265	8	cancer	cancer	NOUN
chd-73	265	9	and	and	CCONJ
chd-73	265	10	correlation	correlation	NOUN
chd-73	265	11	with	with	ADP
chd-73	265	12	pathological	pathological	ADJ
chd-73	265	13	features	feature	NOUN
chd-73	265	14	.	.	PUNCT
chd-73	266	1	clinical	clinical	ADJ
chd-73	266	2	and	and	CCONJ
chd-73	266	3	experimental	experimental	ADJ
chd-73	266	4	pharmacology	pharmacology	NOUN
chd-73	266	5	02	02	NUM
chd-73	266	6	.	.	PUNCT
chd-73	267	1	tsukumo	tsukumo	PROPN
chd-73	267	2	,	,	PUNCT
chd-73	267	3	s.	s.	PROPN
chd-73	267	4	,	,	PUNCT
chd-73	267	5	and	and	CCONJ
chd-73	267	6	yasutomo	yasutomo	PROPN
chd-73	267	7	,	,	PUNCT
chd-73	267	8	k.	k.	PROPN
chd-73	267	9	(	(	PUNCT
chd-73	267	10	2004	2004	NUM
chd-73	267	11	)	)	PUNCT
chd-73	267	12	.	.	PUNCT
chd-73	268	1	notch	notch	ADJ
chd-73	268	2	governing	govern	VERB
chd-73	268	3	mature	mature	ADJ
chd-73	268	4	t	t	NOUN
chd-73	268	5	cell	cell	NOUN
chd-73	268	6	differentiation	differentiation	NOUN
chd-73	268	7	.	.	PUNCT
chd-73	269	1	j	j	PROPN
chd-73	269	2	immunol	immunol	NOUN
chd-73	269	3	173	173	NUM
chd-73	269	4	,	,	PUNCT
chd-73	269	5	7109	7109	NUM
chd-73	269	6	-	-	SYM
chd-73	269	7	7113	7113	NUM
chd-73	269	8	.	.	PUNCT
chd-73	270	1	uzhachenko	uzhachenko	PROPN
chd-73	270	2	,	,	PUNCT
chd-73	270	3	r.	r.	PROPN
chd-73	270	4	,	,	PUNCT
chd-73	270	5	and	and	CCONJ
chd-73	270	6	shanker	shanker	NOUN
chd-73	270	7	,	,	PUNCT
chd-73	270	8	a.	a.	NOUN
chd-73	270	9	(	(	PUNCT
chd-73	270	10	2016	2016	NUM
chd-73	270	11	)	)	PUNCT
chd-73	270	12	.	.	PUNCT
chd-73	271	1	notching	notch	VERB
chd-73	271	2	tumor	tumor	NOUN
chd-73	271	3	:	:	PUNCT
chd-73	271	4	signaling	signal	VERB
chd-73	271	5	through	through	ADP
chd-73	271	6	notch	notch	ADJ
chd-73	271	7	receptors	receptor	NOUN
chd-73	271	8	improves	improve	VERB
chd-73	271	9	antitumor	antitumor	PROPN
chd-73	271	10	t	t	PROPN
chd-73	271	11	cell	cell	NOUN
chd-73	271	12	immunity	immunity	NOUN
chd-73	271	13	.	.	PUNCT
chd-73	272	1	oncoimmunology	oncoimmunology	NOUN
chd-73	272	2	5	5	NUM
chd-73	272	3	,	,	PUNCT
chd-73	272	4	e1122864	e1122864	PROPN
chd-73	272	5	.	.	PUNCT
chd-73	273	1	vigouroux	vigouroux	PROPN
chd-73	273	2	,	,	PUNCT
chd-73	273	3	s.	s.	PROPN
chd-73	273	4	,	,	PUNCT
chd-73	273	5	yvon	yvon	PROPN
chd-73	273	6	,	,	PUNCT
chd-73	273	7	e.	e.	PROPN
chd-73	273	8	,	,	PUNCT
chd-73	273	9	wagner	wagner	PROPN
chd-73	273	10	,	,	PUNCT
chd-73	273	11	h.j	h.j	PROPN
chd-73	273	12	.	.	PROPN
chd-73	273	13	,	,	PUNCT
chd-73	273	14	biagi	biagi	PROPN
chd-73	273	15	,	,	PUNCT
chd-73	273	16	e.	e.	PROPN
chd-73	273	17	,	,	PUNCT
chd-73	273	18	dotti	dotti	PROPN
chd-73	273	19	,	,	PUNCT
chd-73	273	20	g.	g.	PROPN
chd-73	273	21	,	,	PUNCT
chd-73	273	22	sili	sili	PROPN
chd-73	273	23	,	,	PUNCT
chd-73	273	24	u.	u.	PROPN
chd-73	273	25	,	,	PUNCT
chd-73	273	26	lira	lira	PROPN
chd-73	273	27	,	,	PUNCT
chd-73	273	28	c.	c.	PROPN
chd-73	273	29	,	,	PUNCT
chd-73	273	30	rooney	rooney	PROPN
chd-73	273	31	,	,	PUNCT
chd-73	273	32	c.m	c.m	PROPN
chd-73	273	33	.	.	PROPN
chd-73	273	34	,	,	PUNCT
chd-73	273	35	and	and	CCONJ
chd-73	273	36	brenner	brenner	NOUN
chd-73	273	37	,	,	PUNCT
chd-73	273	38	m.k	m.k	PROPN
chd-73	273	39	.	.	PUNCT
chd-73	273	40	(	(	PUNCT
chd-73	273	41	2003	2003	NUM
chd-73	273	42	)	)	PUNCT
chd-73	273	43	.	.	PUNCT
chd-73	274	1	induction	induction	NOUN
chd-73	274	2	of	of	ADP
chd-73	274	3	antigen	antigen	NOUN
chd-73	274	4	-	-	PUNCT
chd-73	274	5	specific	specific	ADJ
chd-73	274	6	regulatory	regulatory	ADJ
chd-73	274	7	t	t	NOUN
chd-73	274	8	cells	cell	NOUN
chd-73	274	9	following	follow	VERB
chd-73	274	10	overexpression	overexpression	NOUN
chd-73	274	11	of	of	ADP
chd-73	274	12	a	a	DET
chd-73	274	13	notch	notch	ADJ
chd-73	274	14	ligand	ligand	NOUN
chd-73	274	15	by	by	ADP
chd-73	274	16	human	human	ADJ
chd-73	274	17	b	b	PROPN
chd-73	274	18	lymphocytes	lymphocyte	NOUN
chd-73	274	19	.	.	PUNCT
chd-73	275	1	j	j	PROPN
chd-73	275	2	virol	virol	PROPN
chd-73	275	3	77	77	NUM
chd-73	275	4	,	,	PUNCT
chd-73	275	5	10872	10872	NUM
chd-73	275	6	-	-	SYM
chd-73	275	7	10880	10880	NUM
chd-73	275	8	.	.	PUNCT
chd-73	276	1	xu	xu	INTJ
chd-73	276	2	,	,	PUNCT
chd-73	276	3	y.	y.	PROPN
chd-73	276	4	,	,	PUNCT
chd-73	276	5	ren	ren	PROPN
chd-73	276	6	,	,	PUNCT
chd-73	276	7	h.	h.	PROPN
chd-73	276	8	,	,	PUNCT
chd-73	276	9	jiang	jiang	PROPN
chd-73	276	10	,	,	PUNCT
chd-73	276	11	j.	j.	PROPN
chd-73	276	12	,	,	PUNCT
chd-73	276	13	wang	wang	PROPN
chd-73	276	14	,	,	PUNCT
chd-73	276	15	q.	q.	PROPN
chd-73	276	16	,	,	PUNCT
chd-73	276	17	wudu	wudu	NOUN
chd-73	276	18	,	,	PUNCT
chd-73	276	19	m.	m.	NOUN
chd-73	276	20	,	,	PUNCT
chd-73	276	21	zhang	zhang	PROPN
chd-73	276	22	,	,	PUNCT
chd-73	276	23	q.	q.	PROPN
chd-73	276	24	,	,	PUNCT
chd-73	276	25	su	su	PROPN
chd-73	276	26	,	,	PUNCT
chd-73	276	27	h.	h.	PROPN
chd-73	276	28	,	,	PUNCT
chd-73	276	29	wang	wang	PROPN
chd-73	276	30	,	,	PUNCT
chd-73	276	31	c.	c.	PROPN
chd-73	276	32	,	,	PUNCT
chd-73	276	33	jiang	jiang	PROPN
chd-73	276	34	,	,	PUNCT
chd-73	276	35	l.	l.	PROPN
chd-73	276	36	,	,	PUNCT
chd-73	276	37	and	and	CCONJ
chd-73	276	38	qiu	qiu	PROPN
chd-73	276	39	,	,	PUNCT
chd-73	276	40	x.	x.	NOUN
chd-73	276	41	(	(	PUNCT
chd-73	276	42	2018	2018	NUM
chd-73	276	43	)	)	PUNCT
chd-73	276	44	.	.	PUNCT
chd-73	277	1	kiaa0247	kiaa0247	PROPN
chd-73	277	2	inhibits	inhibit	VERB
chd-73	277	3	growth	growth	NOUN
chd-73	277	4	,	,	PUNCT
chd-73	277	5	migration	migration	NOUN
chd-73	277	6	,	,	PUNCT
chd-73	277	7	invasion	invasion	NOUN
chd-73	277	8	of	of	ADP
chd-73	277	9	non	non	ADJ
chd-73	277	10	-	-	ADJ
chd-73	277	11	small	small	ADJ
chd-73	277	12	-	-	PUNCT
chd-73	277	13	cell	cell	NOUN
chd-73	277	14	lung	lung	NOUN
chd-73	277	15	cancer	cancer	NOUN
chd-73	277	16	through	through	ADP
chd-73	277	17	regulating	regulate	VERB
chd-73	277	18	the	the	DET
chd-73	277	19	notch	notch	ADJ
chd-73	277	20	pathway	pathway	NOUN
chd-73	277	21	.	.	PUNCT
chd-73	278	1	cancer	cancer	PROPN
chd-73	278	2	sci	sci	PROPN
chd-73	278	3	.	.	PROPN
chd-73	278	4	yaron	yaron	PROPN
chd-73	278	5	,	,	PUNCT
chd-73	278	6	a.	a.	PROPN
chd-73	278	7	,	,	PUNCT
chd-73	278	8	and	and	CCONJ
chd-73	278	9	sprinzak	sprinzak	NOUN
chd-73	278	10	,	,	PUNCT
chd-73	278	11	d.	d.	PROPN
chd-73	278	12	(	(	PUNCT
chd-73	278	13	2012	2012	NUM
chd-73	278	14	)	)	PUNCT
chd-73	278	15	.	.	PUNCT
chd-73	279	1	the	the	DET
chd-73	279	2	cis	cis	NOUN
chd-73	279	3	side	side	NOUN
chd-73	279	4	of	of	ADP
chd-73	279	5	juxtacrine	juxtacrine	ADJ
chd-73	279	6	signaling	signaling	NOUN
chd-73	279	7	:	:	PUNCT
chd-73	279	8	a	a	DET
chd-73	279	9	new	new	ADJ
chd-73	279	10	role	role	NOUN
chd-73	279	11	in	in	ADP
chd-73	279	12	the	the	DET
chd-73	279	13	development	development	NOUN
chd-73	279	14	of	of	ADP
chd-73	279	15	the	the	DET
chd-73	279	16	nervous	nervous	ADJ
chd-73	279	17	system	system	NOUN
chd-73	279	18	.	.	PUNCT
chd-73	280	1	trends	trend	NOUN
chd-73	280	2	neurosci	neurosci	VERB
chd-73	280	3	35	35	NUM
chd-73	280	4	,	,	PUNCT
chd-73	280	5	230	230	NUM
chd-73	280	6	-	-	SYM
chd-73	280	7	239	239	NUM
chd-73	280	8	.	.	PUNCT
chd-73	281	1	yuan	yuan	PROPN
chd-73	281	2	,	,	PUNCT
chd-73	281	3	j.s	j.s	PROPN
chd-73	281	4	.	.	PROPN
chd-73	281	5	,	,	PUNCT
chd-73	281	6	kousis	kousis	PROPN
chd-73	281	7	,	,	PUNCT
chd-73	281	8	p.c	p.c	PROPN
chd-73	281	9	.	.	PROPN
chd-73	281	10	,	,	PUNCT
chd-73	281	11	suliman	suliman	PROPN
chd-73	281	12	,	,	PUNCT
chd-73	281	13	s.	s.	PROPN
chd-73	281	14	,	,	PUNCT
chd-73	281	15	visan	visan	PROPN
chd-73	281	16	,	,	PUNCT
chd-73	281	17	i.	i.	NOUN
chd-73	281	18	,	,	PUNCT
chd-73	281	19	and	and	CCONJ
chd-73	281	20	guidos	guido	NOUN
chd-73	281	21	,	,	PUNCT
chd-73	281	22	c.j	c.j	PROPN
chd-73	281	23	.	.	PROPN
chd-73	281	24	(	(	PUNCT
chd-73	281	25	2010	2010	NUM
chd-73	281	26	)	)	PUNCT
chd-73	281	27	.	.	PUNCT
chd-73	282	1	functions	function	NOUN
chd-73	282	2	of	of	ADP
chd-73	282	3	notch	notch	NOUN
chd-73	282	4	signaling	signal	VERB
chd-73	282	5	in	in	ADP
chd-73	282	6	the	the	DET
chd-73	282	7	immune	immune	ADJ
chd-73	282	8	system	system	NOUN
chd-73	282	9	:	:	PUNCT
chd-73	282	10	consensus	consensus	NOUN
chd-73	282	11	and	and	CCONJ
chd-73	282	12	controversies	controversy	NOUN
chd-73	282	13	.	.	PUNCT
chd-73	283	1	annu	annu	PROPN
chd-73	283	2	rev	rev	VERB
chd-73	283	3	immunol	immunol	PROPN
chd-73	283	4	28	28	NUM
chd-73	283	5	,	,	PUNCT
chd-73	283	6	343	343	NUM
chd-73	283	7	-	-	SYM
chd-73	283	8	365	365	NUM
chd-73	283	9	.	.	PUNCT
chd-73	284	1	yuan	yuan	NOUN
chd-73	284	2	,	,	PUNCT
chd-73	284	3	x.	x.	PROPN
chd-73	284	4	,	,	PUNCT
chd-73	284	5	wu	wu	PROPN
chd-73	284	6	,	,	PUNCT
chd-73	284	7	h.	h.	PROPN
chd-73	284	8	,	,	PUNCT
chd-73	284	9	han	han	PROPN
chd-73	284	10	,	,	PUNCT
chd-73	284	11	n.	n.	PROPN
chd-73	284	12	,	,	PUNCT
chd-73	284	13	xu	xu	PROPN
chd-73	284	14	,	,	PUNCT
chd-73	284	15	h.	h.	PROPN
chd-73	284	16	,	,	PUNCT
chd-73	284	17	chu	chu	PROPN
chd-73	284	18	,	,	PUNCT
chd-73	284	19	q.	q.	PROPN
chd-73	284	20	,	,	PUNCT
chd-73	284	21	yu	yu	PROPN
chd-73	284	22	,	,	PUNCT
chd-73	284	23	s.	s.	PROPN
chd-73	284	24	,	,	PUNCT
chd-73	284	25	chen	chen	PROPN
chd-73	284	26	,	,	PUNCT
chd-73	284	27	y.	y.	PROPN
chd-73	284	28	,	,	PUNCT
chd-73	284	29	and	and	CCONJ
chd-73	284	30	wu	wu	PROPN
chd-73	284	31	,	,	PUNCT
chd-73	284	32	k.	k.	PROPN
chd-73	284	33	(	(	PUNCT
chd-73	284	34	2014	2014	NUM
chd-73	284	35	)	)	PUNCT
chd-73	284	36	.	.	PUNCT
chd-73	285	1	notch	notch	ADJ
chd-73	285	2	signaling	signal	VERB
chd-73	285	3	and	and	CCONJ
chd-73	285	4	emt	emt	PROPN
chd-73	285	5	in	in	ADP
chd-73	285	6	non	non	ADJ
chd-73	285	7	-	-	ADJ
chd-73	285	8	small	small	ADJ
chd-73	285	9	cell	cell	NOUN
chd-73	285	10	lung	lung	NOUN
chd-73	285	11	cancer	cancer	NOUN
chd-73	285	12	:	:	PUNCT
chd-73	285	13	biological	biological	ADJ
chd-73	285	14	significance	significance	NOUN
chd-73	285	15	and	and	CCONJ
chd-73	285	16	therapeutic	therapeutic	ADJ
chd-73	285	17	application	application	NOUN
chd-73	285	18	.	.	PUNCT
chd-73	286	1	j	j	PROPN
chd-73	286	2	hematol	hematol	PROPN
chd-73	286	3	oncol	oncol	ADJ
chd-73	286	4	7	7	NUM
chd-73	286	5	,	,	PUNCT
chd-73	286	6	87	87	NUM
chd-73	286	7	.	.	PUNCT
chd-73	287	1	yvon	yvon	PROPN
chd-73	287	2	,	,	PUNCT
chd-73	287	3	e.s	e.s	PROPN
chd-73	287	4	.	.	PROPN
chd-73	287	5	,	,	PUNCT
chd-73	287	6	vigouroux	vigouroux	PROPN
chd-73	287	7	,	,	PUNCT
chd-73	287	8	s.	s.	PROPN
chd-73	287	9	,	,	PUNCT
chd-73	287	10	rousseau	rousseau	PROPN
chd-73	287	11	,	,	PUNCT
chd-73	287	12	r.f	r.f	PROPN
chd-73	287	13	.	.	PROPN
chd-73	287	14	,	,	PUNCT
chd-73	287	15	biagi	biagi	PROPN
chd-73	287	16	,	,	PUNCT
chd-73	287	17	e.	e.	PROPN
chd-73	287	18	,	,	PUNCT
chd-73	287	19	amrolia	amrolia	PROPN
chd-73	287	20	,	,	PUNCT
chd-73	287	21	p.	p.	NOUN
chd-73	287	22	,	,	PUNCT
chd-73	287	23	dotti	dotti	PROPN
chd-73	287	24	,	,	PUNCT
chd-73	287	25	g.	g.	PROPN
chd-73	287	26	,	,	PUNCT
chd-73	287	27	wagner	wagner	PROPN
chd-73	287	28	,	,	PUNCT
chd-73	287	29	h.j	h.j	PROPN
chd-73	287	30	.	.	PROPN
chd-73	287	31	,	,	PUNCT
chd-73	287	32	and	and	CCONJ
chd-73	287	33	brenner	brenner	NOUN
chd-73	287	34	,	,	PUNCT
chd-73	287	35	m.k	m.k	PROPN
chd-73	287	36	.	.	PUNCT
chd-73	287	37	(	(	PUNCT
chd-73	287	38	2003	2003	NUM
chd-73	287	39	)	)	PUNCT
chd-73	287	40	.	.	PUNCT
chd-73	288	1	overexpression	overexpression	NOUN
chd-73	288	2	of	of	ADP
chd-73	288	3	the	the	DET
chd-73	288	4	notch	notch	ADJ
chd-73	288	5	ligand	ligand	NOUN
chd-73	288	6	,	,	PUNCT
chd-73	288	7	jagged-1	jagged-1	PROPN
chd-73	288	8	,	,	PUNCT
chd-73	288	9	induces	induce	VERB
chd-73	288	10	alloantigen	alloantigen	NOUN
chd-73	288	11	-	-	PUNCT
chd-73	288	12	specific	specific	ADJ
chd-73	288	13	human	human	ADJ
chd-73	288	14	regulatory	regulatory	ADJ
chd-73	288	15	t	t	NOUN
chd-73	288	16	cells	cell	NOUN
chd-73	288	17	.	.	PUNCT
chd-73	289	1	blood	blood	NOUN
chd-73	289	2	102	102	NUM
chd-73	289	3	,	,	PUNCT
chd-73	289	4	3815	3815	NUM
chd-73	289	5	-	-	SYM
chd-73	289	6	3821	3821	NUM
chd-73	289	7	.	.	PUNCT